1	Association	NNP	O	Association	_	0	SENT_1	[p1l89t271r435b319],
2	of	IN	O	of	_	0	SENT_1	[p1l459t271r515b319],
3	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_1	[p1l537t271r977b330],
4	in	IN	O	in	_	0	SENT_1	[p1l1003t271r1050b318],
5	the	DT	O	the	det	8	SENT_1	[p1l1073t272r1168b319],
6	cytochrome	NN	O	cytochrome	nn	8	SENT_1	[p1l1192t272r1540b330],
7	P450	NN	O	p450	nn	8	SENT_1	[p1l1566t271r1721b319],
8	CYP2C9	NN	O	cyp2c9	prep_in	3	SENT_1	[p1l1745t271r1990b319],
9	with	IN	O	with	dep	1	SENT_1	[p1l89t350r214b398],
10	warfarin	NN	O	warfarin	nn	12	SENT_1	[p1l237t350r477b398],
11	dose	NN	O	dose	nn	12	SENT_1	[p1l502t351r640b398],
12	requirement	NN	O	requirement	pobj	9	SENT_1	[p1l665t350r1022b409],
13	and	CC	O	and	_	0	SENT_1	[p1l1045t351r1148b398],
14	risk	NN	O	risk	conj_and	12	SENT_1	[p1l1175t350r1282b398],
15	of	IN	O	of	_	0	SENT_1	[p1l1304t350r1360b398],
16	bleeding	VBG	O	bleed	prepc_of	14	SENT_1	[p1l1382t350r1631b409],
17	complications	NNS	O	complication	nsubj	20	SENT_1	[p1l1652t350r2066b409],
18	Guruprasad	NNP	O	Guruprasad	nn	20	SENT_1	[p1l93t467r282b500],
19	P	NN	O	p	nn	20	SENT_1	[p1l293t467r314b494],
20	Aithal	NNP	O	Aithal	xcomp	16	SENT_1	[p1l326t467r432b499],
21	,	,	O	,	_	0	SENT_1	[p1l326t467r432b499],
22	Christopher	NNP	PERSON	Christopher	nn	24	SENT_1	[p1l450t467r644b500],
23	P	NN	PERSON	p	nn	24	SENT_1	[p1l654t467r675b494],
24	Day	NN	PERSON	day	appos	20	SENT_1	[p1l689t467r758b501],
25	,	,	O	,	_	0	SENT_1	[p1l689t467r758b501],
26	Patrick	NNP	PERSON	Patrick	nn	29	SENT_1	[p1l774t467r893b494],
27	J	NNP	PERSON	J	nn	29	SENT_1	[p1l905t467r922b494],
28	L	NNP	PERSON	L	nn	29	SENT_1	[p1l934t467r950b494],
29	Kesteven	NNP	PERSON	Kesteven	appos	20	SENT_1	[p1l964t467r1126b499],
30	,	,	O	,	_	0	SENT_1	[p1l964t467r1126b499],
31	Ann	NNP	PERSON	Ann	nn	33	SENT_1	[p1l1140t467r1204b494],
32	K	NNP	PERSON	K	nn	33	SENT_1	[p1l1218t467r1241b494],
33	Da/y	NNP	PERSON	Da/y	appos	20	SENT_1	[p1l1253t467r1324b501],

1	Summary	NN	O	summary	_	0	SENT_2	[p1l7t587r428b671],

1	Background	NN	O	background	nsubj	7	SENT_3	[p1l11t763r433b832],
2	The	DT	O	the	det	5	SENT_3	[p1l470t763r596b819],
3	cytochrome	NN	O	cytochrome	nn	5	SENT_3	[p1l634t763r1050b832],
4	P450	NN	O	p450	nn	5	SENT_3	[p1l1090t762r1276b819],
5	CYP2C9	NN	O	cyp2c9	dep	1	SENT_3	[p1l1315t762r1608b819],
6	is	VBZ	O	be	cop	7	SENT_3	[p1l1650t763r1703b819],
7	responsible	JJ	O	responsible	_	0	SENT_3	[p1l1743t763r2143b831],
8	for	IN	O	for	_	0	SENT_3	[p1l7t866r100b923],
9	the	DT	O	the	det	10	SENT_3	[p1l168t866r282b923],
10	metabolism	NN	O	metabolism	prep_for	7	SENT_3	[p1l358t866r764b923],
11	of	IN	O	of	_	0	SENT_3	[p1l840t866r906b923],
12	S	NN	O	s	nn	14	SENT_3	[p1l974t866r1344b923],
13	—	CD	NUMBER	—	num	14	SENT_3	[p1l974t866r1344b923],
14	warfarin	NN	O	warfarin	prep_of	10	SENT_3	[p1l974t866r1344b923],
15	.	.	O	.	_	0	SENT_3	[p1l974t866r1344b923],

1	Two	CD	NUMBER	two	nsubj	2	SENT_4	[p1l1419t866r1561b923],
2	known	JJ	O	known	_	0	SENT_4	[p1l1637t866r1860b923],
3	allelic	JJ	O	allelic	amod	6	SENT_4	[p1l1937t866r2138b923],
4	variants	NNS	O	variant	nn	6	SENT_4	[p1l6t970r291b1027],
5	CYP2C9	NN	O	cyp2c9	nn	6	SENT_4	[p1l350t969r742b1027],
6	*	NN	O	*	dobj	2	SENT_4	[p1l350t969r742b1027],
7	2	CD	NUMBER	2	number	11	SENT_4	[p1l350t969r742b1027],
8	and	CC	O	and	_	0	SENT_4	[p1l786t970r907b1027],
9	CYP2C9	CD	NUMBER	cyp2c9	conj_and	11	SENT_4	[p1l969t969r1360b1027],
10	*	CD	NUMBER	*	number	11	SENT_4	[p1l969t969r1360b1027],
11	3	CD	NUMBER	3	nsubj	12	SENT_4	[p1l969t969r1360b1027],
12	differ	VBP	O	differ	rcmod	6	SENT_4	[p1l1407t969r1585b1027],
13	from	IN	O	from	_	0	SENT_4	[p1l1633t969r1788b1027],
14	the	DT	O	the	det	18	SENT_4	[p1l1840t970r1954b1027],
15	wild	JJ	O	wild	amod	18	SENT_4	[p1l2003t970r2143b1027],
16	type	NN	O	type	nn	18	SENT_4	[p1l6t1077r158b1143],
17	CYP2C9	CD	NUMBER	cyp2c9	num	18	SENT_4	[p1l199t1073r585b1130],
18	*	NN	O	*	prep_from	12	SENT_4	[p1l199t1073r585b1130],
19	1	CD	NUMBER	1	dobj	12	SENT_4	[p1l199t1073r585b1130],
20	by	IN	O	by	_	0	SENT_4	[p1l617t1074r690b1143],
21	a	DT	O	a	det	24	SENT_4	[p1l726t1087r761b1130],
22	single	JJ	O	single	amod	24	SENT_4	[p1l795t1074r1002b1144],
23	aminoacid	JJ	O	aminoacid	amod	24	SENT_4	[p1l1036t1074r1394b1130],
24	substitution	NN	O	substitution	prep_by	2	SENT_4	[p1l1429t1074r1850b1130],
25	in	IN	O	in	_	0	SENT_4	[p1l1888t1074r1941b1129],
26	each	DT	O	each	det	27	SENT_4	[p1l1976t1074r2142b1130],
27	case	NN	O	case	prep_in	24	SENT_4	[p1l9t1190r194b1234],
28	.	.	O	.	_	0	SENT_4	[p1l9t1190r194b1234],

1	The	DT	O	the	det	3	SENT_5	[p1l251t1177r377b1234],
2	allelic	JJ	O	allelic	amod	3	SENT_5	[p1l435t1177r636b1234],
3	variants	NNS	O	variant	nsubjpass	5	SENT_5	[p1l694t1177r978b1234],
4	are	VBP	O	be	auxpass	5	SENT_5	[p1l1034t1190r1141b1234],
5	associated	VBN	O	associate	_	0	SENT_5	[p1l1198t1177r1580b1234],
6	with	IN	O	with	_	0	SENT_5	[p1l1635t1177r1784b1234],
7	impaired	JJ	O	impaired	amod	8	SENT_5	[p1l1845t1177r2142b1246],
8	hydroxylation	NN	O	hydroxylation	prep_with	5	SENT_5	[p1l11t1280r480b1350],
9	of	IN	O	of	_	0	SENT_5	[p1l525t1279r592b1336],
10	S	NN	O	s	nn	12	SENT_5	[p1l629t1279r977b1336],
11	—	CD	NUMBER	—	num	12	SENT_5	[p1l629t1279r977b1336],
12	warfarin	NN	O	warfarin	prep_of	8	SENT_5	[p1l629t1279r977b1336],
13	in	IN	O	in	prep	5	SENT_5	[p1l1024t1280r1077b1336],
14	in	IN	O	in	pcomp	13	SENT_5	[p1l1125t1280r1360b1336],
15	—	FW	O	—	nn	16	SENT_5	[p1l1125t1280r1360b1336],
16	vitro	FW	O	vitro	amod	18	SENT_5	[p1l1125t1280r1360b1336],
17	expression	NN	O	expression	nn	18	SENT_5	[p1l1401t1280r1782b1349],
18	systems	NNS	O	system	pobj	14	SENT_5	[p1l1827t1283r2139b1350],
19	.	.	O	.	_	0	SENT_5	[p1l1827t1283r2139b1350],

1	We	PRP	O	we	nsubj	3	SENT_6	[p1l8t1383r120b1439],
2	have	VBP	O	have	aux	3	SENT_6	[p1l168t1383r328b1439],
3	studied	VBN	O	study	_	0	SENT_6	[p1l374t1383r630b1439],
4	the	DT	O	the	det	5	SENT_6	[p1l675t1383r788b1439],
5	effect	NN	O	effect	dobj	3	SENT_6	[p1l834t1382r1035b1439],
6	of	IN	O	of	_	0	SENT_6	[p1l1082t1382r1149b1439],
7	CYP2C9	NN	O	cyp2c9	nn	8	SENT_6	[p1l1193t1382r1489b1439],
8	polymorphism	NN	O	polymorphism	prep_of	5	SENT_6	[p1l1531t1383r2015b1452],
9	on	IN	O	on	_	0	SENT_6	[p1l2063t1396r2142b1439],
10	the	DT	O	the	prep_on	3	SENT_6	[p1l8t1486r121b1543],
11	in	IN	O	in	_	0	SENT_6	[p1l155t1486r370b1543],
12	—	FW	O	—	nn	15	SENT_6	[p1l155t1486r370b1543],
13	vivo	FW	O	vivo	nn	15	SENT_6	[p1l155t1486r370b1543],
14	warfarin	NN	O	warfarin	nn	15	SENT_6	[p1l397t1486r681b1543],
15	dose	NN	O	dose	prep_in	10	SENT_6	[p1l713t1486r876b1543],
16	requirement	NN	O	requirement	dep	15	SENT_6	[p1l909t1486r1353b1555],
17	.	.	O	.	_	0	SENT_6	[p1l909t1486r1353b1555],

1	Methods	NNS	O	method	nn	2	SENT_7	[p1l12t1642r319b1698],
2	Patients	NNS	O	patient	nsubjpass	62	SENT_7	[p1l352t1642r647b1698],
3	with	IN	O	with	_	0	SENT_7	[p1l673t1642r821b1698],
4	a	DT	O	a	det	8	SENT_7	[p1l855t1655r890b1698],
5	daily	JJ	SET	daily	amod	8	SENT_7	[p1l920t1642r1080b1712],
6	warfarin	NN	O	warfarin	nn	8	SENT_7	[p1l1109t1641r1392b1698],
7	dose	NN	O	dose	nn	8	SENT_7	[p1l1424t1642r1588b1698],
8	requirement	NN	O	requirement	prep_with	2	SENT_7	[p1l1621t1642r2041b1711],
9	of	IN	O	of	_	0	SENT_7	[p1l2074t1641r2141b1698],
10	1-5	CD	NUMBER	1-5	num	11	SENT_7	[p1l13t1745r124b1801],
11	mg	NN	O	mg	prep_of	8	SENT_7	[p1l164t1753r265b1815],
12	or	CC	O	or	cc	13	SENT_7	[p1l304t1758r371b1801],
13	less	JJR	O	less	dep	11	SENT_7	[p1l410t1745r546b1801],
14	(	CD	NUMBER	(	num	16	SENT_7	[p1l583t1745r919b1814],
15	low-dose	JJ	O	low-dose	amod	16	SENT_7	[p1l583t1745r919b1814],
16	group	NN	O	group	dep	13	SENT_7	[p1l955t1753r1173b1815],
17	,	,	O	,	_	0	SENT_7	[p1l955t1753r1173b1815],
18	n	NN	O	n	appos	11	SENT_7	[p1l1217t1744r1442b1814],
19	=	JJ	O	=	amod	21	SENT_7	[p1l1217t1744r1442b1814],
20	36	CD	NUMBER	36	tmod	19	SENT_7	[p1l1217t1744r1442b1814],
21	)	NN	O	)	dep	18	SENT_7	[p1l1217t1744r1442b1814],
22	,	,	O	,	_	0	SENT_7	[p1l1217t1744r1442b1814],
23	randomly	RB	O	randomly	advmod	11	SENT_7	[p1l1486t1745r1801b1814],
24	selected	VBN	O	select	amod	25	SENT_7	[p1l1840t1745r2141b1801],
25	patients	NNS	O	patient	dep	11	SENT_7	[p1l12t1848r299b1917],
26	with	IN	O	with	_	0	SENT_7	[p1l337t1848r486b1904],
27	a	DT	O	a	det	29	SENT_7	[p1l531t1861r567b1904],
28	wide	JJ	O	wide	amod	29	SENT_7	[p1l606t1848r770b1904],
29	range	NN	O	range	prep_with	25	SENT_7	[p1l814t1856r1008b1919],
30	of	IN	O	of	_	0	SENT_7	[p1l1049t1847r1116b1904],
31	dose	NN	O	dose	nn	32	SENT_7	[p1l1152t1848r1317b1904],
32	requirements	NNS	O	requirement	prep_of	25	SENT_7	[p1l1361t1848r1825b1917],
33	from	IN	O	from	_	0	SENT_7	[p1l1863t1847r2018b1904],
34	an	DT	O	a	det	36	SENT_7	[p1l2063t1861r2141b1904],
35	anticoagulant	JJ	O	anticoagulant	amod	36	SENT_7	[p1l12t1951r496b2021],
36	clinic	NN	O	clinic	prep_from	25	SENT_7	[p1l548t1951r731b2007],
37	in	IN	O	in	_	0	SENT_7	[p1l788t1951r841b2006],
38	north-east	NN	O	north-east	nn	39	SENT_7	[p1l896t1951r1250b2007],
39	England	NNP	LOCATION	England	prep_in	36	SENT_7	[p1l1305t1951r1579b2021],
40	(	CD	NUMBER	(	num	39	SENT_7	[p1l1632t1951r1844b2020],
41	clinic	NN	O	clinic	nn	43	SENT_7	[p1l1632t1951r1844b2020],
42	control	NN	O	control	nn	43	SENT_7	[p1l1898t1951r2140b2007],
43	group	NN	O	group	dep	36	SENT_7	[p1l8t2062r227b2125],
44	,	,	O	,	_	0	SENT_7	[p1l8t2062r227b2125],
45	n	NN	O	n	prep_from	25	SENT_7	[p1l319t2054r548b2124],
46	=	JJ	O	=	amod	48	SENT_7	[p1l319t2054r548b2124],
47	52	CD	NUMBER	52	tmod	46	SENT_7	[p1l319t2054r548b2124],
48	)	NN	O	)	dep	45	SENT_7	[p1l319t2054r548b2124],
49	,	,	O	,	_	0	SENT_7	[p1l319t2054r548b2124],
50	and	CC	O	and	_	0	SENT_7	[p1l640t2054r761b2111],
51	100	CD	NUMBER	100	num	53	SENT_7	[p1l853t2054r988b2111],
52	healthy	JJ	O	healthy	amod	53	SENT_7	[p1l1078t2054r1331b2124],
53	controls	NNS	O	control	prep_from	25	SENT_7	[p1l1419t2054r1707b2111],
54	from	IN	O	from	_	0	SENT_7	[p1l1790t2054r1945b2111],
55	the	DT	O	the	det	56	SENT_7	[p1l2032t2054r2145b2111],
56	community	NN	O	community	prep_from	53	SENT_7	[p1l9t2157r397b2227],
57	in	IN	O	in	_	0	SENT_7	[p1l447t2157r500b2212],
58	the	DT	O	the	det	60	SENT_7	[p1l546t2157r659b2213],
59	same	JJ	O	same	amod	60	SENT_7	[p1l706t2170r892b2213],
60	region	NN	O	region	prep_in	56	SENT_7	[p1l942t2157r1154b2228],
61	were	VBD	O	be	auxpass	62	SENT_7	[p1l1200t2170r1369b2213],
62	studied	VBN	O	study	_	0	SENT_7	[p1l1416t2157r1695b2213],
63	.	.	O	.	_	0	SENT_7	[p1l1416t2157r1695b2213],

1	Genotyping	VBG	O	genotype	dep	13	SENT_8	[p1l1745t2157r2142b2228],
2	for	IN	O	for	_	0	SENT_8	[p1l9t2259r101b2316],
3	the	DT	O	the	det	5	SENT_8	[p1l127t2260r241b2316],
4	CYP2C9	NN	O	cyp2c9	nn	5	SENT_8	[p1l276t2259r668b2316],
5	*	NN	O	*	prep_for	1	SENT_8	[p1l276t2259r668b2316],
6	2	CD	NUMBER	2	number	10	SENT_8	[p1l276t2259r668b2316],
7	and	CC	O	and	_	0	SENT_8	[p1l692t2260r813b2316],
8	CYP2C9	CD	NUMBER	cyp2c9	num	11	SENT_8	[p1l852t2259r1243b2316],
9	*	CD	NUMBER	*	number	10	SENT_8	[p1l852t2259r1243b2316],
10	3	CD	NUMBER	3	num	11	SENT_8	[p1l852t2259r1243b2316],
11	alleles	NNS	O	allele	nsubjpass	13	SENT_8	[p1l1269t2260r1495b2316],
12	was	VBD	O	be	auxpass	13	SENT_8	[p1l1521t2273r1662b2316],
13	done	VBN	O	do	_	0	SENT_8	[p1l1691t2260r1858b2316],
14	by	IN	O	by	_	0	SENT_8	[p1l1890t2260r1963b2330],
15	PCR	NN	O	pcr	nn	16	SENT_8	[p1l1995t2259r2139b2316],
16	analysis	NN	O	analysis	agent	13	SENT_8	[p1l10t2363r314b2433],
17	.	.	O	.	_	0	SENT_8	[p1l10t2363r314b2433],

1	Case	NNP	O	Case	nn	2	SENT_9	[p1l399t2363r572b2420],
2	notes	NNS	O	note	nsubjpass	4	SENT_9	[p1l654t2366r848b2420],
3	were	VBD	O	be	auxpass	4	SENT_9	[p1l923t2376r1093b2420],
4	reviewed	VBN	O	review	_	0	SENT_9	[p1l1175t2363r1484b2420],
5	to	TO	O	to	aux	6	SENT_9	[p1l1562t2366r1633b2420],
6	assess	VB	O	assess	xcomp	4	SENT_9	[p1l1714t2376r1955b2420],
7	the	DT	O	the	det	8	SENT_9	[p1l2030t2363r2144b2420],
8	difficulties	NNS	O	difficulty	dobj	6	SENT_9	[p1l10t2465r381b2522],
9	encountered	VBN	O	encounter	partmod	8	SENT_9	[p1l434t2466r873b2522],
10	during	IN	O	during	_	0	SENT_9	[p1l929t2466r1145b2537],
11	the	DT	O	the	det	12	SENT_9	[p1l1198t2466r1311b2522],
12	induction	NN	O	induction	prep_during	9	SENT_9	[p1l1369t2466r1690b2522],
13	of	IN	O	of	_	0	SENT_9	[p1l1746t2465r1813b2522],
14	warfarin	NN	O	warfarin	nn	15	SENT_9	[p1l1859t2465r2142b2522],
15	therapy	NN	O	therapy	prep_of	12	SENT_9	[p1l7t2569r272b2639],
16	and	CC	O	and	_	0	SENT_9	[p1l325t2569r446b2625],
17	bleeding	NN	O	bleeding	nn	18	SENT_9	[p1l500t2569r794b2639],
18	complications	NNS	O	complication	prep_of	12	SENT_9	[p1l845t2569r1343b2638],
19	in	IN	O	in	_	0	SENT_9	[p1l1395t2569r1448b2624],
20	the	DT	O	the	det	21	SENT_9	[p1l1498t2569r1612b2625],
21	low-dose	JJ	O	low-dose	prep_in	9	SENT_9	[p1l1665t2569r1969b2625],
22	and	CC	O	and	_	0	SENT_9	[p1l2021t2569r2142b2625],
23	clinic	NN	O	clinic	nn	25	SENT_9	[p1l9t2672r192b2729],
24	control	NN	O	control	nn	25	SENT_9	[p1l225t2672r467b2729],
25	groups	NNS	O	group	prep_in	9	SENT_9	[p1l499t2680r758b2743],
26	.	.	O	.	_	0	SENT_9	[p1l499t2680r758b2743],

1	Findings	NNS	O	finding	nsubj	30	SENT_10	[p1l12t2826r305b2897],
2	The	DT	O	the	det	4	SENT_10	[p1l340t2827r466b2883],
3	odds	NNS	O	odds	nn	4	SENT_10	[p1l505t2827r670b2883],
4	ratio	NN	O	ratio	npadvmod	1	SENT_10	[p1l710t2827r866b2883],
5	for	IN	O	for	_	0	SENT_10	[p1l903t2826r996b2883],
6	individuals	NNS	O	individual	prep_for	1	SENT_10	[p1l1035t2827r1406b2883],
7	with	IN	O	with	_	0	SENT_10	[p1l1440t2827r1589b2883],
8	a	DT	O	a	det	12	SENT_10	[p1l1631t2840r1667b2883],
9	low	JJ	O	low	amod	12	SENT_10	[p1l1709t2827r1819b2883],
10	warfarin	NN	O	warfarin	nn	12	SENT_10	[p1l1858t2826r2142b2883],
11	dose	NN	O	dose	nn	12	SENT_10	[p1l9t2930r174b2986],
12	requirement	NN	O	requirement	prep_with	6	SENT_10	[p1l236t2930r657b2998],
13	having	VBG	O	have	partmod	12	SENT_10	[p1l721t2930r946b3000],
14	one	CD	NUMBER	one	num	17	SENT_10	[p1l1007t2943r1131b2986],
15	or	CC	O	or	_	0	SENT_10	[p1l1191t2943r1258b2986],
16	more	JJR	O	more	conj_or	14	SENT_10	[p1l1317t2943r1489b2986],
17	CYP2C9	NN	O	cyp2c9	npadvmod	18	SENT_10	[p1l1555t2929r1850b2986],
18	variant	JJ	O	variant	amod	19	SENT_10	[p1l1901t2930r2143b2986],
19	alleles	NNS	O	allele	dobj	13	SENT_10	[p1l11t3033r237b3090],
20	compared	VBN	O	compare	_	0	SENT_10	[p1l293t3033r638b3102],
21	with	IN	O	with	prepc_compared_with	19	SENT_10	[p1l694t3033r843b3090],
22	the	DT	O	the	det	24	SENT_10	[p1l899t3033r1013b3090],
23	normal	JJ	O	normal	amod	24	SENT_10	[p1l1073t3033r1303b3090],
24	population	NN	O	population	pobj	19	SENT_10	[p1l1368t3033r1733b3102],
25	was	VBD	O	be	cop	30	SENT_10	[p1l1789t3046r1930b3090],
26	6-21	CD	PERCENT	6-21	num	30	SENT_10	[p1l1986t3033r2144b3090],
27	(	CD	PERCENT	(	number	28	SENT_10	[p1l10t3135r187b3205],
28	95	CD	PERCENT	95	dep	29	SENT_10	[p1l10t3135r187b3205],
29	%	NN	PERCENT	%	dep	30	SENT_10	[p1l10t3135r187b3205],
30	Cl	NN	O	cl	_	0	SENT_10	[p1l228t3135r292b3192],
31	248-156	CD	NUMBER	248-156	num	32	SENT_10	[p1l342t3135r754b3205],
32	)	NN	O	)	dep	30	SENT_10	[p1l342t3135r754b3205],
33	.	.	O	.	_	0	SENT_10	[p1l342t3135r754b3205],

1	Patients	NNS	O	patient	nsubj	8	SENT_11	[p1l801t3136r1096b3192],
2	in	IN	O	in	_	0	SENT_11	[p1l1140t3136r1193b3191],
3	the	DT	O	the	det	5	SENT_11	[p1l1234t3136r1348b3192],
4	low-dose	JJ	O	low-dose	amod	5	SENT_11	[p1l1393t3136r1697b3192],
5	group	NN	O	group	prep_in	1	SENT_11	[p1l1737t3144r1936b3207],
6	were	VBD	O	be	cop	8	SENT_11	[p1l1974t3149r2144b3192],
7	more	RBR	O	more	advmod	8	SENT_11	[p1l13t3252r184b3295],
8	likely	JJ	O	likely	_	0	SENT_11	[p1l227t3239r406b3308],
9	to	TO	O	to	aux	10	SENT_11	[p1l444t3242r514b3295],
10	have	VB	O	have	xcomp	8	SENT_11	[p1l556t3239r716b3295],
11	difficulties	NNS	O	difficulty	dobj	10	SENT_11	[p1l756t3238r1126b3295],
12	at	IN	O	at	_	0	SENT_11	[p1l1166t3242r1230b3295],
13	the	DT	O	the	det	14	SENT_11	[p1l1269t3239r1383b3295],
14	time	NN	O	time	prep_at	11	SENT_11	[p1l1419t3239r1577b3295],
15	of	IN	O	of	_	0	SENT_11	[p1l1616t3238r1683b3295],
16	induction	NN	O	induction	prep_of	14	SENT_11	[p1l1720t3239r2041b3295],
17	of	IN	O	of	_	0	SENT_11	[p1l2083t3238r2150b3295],
18	warfarin	NN	O	warfarin	nn	19	SENT_11	[p1l7t3342r290b3399],
19	therapy	NN	O	therapy	prep_of	16	SENT_11	[p1l335t3342r600b3412],
20	(	CD	NUMBER	(	num	22	SENT_11	[p1l647t3342r834b3412],
21	5-97	CD	NUMBER	5-97	num	22	SENT_11	[p1l647t3342r834b3412],
22	[	NN	O	[	dep	19	SENT_11	[p1l883t3342r1373b3412],
23	2-26-15-82	CD	DATE	2-26-15-82	num	25	SENT_11	[p1l883t3342r1373b3412],
24	]	CD	NUMBER	]	num	25	SENT_11	[p1l883t3342r1373b3412],
25	)	NN	O	)	dep	22	SENT_11	[p1l883t3342r1373b3412],
26	and	CC	O	and	_	0	SENT_11	[p1l1427t3342r1548b3399],
27	have	VBP	O	have	aux	28	SENT_11	[p1l1597t3342r1757b3399],
28	increased	VBN	O	increase	conj_and	8	SENT_11	[p1l1805t3342r2143b3399],
29	risk	NN	O	risk	iobj	28	SENT_11	[p1l11t3445r134b3501],
30	of	IN	O	of	_	0	SENT_11	[p1l204t3444r271b3501],
31	major	JJ	O	major	amod	33	SENT_11	[p1l335t3445r529b3515],
32	bleeding	NN	O	bleeding	nn	33	SENT_11	[p1l596t3445r890b3516],
33	complications	NNS	O	complication	prep_of	29	SENT_11	[p1l959t3445r1456b3514],
34	(	CD	NUMBER	(	num	36	SENT_11	[p1l1523t3445r1691b3514],
35	rate	NN	O	rate	nn	36	SENT_11	[p1l1523t3445r1691b3514],
36	ratio	NN	O	ratio	dobj	28	SENT_11	[p1l1761t3445r1918b3501],
37	3-68	CD	NUMBER	3-68	num	38	SENT_11	[p1l1985t3444r2144b3501],
38	[	CD	NUMBER	[	dep	36	SENT_11	[p1l13t3547r455b3617],
39	1-43-9-50	CD	NUMBER	1-43-9-50	num	41	SENT_11	[p1l13t3547r455b3617],
40	]	CD	NUMBER	]	num	41	SENT_11	[p1l13t3547r455b3617],
41	)	NN	O	)	dobj	8	SENT_11	[p1l13t3547r455b3617],
42	when	WRB	O	when	dep	41	SENT_11	[p1l492t3548r676b3604],
43	compared	VBN	O	compare	_	0	SENT_11	[p1l711t3548r1056b3616],
44	with	IN	O	with	prepc_compared_with	8	SENT_11	[p1l1088t3548r1236b3604],
45	randomly	RB	O	randomly	advmod	48	SENT_11	[p1l1273t3548r1589b3617],
46	selected	VBN	O	select	amod	48	SENT_11	[p1l1623t3548r1923b3604],
47	clinic	NN	O	clinic	nn	48	SENT_11	[p1l1957t3548r2140b3604],
48	controls	NNS	O	control	pobj	8	SENT_11	[p1l9t3651r316b3708],
49	.	.	O	.	_	0	SENT_11	[p1l9t3651r316b3708],

1	Interpretation	NN	O	interpretation	nsubj	4	SENT_12	[p2l12t56r497b126],
2	We	PRP	O	we	nsubj	4	SENT_12	[p2l560t57r672b113],
3	have	VBP	O	have	aux	4	SENT_12	[p2l738t57r898b113],
4	shown	VBN	O	show	_	0	SENT_12	[p2l962t57r1183b113],
5	that	IN	O	that	complm	7	SENT_12	[p2l1246t57r1388b113],
6	there	EX	O	there	expl	7	SENT_12	[p2l1451t57r1636b113],
7	is	VBZ	O	be	ccomp	4	SENT_12	[p2l1703t57r1756b113],
8	a	DT	O	a	det	10	SENT_12	[p2l1820t70r1856b113],
9	strong	JJ	O	strong	amod	10	SENT_12	[p2l1921t60r2142b127],
10	association	NN	O	association	nsubj	7	SENT_12	[p2l11t160r414b216],
11	between	IN	O	between	_	0	SENT_12	[p2l489t160r785b216],
12	CYP2C9	NN	O	cyp2c9	nn	14	SENT_12	[p2l864t159r1158b216],
13	variant	JJ	O	variant	amod	14	SENT_12	[p2l1219t160r1461b216],
14	alleles	NNS	O	allele	prep_between	10	SENT_12	[p2l1535t160r1761b216],
15	and	CC	O	and	_	0	SENT_12	[p2l1832t160r1953b216],
16	low	JJ	O	low	amod	19	SENT_12	[p2l2028t160r2138b216],
17	warfarin	NN	O	warfarin	nn	19	SENT_12	[p2l7t263r290b320],
18	dose	NN	O	dose	nn	19	SENT_12	[p2l375t264r538b320],
19	requirement	NN	O	requirement	prep_between	10	SENT_12	[p2l624t264r1067b333],
20	.	.	O	.	_	0	SENT_12	[p2l624t264r1067b333],

1	CYP2C9	NN	O	cyp2c9	nn	2	SENT_13	[p2l1159t264r1454b320],
2	genotyping	NN	O	genotyping	nsubj	4	SENT_13	[p2l1529t264r1920b335],
3	may	MD	O	may	aux	4	SENT_13	[p2l2006t277r2145b334],
4	identify	VB	O	identify	_	0	SENT_13	[p2l13t366r268b437],
5	a	DT	O	a	det	6	SENT_13	[p2l332t380r367b423],
6	subgroup	NN	O	subgroup	dobj	4	SENT_13	[p2l429t367r753b437],
7	of	IN	O	of	_	0	SENT_13	[p2l813t366r880b423],
8	patients	NNS	O	patient	prep_of	6	SENT_13	[p2l939t367r1226b436],
9	who	WP	O	who	nsubj	10	SENT_13	[p2l1284t367r1426b423],
10	have	VBP	O	have	rcmod	8	SENT_13	[p2l1490t367r1650b423],
11	difficulty	NN	O	difficulty	dobj	10	SENT_13	[p2l1711t366r2013b437],
12	at	IN	O	at	_	0	SENT_13	[p2l2077t370r2142b423],
13	induction	NN	O	induction	prep_at	11	SENT_13	[p2l13t470r333b526],
14	of	IN	O	of	_	0	SENT_13	[p2l366t469r433b526],
15	warfarin	NN	O	warfarin	nn	16	SENT_13	[p2l454t469r737b526],
16	therapy	NN	O	therapy	prep_of	13	SENT_13	[p2l766t470r1032b539],
17	and	CC	O	and	_	0	SENT_13	[p2l1064t470r1185b526],
18	are	VBP	O	be	cop	19	SENT_13	[p2l1218t483r1325b526],
19	potentially	RB	O	potentially	conj_and	10	SENT_13	[p2l1358t470r1726b539],
20	at	IN	O	at	_	0	SENT_13	[p2l1759t473r1823b526],
21	a	DT	O	a	det	23	SENT_13	[p2l1856t483r1892b526],
22	higher	JJR	O	higher	amod	23	SENT_13	[p2l1925t470r2141b540],
23	risk	NN	O	risk	prep_at	19	SENT_13	[p2l11t573r134b629],
24	of	IN	O	of	_	0	SENT_13	[p2l166t572r233b629],
25	bleeding	VBG	O	bleed	amod	26	SENT_13	[p2l259t573r553b644],
26	complications	NNS	O	complication	prep_of	23	SENT_13	[p2l584t573r1101b642],
27	.	.	O	.	_	0	SENT_13	[p2l584t573r1101b642],

1	Lancet	NNP	O	Lancet	_	0	SENT_14	[p2l15t675r252b731],
2	1998	CD	DATE	1998	num	1	SENT_14	[p2l281t674r485b741],
3	;	:	O	;	_	0	SENT_14	[p2l281t674r485b741],
4	353	CD	NUMBER	353	num	6	SENT_14	[p2l517t674r679b731],
5	:	:	O	:	_	0	SENT_14	[p2l517t674r679b731],
6	717-19	CD	NUMBER	717-19	dep	1	SENT_14	[p2l713t674r985b731],
7	See	VB	O	see	rcmod	6	SENT_14	[p2l13t778r143b835],
8	Commentary	JJ	O	commentary	amod	10	SENT_14	[p2l173t778r623b848],
9	page	NN	O	page	nn	10	SENT_14	[p2l647t787r820b849],
10	xxxx	NN	O	xxxx	dobj	7	SENT_14	[p2l843t793r1013b834],

1	Introduction	NN	O	introduction	nn	2	SENT_15	[p2l13t932r559b999],
2	Warfarin	NN	O	warfarin	nsubjpass	19	SENT_15	[p2l7t1036r334b1097],
3	is	VBZ	O	be	cop	6	SENT_15	[p2l378t1037r430b1097],
4	the	DT	O	the	det	6	SENT_15	[p2l474t1037r587b1097],
5	oral	JJ	O	oral	amod	6	SENT_15	[p2l633t1037r769b1097],
6	anticoagulant	NN	O	anticoagulant	_	0	SENT_15	[p2l815t1037r1310b1113],
7	of	IN	O	of	_	0	SENT_15	[p2l1354t1036r1432b1097],
8	choice	NN	O	choice	prep_of	6	SENT_15	[p2l1467t1037r1697b1097],
9	in	IN	O	in	_	0	SENT_15	[p2l1742t1037r1810b1096],
10	the	DT	O	the	det	11	SENT_15	[p2l1853t1037r1965b1097],
11	UK	NNP	LOCATION	UK	prep_in	8	SENT_15	[p2l2009t1038r2149b1097],
12	and	CC	O	and	_	0	SENT_15	[p2l12t1134r144b1195],
13	many	JJ	O	many	amod	15	SENT_15	[p2l183t1154r385b1210],
14	other	JJ	O	other	amod	15	SENT_15	[p2l424t1134r615b1194],
15	countries	NNS	O	country	conj_and	11	SENT_15	[p2l653t1134r986b1194],
16	and	CC	O	and	_	0	SENT_15	[p2l1029t1134r1162b1195],
17	is	VBZ	O	be	aux	19	SENT_15	[p2l1201t1134r1252b1194],
18	being	VBG	O	be	auxpass	19	SENT_15	[p2l1292t1134r1493b1210],
19	prescribed	VBN	O	prescribe	conj_and	6	SENT_15	[p2l1529t1134r1911b1210],
20	to	TO	O	to	_	0	SENT_15	[p2l1949t1148r2019b1195],
21	an	DT	O	a	det	23	SENT_15	[p2l2061t1154r2146b1194],
22	increasing	VBG	O	increase	amod	23	SENT_15	[p2l8t1233r377b1309],
23	number	NN	O	number	prep_to	19	SENT_15	[p2l447t1233r736b1293],
24	of	IN	O	of	_	0	SENT_15	[p2l807t1232r885b1293],
25	patients	NNS	O	patient	prep_of	23	SENT_15	[p2l945t1233r1252b1309],
26	.	.	O	.	_	0	SENT_15	[p2l945t1233r1252b1309],

1	The	DT	O	the	det	2	SENT_16	[p2l1329t1233r1477b1293],
2	risk	NN	O	risk	nsubj	9	SENT_16	[p2l1549t1233r1680b1293],
3	of	IN	O	of	_	0	SENT_16	[p2l1751t1232r1829b1293],
4	serious	JJ	O	serious	amod	5	SENT_16	[p2l1892t1233r2142b1293],
5	haemorrhage	NN	O	haemorrhage	prep_of	2	SENT_16	[p2l7t1330r485b1406],
6	during	IN	O	during	_	0	SENT_16	[p2l523t1330r764b1406],
7	warfarin	NN	O	warfarin	nn	8	SENT_16	[p2l797t1330r1100b1391],
8	therapy	NN	O	therapy	prep_during	5	SENT_16	[p2l1135t1330r1411b1406],
9	ranges	VBZ	O	range	_	0	SENT_16	[p2l1445t1350r1677b1406],
10	from	IN	O	from	_	0	SENT_16	[p2l1715t1330r1889b1390],
11	1-3	CD	NUMBER	1-3	num	13	SENT_16	[p2l1934t1332r2035b1391],
12	to	TO	NUMBER	to	dep	13	SENT_16	[p2l2065t1344r2135b1390],
13	4-2	CD	NUMBER	4-2	prep_from	9	SENT_16	[p2l9t1431r117b1488],
14	per	IN	O	per	_	0	SENT_16	[p2l172t1448r291b1505],
15	100	CD	NUMBER	100	num	17	SENT_16	[p2l352t1431r478b1489],
16	patient	NN	O	patient	nn	17	SENT_16	[p2l533t1429r788b1505],
17	years	NNS	DURATION	year	prep_per	13	SENT_16	[p2l840t1448r1023b1505],
18	of	IN	O	of	_	0	SENT_16	[p2l1080t1428r1158b1489],
19	exposure	NN	O	exposure	prep_of	17	SENT_16	[p2l1203t1429r2145b1505],
20	.1	CD	NUMBER	.1	num	19	SENT_16	[p2l1203t1429r2145b1505],
21	>	JJR	O	>	amod	23	SENT_16	[p2l1203t1429r2145b1505],
22	2Haemorrhage	NN	O	2haemorrhage	nn	23	SENT_16	[p2l1203t1429r2145b1505],
23	incidence	NN	O	incidence	dobj	9	SENT_16	[p2l8t1526r355b1587],
24	is	VBZ	O	be	auxpass	25	SENT_16	[p2l475t1526r527b1587],
25	associated	VBN	O	associate	rcmod	23	SENT_16	[p2l650t1526r1019b1587],
26	with	IN	O	with	_	0	SENT_16	[p2l1136t1526r1295b1587],
27	the	DT	O	the	det	28	SENT_16	[p2l1414t1526r1525b1587],
28	intensity	NN	O	intensity	prep_with	25	SENT_16	[p2l1646t1526r1958b1602],
29	of	IN	O	of	_	0	SENT_16	[p2l2077t1526r2154b1586],
30	anticoagulation	NN	O	anticoagulation	prep_of	28	SENT_16	[p2l10t1625r595b1701],
31	,	,	O	,	_	0	SENT_16	[p2l10t1625r595b1701],
32	with	IN	O	with	_	0	SENT_16	[p2l637t1625r796b1685],
33	the	DT	O	the	det	34	SENT_16	[p2l836t1625r948b1685],
34	deviation	NN	O	deviation	prep_with	25	SENT_16	[p2l990t1625r1325b1685],
35	in	IN	O	in	_	0	SENT_16	[p2l1365t1625r1434b1684],
36	prothrombin	NN	O	prothrombin	nn	37	SENT_16	[p2l1473t1625r1943b1701],
37	time	NN	O	time	prep_in	34	SENT_16	[p2l1983t1625r2143b1685],

1	Departments	NNP	O	Departments	_	0	SENT_17	[p2l12t1801r415b1862],
2	of	IN	O	of	_	0	SENT_17	[p2l439t1801r499b1851],
3	Medicine	NNP	O	Medicine	prep_of	1	SENT_17	[p2l523t1801r807b1851],
4	(	CD	NUMBER	(	num	3	SENT_17	[p2l833t1801r899b1862],
5	G	NNP	O	G	nn	8	SENT_17	[p2l833t1801r899b1862],
6	P	NN	O	p	nn	8	SENT_17	[p2l928t1801r962b1850],
7	Aithal	NNP	O	Aithal	nn	8	SENT_17	[p2l990t1801r1168b1851],
8	MRCP	NNP	O	MRCP	dep	26	SENT_17	[p2l1200t1814r1357b1860],
9	,	,	O	,	_	0	SENT_17	[p2l1200t1814r1357b1860],
10	C	NNP	O	C	nn	13	SENT_17	[p2l1387t1801r1425b1851],
11	P	NN	O	p	nn	13	SENT_17	[p2l1457t1801r1490b1851],
12	Day	NN	DURATION	day	nn	13	SENT_17	[p2l1523t1801r1632b1863],
13	FRCP	NN	O	frcp	dep	26	SENT_17	[p2l1661t1814r1801b1860],
14	,	,	O	,	_	0	SENT_17	[p2l1661t1814r1801b1860],
15	P	NN	O	p	nn	20	SENT_17	[p2l12t1889r46b1938],
16	J	NN	O	j	nn	20	SENT_17	[p2l74t1889r97b1939],
17	L	NN	O	l	nn	20	SENT_17	[p2l128t1889r158b1938],
18	Kesteven	NN	O	kesteven	nn	20	SENT_17	[p2l185t1889r469b1939],
19	FRCPath	NN	O	frcpath	nn	20	SENT_17	[p2l498t1889r717b1950],
20	)	NN	O	)	dep	26	SENT_17	[p2l498t1889r717b1950],
21	and	CC	O	and	_	0	SENT_17	[p2l748t1889r858b1939],
22	Pharmacological	JJ	O	pharmacological	amod	23	SENT_17	[p2l886t1889r1405b1951],
23	Sciences	NNPS	O	Sciences	dep	26	SENT_17	[p2l1430t1889r1715b1939],
24	(	CD	NUMBER	(	dep	26	SENT_17	[p2l11t1977r74b2039],
25	A	DT	O	a	det	26	SENT_17	[p2l11t1977r74b2039],
26	K	NN	O	k	dep	1	SENT_17	[p2l128t1977r166b2027],
27	Daly	NNP	PERSON	Daly	nn	29	SENT_17	[p2l194t1977r322b2039],
28	PhD	NN	O	phd	nn	29	SENT_17	[p2l350t1977r485b2039],
29	)	NN	O	)	dep	26	SENT_17	[p2l350t1977r485b2039],
30	,	,	O	,	_	0	SENT_17	[p2l350t1977r485b2039],
31	University	NNP	ORGANIZATION	University	appos	29	SENT_17	[p2l514t1977r824b2039],
32	of	IN	ORGANIZATION	of	_	0	SENT_17	[p2l848t1977r907b2027],
33	Newcastle	NNP	ORGANIZATION	Newcastle	prep_of	31	SENT_17	[p2l930t1977r1257b2027],
34	upon	IN	O	upon	_	0	SENT_17	[p2l1284t1989r1430b2039],
35	Tyne	NNP	ORGANIZATION	Tyne	nn	37	SENT_17	[p2l1455t1978r1601b2039],
36	Medical	NNP	ORGANIZATION	Medical	nn	37	SENT_17	[p2l1628t1977r1872b2027],
37	School	NNP	ORGANIZATION	School	prep_upon	33	SENT_17	[p2l1897t1977r2127b2038],
38	,	,	O	,	_	0	SENT_17	[p2l1897t1977r2127b2038],
39	Newcastle	NNP	ORGANIZATION	Newcastle	appos	37	SENT_17	[p2l11t2066r338b2116],
40	upon	IN	O	upon	_	0	SENT_17	[p2l364t2077r510b2127],
41	Tyne	NNP	O	Tyne	nn	43	SENT_17	[p2l535t2066r681b2127],
42	NE2	NNP	O	NE2	nn	43	SENT_17	[p2l708t2065r832b2115],
43	4HH	NN	O	4hh	prep_upon	39	SENT_17	[p2l857t2066r1008b2126],
44	,	,	O	,	_	0	SENT_17	[p2l857t2066r1008b2126],
45	UK	NNP	LOCATION	UK	nn	46	SENT_17	[p2l1037t2066r1125b2116],
46	Correspondence	NNP	O	Correspondence	appos	37	SENT_17	[p2l10t2166r518b2228],
47	to	TO	O	to	infmod	46	SENT_17	[p2l541t2168r623b2217],
48	:	:	O	:	_	0	SENT_17	[p2l541t2168r623b2217],
49	Dr	NNP	O	Dr	nn	52	SENT_17	[p2l654t2167r718b2216],
50	Ann	NNP	PERSON	Ann	nn	52	SENT_17	[p2l741t2167r858b2216],
51	K	NNP	PERSON	K	nn	52	SENT_17	[p2l889t2167r928b2216],
52	Daly	NNP	PERSON	Daly	dep	46	SENT_17	[p2l955t2167r1083b2228],
53	(	NN	O	(	dep	52	SENT_17	[p2l10t2255r237b2316],
54	e	SYM	O	e	dep	55	SENT_17	[p2l10t2255r237b2316],
55	—	CD	NUMBER	—	dep	31	SENT_17	[p2l10t2255r237b2316],
56	mai	FW	O	mai	nn	57	SENT_17	[p2l10t2255r237b2316],
57	|	FW	O	|	dep	31	SENT_17	[p2l10t2255r237b2316],
58	:	:	O	:	_	0	SENT_17	[p2l10t2255r237b2316],
59	a.k.daly@newcastle.ac.uk	NN	O	a.k.daly@newcastle.ac.uk	nn	61	SENT_17	[p2l268t2254r1109b2317],
60	)	CD	NUMBER	)	num	61	SENT_17	[p2l268t2254r1109b2317],
61	ratio	NN	O	ratio	dep	1	SENT_17	[p2l11t2342r176b2402],
62	shown	VBN	O	show	partmod	61	SENT_17	[p2l223t2342r456b2403],
63	to	TO	O	to	aux	68	SENT_17	[p2l498t2356r568b2402],
64	be	VB	O	be	cop	68	SENT_17	[p2l611t2342r696b2402],
65	the	DT	O	the	det	68	SENT_17	[p2l739t2342r851b2402],
66	strongest	JJS	O	strongest	amod	68	SENT_17	[p2l897t2356r1225b2418],
67	risk	NN	O	risk	nn	68	SENT_17	[p2l1267t2342r1398b2402],
68	factor	NN	O	factor	xcomp	62	SENT_17	[p2l1439t2342r1650b2402],
69	for	IN	O	for	_	0	SENT_17	[p2l1691t2342r1794b2402],
70	bleeding	VBG	O	bleed	amod	71	SENT_17	[p2l1834t2342r2146b2418],
71	complications	NNS	O	complication	prep_for	68	SENT_17	[p2l14t2442r568b2518],
72	?	.	O	?	_	0	SENT_17	[p2l14t2442r568b2518],

1	’	NN	O	’	_	0	SENT_18	[p2l14t2442r568b2518],

1	Widespread	JJ	O	widespread	amod	3	SENT_19	[p2l95t2540r531b2616],
2	interindividual	JJ	O	interindividual	amod	3	SENT_19	[p2l563t2540r1098b2601],
3	variation	NN	O	variation	nsubj	13	SENT_19	[p2l1128t2540r1449b2601],
4	in	IN	O	in	_	0	SENT_19	[p2l1481t2540r1550b2600],
5	the	DT	O	the	det	6	SENT_19	[p2l1580t2540r1692b2600],
6	response	NN	O	response	prep_in	3	SENT_19	[p2l1725t2560r2041b2616],
7	to	TO	O	to	_	0	SENT_19	[p2l2073t2554r2143b2600],
8	a	DT	O	a	det	10	SENT_19	[p2l14t2659r49b2700],
9	given	VBN	O	give	amod	10	SENT_19	[p2l105t2640r297b2716],
10	dose	NN	O	dose	prep_to	6	SENT_19	[p2l354t2640r516b2700],
11	of	IN	O	of	_	0	SENT_19	[p2l574t2639r651b2700],
12	warfarin	NN	O	warfarin	prep_of	10	SENT_19	[p2l696t2639r999b2700],
13	makes	VBZ	O	make	_	0	SENT_19	[p2l1054t2640r1280b2700],
14	the	DT	O	the	det	15	SENT_19	[p2l1337t2640r1449b2700],
15	prediction	NN	O	prediction	nsubj	21	SENT_19	[p2l1504t2640r1879b2716],
16	of	IN	O	of	_	0	SENT_19	[p2l1936t2639r2013b2700],
17	an	DT	O	a	det	20	SENT_19	[p2l2061t2659r2145b2700],
18	accurate	JJ	O	accurate	amod	20	SENT_19	[p2l14t2751r317b2797],
19	maintenance	NN	O	maintenance	nn	20	SENT_19	[p2l375t2737r842b2797],
20	dose	NN	O	dose	prep_of	15	SENT_19	[p2l901t2737r1064b2797],
21	difficult	JJ	O	difficult	xcomp	13	SENT_19	[p2l1123t2737r1427b2809],
22	,	,	O	,	_	0	SENT_19	[p2l1123t2737r1427b2809],
23	with	IN	O	with	_	0	SENT_19	[p2l1486t2737r1645b2797],
24	an	DT	O	a	det	27	SENT_19	[p2l1703t2757r1788b2797],
25	effective	JJ	O	effective	amod	27	SENT_19	[p2l1846t2737r2144b2797],
26	daily	JJ	SET	daily	amod	27	SENT_19	[p2l12t2837r185b2913],
27	dose	NN	O	dose	prep_with	13	SENT_19	[p2l217t2837r380b2897],
28	ranging	VBG	O	range	partmod	27	SENT_19	[p2l414t2837r690b2913],
29	from	IN	O	from	_	0	SENT_19	[p2l722t2836r896b2897],
30	0-5	CD	NUMBER	0-5	num	31	SENT_19	[p2l931t2839r1039b2897],
31	mg	NN	O	mg	prep_from	28	SENT_19	[p2l1077t2856r1191b2913],
32	to	TO	O	to	_	0	SENT_19	[p2l1223t2851r1292b2897],
33	60	CD	NUMBER	60	num	34	SENT_19	[p2l1331t2839r1415b2897],
34	mg	NN	O	mg	prep_to	28	SENT_19	[p2l1451t2839r1646b2913],
35	.	.	O	.	_	0	SENT_19	[p2l1451t2839r1646b2913],

1	“	NN	O	“	nn	4	SENT_20	[p2l1451t2839r1646b2913],
2	Standardised	JJ	O	standardised	amod	4	SENT_20	[p2l1667t2837r2142b2897],
3	induction	NN	O	induction	nn	4	SENT_20	[p2l10t2935r362b2995],
4	regimens	NNS	O	regimen	nsubj	21	SENT_20	[p2l425t2935r776b3011],
5	,	,	O	,	_	0	SENT_20	[p2l425t2935r776b3011],
6	with	IN	O	with	_	0	SENT_20	[p2l841t2935r1000b2996],
7	monitoring	NN	O	monitoring	prep_with	21	SENT_20	[p2l1063t2935r1473b3011],
8	of	IN	O	of	_	0	SENT_20	[p2l1536t2935r1614b2995],
9	International	NNP	MISC	International	nn	14	SENT_20	[p2l1668t2935r2142b2995],
10	Normalised	NNP	MISC	Normalised	nn	14	SENT_20	[p2l9t3035r438b3095],
11	Ratio	NNP	MISC	Ratio	nn	14	SENT_20	[p2l468t3035r661b3095],
12	(	CD	NUMBER	(	num	14	SENT_20	[p2l698t3035r912b3110],
13	INR	NN	O	inr	nn	14	SENT_20	[p2l698t3035r912b3110],
14	)	NN	O	)	prep_of	7	SENT_20	[p2l698t3035r912b3110],
15	over	IN	O	over	_	0	SENT_20	[p2l949t3054r1104b3095],
16	the	DT	O	the	det	17	SENT_20	[p2l1131t3035r1242b3095],
17	ﬁrst	NN	O	ﬁrst	prep_over	14	SENT_20	[p2l1272t3034r1413b3095],
18	4	CD	DURATION	4	num	19	SENT_20	[p2l1442t3037r1483b3094],
19	days	NNS	NUMBER	day	tmod	14	SENT_20	[p2l1515t3035r1696b3110],
20	,	,	O	,	_	0	SENT_20	[p2l1515t3035r1696b3110],
21	have	VBP	O	have	_	0	SENT_20	[p2l1727t3035r1892b3095],
22	only	RB	O	only	advmod	27	SENT_20	[p2l1923t3035r2079b3111],
23	a	DT	O	a	det	27	SENT_20	[p2l2108t3054r2143b3095],
24	69	CD	PERCENT	69	number	25	SENT_20	[p2l14t3133r173b3196],
25	%	NN	PERCENT	%	amod	27	SENT_20	[p2l14t3133r173b3196],
26	success	NN	O	success	nn	27	SENT_20	[p2l221t3153r483b3194],
27	rate	NN	O	rate	dobj	21	SENT_20	[p2l527t3147r663b3194],
28	in	IN	O	in	_	0	SENT_20	[p2l705t3133r774b3193],
29	predicting	VBG	O	predict	prepc_in	27	SENT_20	[p2l814t3133r1186b3209],
30	the	DT	O	the	det	33	SENT_20	[p2l1226t3133r1338b3194],
31	correct	JJ	O	correct	amod	33	SENT_20	[p2l1382t3147r1635b3194],
32	maintenance	NN	O	maintenance	nn	33	SENT_20	[p2l1676t3133r2142b3194],
33	dosef	NN	O	dosef	dobj	29	SENT_20	[p2l12t3233r223b3306],
34	and	CC	O	and	_	0	SENT_20	[p2l255t3233r409b3305],
35	,	,	O	,	_	0	SENT_20	[p2l255t3233r409b3305],
36	although	IN	O	although	mark	50	SENT_20	[p2l444t3233r763b3309],
37	complex	JJ	O	complex	amod	38	SENT_20	[p2l795t3233r1103b3309],
38	normograms	NNS	O	normogram	nsubjpass	50	SENT_20	[p2l1131t3252r1594b3309],
39	and	CC	O	and	_	0	SENT_20	[p2l1628t3233r1761b3293],
40	computer	NN	O	computer	nn	41	SENT_20	[p2l1792t3246r2144b3309],
41	programs	NNS	O	program	nsubjpass	50	SENT_20	[p2l11t3351r354b3407],
42	requiring	VBG	O	require	partmod	38	SENT_20	[p2l409t3331r744b3407],
43	protein	NN	O	protein	nn	44	SENT_20	[p2l794t3331r1057b3407],
44	C	NN	O	c	dobj	42	SENT_20	[p2l1112t3331r1169b3392],
45	and	CC	O	and	_	0	SENT_20	[p2l1227t3331r1360b3392],
46	S	NN	O	s	nn	47	SENT_20	[p2l1415t3331r1457b3392],
47	estimations	NNS	O	estimation	dobj	42	SENT_20	[p2l1514t3331r1925b3392],
48	have	VBP	O	have	aux	50	SENT_20	[p2l1979t3331r2144b3392],
49	been	VBN	O	be	auxpass	50	SENT_20	[p2l9t3431r183b3491],
50	shown	VBN	O	show	advcl	64	SENT_20	[p2l245t3431r479b3491],
51	to	TO	O	to	aux	52	SENT_20	[p2l539t3444r608b3491],
52	improve	VB	O	improve	xcomp	50	SENT_20	[p2l671t3431r969b3507],
53	the	DT	O	the	det	54	SENT_20	[p2l1031t3431r1143b3491],
54	prediction	NN	O	prediction	dobj	52	SENT_20	[p2l1204t3431r1578b3507],
55	they	PRP	O	they	nsubj	64	SENT_20	[p2l1639t3431r1794b3507],
56	are	VBP	O	be	cop	64	SENT_20	[p2l1855t3450r1961b3491],
57	not	RB	O	not	neg	64	SENT_20	[p2l2023t3444r2144b3491],
58	suitable	JJ	O	suitable	amod	64	SENT_20	[p2l12t3529r291b3590],
59	for	IN	O	for	_	0	SENT_20	[p2l318t3529r421b3590],
60	routine	JJ	O	routine	amod	61	SENT_20	[p2l445t3529r708b3590],
61	use	NN	O	use	prep_for	58	SENT_20	[p2l735t3530r1031b3590],
62	.7	CD	NUMBER	.7	tmod	58	SENT_20	[p2l735t3530r1031b3590],
63	An	DT	O	a	det	64	SENT_20	[p2l735t3530r1031b3590],
64	understanding	NN	O	understanding	conj_and	21	SENT_20	[p2l1057t3529r1586b3605],
65	of	IN	O	of	_	0	SENT_20	[p2l1613t3529r1690b3590],
66	the	DT	O	the	det	67	SENT_20	[p2l1707t3529r1819b3590],
67	genetics	NNS	O	genetics	prep_of	64	SENT_20	[p2l1847t3529r2136b3605],
68	of	IN	O	of	_	0	SENT_20	[p2l14t3629r91b3689],
69	warfarin	NN	O	warfarin	nn	70	SENT_20	[p2l120t3629r423b3689],
70	metabolism	NN	O	metabolism	prep_of	67	SENT_20	[p2l462t3629r888b3689],
71	and	CC	O	and	_	0	SENT_20	[p2l929t3629r1062b3689],
72	the	DT	O	the	det	73	SENT_20	[p2l1102t3629r1214b3689],
73	identiﬁcation	NN	O	identiﬁcation	nsubj	88	SENT_20	[p2l1254t3629r1738b3689],
74	of	IN	O	of	_	0	SENT_20	[p2l1779t3629r1857b3689],
75	genetic	JJ	O	genetic	amod	76	SENT_20	[p2l1887t3629r2144b3705],
76	factors	NNS	O	factor	prep_of	73	SENT_20	[p2l12t3727r254b3788],
77	that	WDT	O	that	nsubj	78	SENT_20	[p2l286t3727r429b3788],
78	contribute	VBP	O	contribute	rcmod	76	SENT_20	[p2l461t3727r836b3788],
79	to	TO	O	to	_	0	SENT_20	[p2l868t3741r937b3788],
80	the	DT	O	the	det	81	SENT_20	[p2l970t3727r1082b3788],
81	individuality	NN	O	individuality	prep_to	78	SENT_20	[p2l1113t3727r1571b3803],
82	of	IN	O	of	_	0	SENT_20	[p2l1602t3727r1680b3788],
83	the	DT	O	the	det	86	SENT_20	[p2l1700t3727r1812b3788],
84	warfarin	NN	O	warfarin	nn	86	SENT_20	[p2l1842t3727r2146b3788],
85	dose	NN	O	dose	nn	86	SENT_20	[p3l12t19r174b79],
86	response	NN	O	response	prep_of	81	SENT_20	[p3l211t38r527b95],
87	may	MD	O	may	aux	88	SENT_20	[p3l564t38r718b95],
88	help	VB	O	help	conj_and	21	SENT_20	[p3l751t19r905b95],
89	to	TO	O	to	aux	90	SENT_20	[p3l943t33r1012b79],
90	ameliorate	VB	O	ameliorate	xcomp	88	SENT_20	[p3l1052t19r1432b79],
91	clinical	JJ	O	clinical	amod	92	SENT_20	[p3l1471t19r1726b79],
92	difﬁculties	NNS	O	difﬁculties	dobj	90	SENT_20	[p3l1764t19r2141b79],
93	associated	VBN	O	associate	partmod	92	SENT_20	[p3l12t117r381b178],
94	with	IN	O	with	_	0	SENT_20	[p3l406t117r565b178],
95	warfarin	NN	O	warfarin	nn	96	SENT_20	[p3l590t117r893b178],
96	therapy	NN	O	therapy	prep_with	93	SENT_20	[p3l919t117r1212b193],
97	.	.	O	.	_	0	SENT_20	[p3l919t117r1212b193],

1	The	DT	O	the	det	3	SENT_21	[p3l96t217r245b277],
2	asymmetric	JJ	O	asymmetric	amod	3	SENT_21	[p3l286t217r704b293],
3	carbon	NN	O	carbon	nsubj	9	SENT_21	[p3l746t217r995b277],
4	of	IN	O	of	_	0	SENT_21	[p3l1035t217r1113b277],
5	warfarin	NN	O	warfarin	nn	8	SENT_21	[p3l1140t217r1443b277],
6	(	CD	NUMBER	(	num	8	SENT_21	[p3l1488t217r1650b292],
7	C9	NN	O	c9	nn	8	SENT_21	[p3l1488t217r1650b292],
8	)	NN	O	)	prep_of	3	SENT_21	[p3l1488t217r1650b292],
9	gives	VBZ	O	give	_	0	SENT_21	[p3l1695t217r1870b293],
10	rise	NN	O	rise	dobj	9	SENT_21	[p3l1910t217r2034b277],
11	to	TO	O	to	_	0	SENT_21	[p3l2074t231r2143b277],
12	two	CD	NUMBER	two	num	14	SENT_21	[p3l10t328r141b375],
13	enantiomeric	JJ	O	enantiomeric	amod	14	SENT_21	[p3l215t315r692b375],
14	forms	NNS	O	form	prep_to	9	SENT_21	[p3l763t314r993b386],
15	,	,	O	,	_	0	SENT_21	[p3l763t314r993b386],
16	R-warfarin	NN	O	r-warfarin	appos	14	SENT_21	[p3l1068t314r1460b375],
17	and	CC	O	and	_	0	SENT_21	[p3l1532t314r1665b375],
18	S-warfarin	NN	O	s-warfarin	conj_and	16	SENT_21	[p3l1738t314r2139b386],
19	,	,	O	,	_	0	SENT_21	[p3l1738t314r2139b386],
20	which	WDT	O	which	nsubjpass	23	SENT_21	[p3l9t414r227b474],
21	are	VBP	O	be	auxpass	23	SENT_21	[p3l267t433r373b474],
22	differentially	RB	O	differentially	advmod	23	SENT_21	[p3l414t414r873b490],
23	metabolised	VBN	O	metabolise	rcmod	14	SENT_21	[p3l909t414r1369b474],
24	.	.	O	.	_	0	SENT_21	[p3l909t414r1369b474],

1	When	WRB	O	when	advmod	2	SENT_22	[p3l1410t414r1630b474],
2	administered	VBN	O	administer	advcl	8	SENT_22	[p3l1669t414r2143b474],
3	as	IN	O	as	_	0	SENT_22	[p3l13t532r80b573],
4	a	DT	O	a	det	5	SENT_22	[p3l110t532r145b573],
5	racemate	NN	O	racemate	prep_as	2	SENT_22	[p3l172t527r525b585],
6	,	,	O	,	_	0	SENT_22	[p3l172t527r525b585],
7	S-warfarin	NN	O	s-warfarin	nsubj	8	SENT_22	[p3l557t512r937b573],
8	is	VBZ	O	be	_	0	SENT_22	[p3l964t513r1015b573],
9	about	IN	O	about	advmod	8	SENT_22	[p3l1046t512r1252b573],
10	three	CD	NUMBER	three	num	11	SENT_22	[p3l1278t512r1461b573],
11	times	NNS	O	time	pobj	9	SENT_22	[p3l1488t512r1682b573],
12	as	IN	O	as	_	0	SENT_22	[p3l1712t532r1779b573],
13	potent	JJ	O	potent	prep_as	9	SENT_22	[p3l1807t527r2044b588],
14	as	IN	O	as	mark	72	SENT_22	[p3l2071t532r2139b573],
15	R-warfarinf	NN	O	r-warfarinf	nsubjpass	72	SENT_22	[p3l12t612r451b672],
16	‘	CD	NUMBER	‘	num	15	SENT_22	[p3l12t612r451b672],
17	The	DT	O	the	det	20	SENT_22	[p3l490t612r638b672],
18	cytochrome	NN	O	cytochrome	nn	20	SENT_22	[p3l717t612r1144b688],
19	P450	NN	O	p450	nn	20	SENT_22	[p3l1221t613r1409b672],
20	CYPZC9	NN	O	cypzc9	nsubj	24	SENT_22	[p3l1491t612r1821b672],
21	is	VBZ	O	be	cop	24	SENT_22	[p3l1901t612r1952b672],
22	the	DT	O	the	det	24	SENT_22	[p3l2030t612r2142b672],
23	principal	JJ	O	principal	amod	24	SENT_22	[p3l11t710r333b786],
24	enzyme	NN	O	enzyme	rcmod	15	SENT_22	[p3l396t730r669b786],
25	that	WDT	O	that	nsubj	26	SENT_22	[p3l730t710r873b771],
26	catalyses	VBZ	O	catalys	rcmod	24	SENT_22	[p3l934t710r1247b786],
27	the	DT	O	the	det	28	SENT_22	[p3l1309t710r1421b771],
28	conversion	NN	O	conversion	dobj	26	SENT_22	[p3l1484t711r1877b771],
29	of	IN	O	of	_	0	SENT_22	[p3l1939t710r2016b771],
30	Swarfarin	NN	LOCATION	swarfarin	prep_of	28	SENT_22	[p3l2070t711r2144b771, p3l9t809r312b870],
31	to	TO	O	to	_	0	SENT_22	[p3l341t823r411b869],
32	inactive	JJ	O	inactive	amod	33	SENT_22	[p3l443t809r723b870],
33	6-hydroxy	NN	O	6-hydroxy	prep_to	26	SENT_22	[p3l757t809r1127b885],
34	and	CC	O	and	_	0	SENT_22	[p3l1158t809r1291b870],
35	7	CD	NUMBER	7	number	36	SENT_22	[p3l1323t809r1694b885],
36	—	CD	NUMBER	—	num	38	SENT_22	[p3l1323t809r1694b885],
37	hydroxy	NN	O	hydroxy	nn	38	SENT_22	[p3l1323t809r1694b885],
38	metabolites	NNS	O	metabolite	conj_and	33	SENT_22	[p3l1723t809r2141b869],
39	whereas	IN	O	whereas	mark	47	SENT_22	[p3l9t908r300b969],
40	the	DT	O	the	det	42	SENT_22	[p3l332t908r444b969],
41	oxidative	JJ	O	oxidative	amod	42	SENT_22	[p3l477t908r803b969],
42	metabolism	NN	O	metabolism	nsubjpass	47	SENT_22	[p3l834t908r1259b969],
43	of	IN	O	of	_	0	SENT_22	[p3l1292t908r1369b969],
44	R-warfarin	NN	O	r-warfarin	prep_of	42	SENT_22	[p3l1391t908r1783b969],
45	is	VBZ	O	be	auxpass	47	SENT_22	[p3l1814t908r1865b969],
46	mainly	RB	O	mainly	advmod	47	SENT_22	[p3l1897t908r2145b984],
47	catalysed	VBN	O	catalyse	advcl	26	SENT_22	[p3l13t1007r342b1083],
48	by	IN	O	by	_	0	SENT_22	[p3l390t1007r477b1083],
49	CYP1A2	NN	O	cyp1a2	agent	47	SENT_22	[p3l528t1007r855b1068],
50	and	CC	O	and	_	0	SENT_22	[p3l908t1007r1041b1068],
51	CYP3A4	NN	O	cyp3a4	agent	47	SENT_22	[p3l1093t1007r1469b1068],
52	.9	CD	NUMBER	.9	num	51	SENT_22	[p3l1093t1007r1469b1068],
53	The	DT	O	the	det	54	SENT_22	[p3l1495t1007r1644b1067],
54	existence	NN	O	existence	tmod	47	SENT_22	[p3l1695t1007r2024b1067],
55	of	IN	O	of	_	0	SENT_22	[p3l2076t1007r2153b1067],
56	genetic	JJ	O	genetic	amod	57	SENT_22	[p3l11t1107r269b1182],
57	polymorphisms	NNS	O	polymorphism	prep_of	54	SENT_22	[p3l354t1106r917b1182],
58	in	IN	O	in	_	0	SENT_22	[p3l1004t1107r1072b1166],
59	CYPZC9	NN	O	cypzc9	prep_in	57	SENT_22	[p3l1160t1107r1478b1167],
60	giving	VBG	O	give	xcomp	47	SENT_22	[p3l1561t1106r1779b1182],
61	rise	NN	O	rise	dobj	60	SENT_22	[p3l1863t1107r1987b1167],
62	to	TO	O	to	_	0	SENT_22	[p3l2073t1121r2142b1167],
63	functionally	RB	O	functionally	advmod	64	SENT_22	[p3l12t1205r447b1281],
64	signiﬁcant	JJ	O	signiﬁcant	amod	65	SENT_22	[p3l484t1205r857b1281],
65	effects	NNS	O	effect	prep_to	60	SENT_22	[p3l895t1205r1122b1265],
66	on	IN	O	on	_	0	SENT_22	[p3l1163t1225r1253b1265],
67	enzyme	NN	O	enzyme	nn	68	SENT_22	[p3l1291t1224r1564b1281],
68	activity	NN	O	activity	prep_on	65	SENT_22	[p3l1605t1205r1865b1281],
69	is	VBZ	O	be	auxpass	72	SENT_22	[p3l1901t1205r1952b1265],
70	now	RB	DATE	now	advmod	72	SENT_22	[p3l1991t1225r2146b1266],
71	well	RB	O	well	advmod	72	SENT_22	[p3l10t1305r156b1365],
72	established	VBN	O	establish	advcl	8	SENT_22	[p3l268t1305r687b1365],
73	.	.	O	.	_	0	SENT_22	[p3l268t1305r687b1365],

1	In	IN	O	in	dep	16	SENT_23	[p3l802t1306r880b1364],
2	addition	NN	O	addition	pobj	1	SENT_23	[p3l991t1305r1292b1365],
3	to	TO	O	to	_	0	SENT_23	[p3l1401t1318r1471b1365],
4	the	DT	O	the	det	10	SENT_23	[p3l1582t1305r1694b1365],
5	wild	JJ	O	wild	amod	10	SENT_23	[p3l1803t1305r2144b1381],
6	—	NN	O	—	nn	10	SENT_23	[p3l1803t1305r2144b1381],
7	type	NN	O	type	nn	10	SENT_23	[p3l1803t1305r2144b1381],
8	(	CD	NUMBER	(	num	10	SENT_23	[p3l18t1402r365b1477],
9	CYPZC9	NN	O	cypzc9	nn	10	SENT_23	[p3l18t1402r365b1477],
10	*	NN	O	*	prep_to	2	SENT_23	[p3l378t1398r478b1477],
11	1	CD	NUMBER	1	number	12	SENT_23	[p3l378t1398r478b1477],
12	)	CD	NUMBER	)	num	13	SENT_23	[p3l378t1398r478b1477],
13	allele	NN	O	allele	dep	10	SENT_23	[p3l518t1402r724b1475],
14	,	,	O	,	_	0	SENT_23	[p3l518t1402r724b1475],
15	point	NN	O	point	nn	16	SENT_23	[p3l758t1402r951b1478],
16	mutations	NNS	O	mutation	_	0	SENT_23	[p3l982t1402r1347b1463],
17	in	IN	O	in	_	0	SENT_23	[p3l1381t1402r1450b1462],
18	the	DT	O	the	det	21	SENT_23	[p3l1482t1402r1594b1463],
19	CYPZC9	NN	O	cypzc9	nn	21	SENT_23	[p3l1629t1402r1947b1463],
20	gene	NN	O	gene	nn	21	SENT_23	[p3l1978t1422r2143b1478],
21	result	NN	O	result	prep_in	16	SENT_23	[p3l10t1501r213b1561],
22	in	IN	O	in	_	0	SENT_23	[p3l247t1501r316b1560],
23	two	CD	NUMBER	two	num	25	SENT_23	[p3l350t1515r482b1561],
24	allelic	JJ	O	allelic	amod	25	SENT_23	[p3l520t1501r726b1561],
25	variants	NNS	O	variant	prep_in	16	SENT_23	[p3l761t1501r1454b1561],
26	.	.	O	.	_	0	SENT_23	[p3l761t1501r1454b1561],

1	—	NN	O	—	_	0	SENT_24	[p3l761t1501r1454b1561],
2	.	.	O	.	_	0	SENT_24	[p3l761t1501r1454b1561],

1	CYP2C9	NN	O	cyp2c9	nn	2	SENT_25	[p3l761t1501r1454b1561],
2	*	NN	O	*	nsubj	30	SENT_25	[p3l1467t1497r1562b1573],
3	2	CD	NUMBER	2	tmod	2	SENT_25	[p3l1467t1497r1562b1573],
4	,	,	O	,	_	0	SENT_25	[p3l1467t1497r1562b1573],
5	where	WRB	O	where	advmod	7	SENT_25	[p3l1598t1501r1816b1561],
6	cysteine	NN	O	cysteine	nsubj	7	SENT_25	[p3l1854t1501r2142b1576],
7	substitutes	VBZ	O	substitute	rcmod	3	SENT_25	[p3l12t1599r398b1659],
8	for	IN	O	for	_	0	SENT_25	[p3l501t1599r604b1659],
9	arginine	NN	O	arginine	prep_for	7	SENT_25	[p3l704t1599r996b1675],
10	at	IN	O	at	_	0	SENT_25	[p3l1100t1613r1164b1659],
11	aminoacid	JJ	O	aminoacid	amod	12	SENT_25	[p3l1266t1599r1645b1660],
12	144	CD	NUMBER	144	prep_at	9	SENT_25	[p3l1755t1601r1904b1672],
13	,	,	O	,	_	0	SENT_25	[p3l1755t1601r1904b1672],
14	and	CC	O	and	_	0	SENT_25	[p3l2010t1599r2143b1660],
15	CYP2C9	NN	O	cyp2c9	conj_and	9	SENT_25	[p3l13t1695r439b1772],
16	*	CD	NUMBER	*	number	17	SENT_25	[p3l13t1695r439b1772],
17	3	CD	NUMBER	3	dep	15	SENT_25	[p3l13t1695r439b1772],
18	,	,	O	,	_	0	SENT_25	[p3l13t1695r439b1772],
19	where	WRB	O	where	advmod	21	SENT_25	[p3l492t1699r709b1760],
20	leucine	NN	O	leucine	nsubj	21	SENT_25	[p3l762t1699r1020b1760],
21	substitutes	VBZ	O	substitute	advcl	7	SENT_25	[p3l1074t1699r1460b1760],
22	for	IN	O	for	_	0	SENT_25	[p3l1512t1699r1615b1760],
23	isoleucine	NN	O	isoleucine	prep_for	21	SENT_25	[p3l1665t1699r2025b1760],
24	at	IN	O	at	_	0	SENT_25	[p3l2079t1713r2144b1760],
25	residue	NN	O	residue	prep_at	21	SENT_25	[p3l10t1797r272b1858],
26	359.10	CD	NUMBER	359.10	num	25	SENT_25	[p3l358t1797r565b1858],
27	Both	CC	O	both	dep	25	SENT_25	[p3l649t1797r825b1857],
28	allelic	JJ	O	allelic	amod	29	SENT_25	[p3l911t1797r1117b1857],
29	variants	NNS	O	variant	conj	25	SENT_25	[p3l1200t1797r1484b1858],
30	have	VBP	O	have	_	0	SENT_25	[p3l1568t1797r1734b1858],
31	impaired	JJ	O	impaired	amod	32	SENT_25	[p3l1818t1797r2143b1873],
32	hydroxylation	NN	O	hydroxylation	dobj	30	SENT_25	[p3l9t1897r514b1973],
33	of	IN	O	of	_	0	SENT_25	[p3l559t1896r637b1957],
34	S-warfarin	NN	MISC	s-warfarin	prep_of	32	SENT_25	[p3l670t1896r1054b1957],
35	when	WRB	O	when	advmod	36	SENT_25	[p3l1095t1897r1292b1957],
36	expressed	VBN	O	express	advcl	30	SENT_25	[p3l1337t1897r1689b1973],
37	in	FW	O	in	nn	38	SENT_25	[p3l1732t1897r1801b1956],
38	vitro	FW	O	vitro	advmod	36	SENT_25	[p3l1842t1897r2142b1957],
39	.	.	O	.	_	0	SENT_25	[p3l1842t1897r2142b1957],

1	”’	NN	O	”’	nsubj	12	SENT_26	[p3l1842t1897r2142b1957],
2	12	CD	NUMBER	12	num	1	SENT_26	[p3l1842t1897r2142b1957],
3	The	DT	O	the	det	5	SENT_26	[p3l9t1994r158b2055],
4	CYP2C9	NN	O	cyp2c9	nn	5	SENT_26	[p3l196t1990r601b2055],
5	*	NN	O	*	dep	1	SENT_26	[p3l196t1990r601b2055],
6	3	CD	NUMBER	3	num	7	SENT_26	[p3l196t1990r601b2055],
7	variant	NN	O	variant	dep	1	SENT_26	[p3l630t1994r882b2055],
8	is	VBZ	O	be	cop	12	SENT_26	[p3l913t1994r965b2055],
9	less	JJR	O	less	mwe	10	SENT_26	[p3l999t1994r1124b2055],
10	than	IN	O	than	quantmod	11	SENT_26	[p3l1157t1994r1319b2055],
11	5	CD	PERCENT	5	num	12	SENT_26	[p3l1354t1994r1467b2057],
12	%	NN	PERCENT	%	_	0	SENT_26	[p3l1354t1994r1467b2057],
13	as	IN	O	as	_	0	SENT_26	[p3l1505t2015r1573b2055],
14	efﬁcient	NN	O	efﬁcient	prep_as	12	SENT_26	[p3l1608t1994r1899b2055],
15	as	IN	O	as	_	0	SENT_26	[p3l1931t2015r1999b2055],
16	the	DT	O	the	det	20	SENT_26	[p3l2032t1994r2144b2055],
17	wild	JJ	O	wild	amod	20	SENT_26	[p3l9t2094r350b2170],
18	—	NN	O	—	nn	20	SENT_26	[p3l9t2094r350b2170],
19	type	NN	O	type	nn	20	SENT_26	[p3l9t2094r350b2170],
20	enzyme	NN	O	enzyme	prep_as	14	SENT_26	[p3l385t2113r681b2170],
21	,	,	O	,	_	0	SENT_26	[p3l385t2113r681b2170],
22	while	IN	O	while	mark	26	SENT_26	[p3l715t2094r908b2154],
23	CYPZC9	NN	O	cypzc9	nn	24	SENT_26	[p3l946t2094r1264b2154],
24	*	NN	O	*	nsubj	26	SENT_26	[p3l1277t2090r1351b2153],
25	2	CD	NUMBER	2	dep	24	SENT_26	[p3l1277t2090r1351b2153],
26	shows	VBZ	O	show	advcl	12	SENT_26	[p3l1383t2094r1599b2154],
27	about	IN	O	about	_	0	SENT_26	[p3l1635t2094r1842b2154],
28	12	CD	PERCENT	12	num	29	SENT_26	[p3l1884t2094r2037b2156],
29	%	NN	PERCENT	%	prep_about	26	SENT_26	[p3l1884t2094r2037b2156],
30	of	IN	O	of	_	0	SENT_26	[p3l2076t2094r2153b2154],
31	wild	JJ	O	wild	amod	34	SENT_26	[p3l10t2192r351b2268],
32	—	NN	O	—	nn	34	SENT_26	[p3l10t2192r351b2268],
33	type	NN	O	type	nn	34	SENT_26	[p3l10t2192r351b2268],
34	activity	NN	O	activity	prep_of	29	SENT_26	[p3l384t2192r665b2268],
35	,	,	O	,	_	0	SENT_26	[p3l384t2192r665b2268],
36	apparently	RB	O	apparently	advmod	26	SENT_26	[p3l701t2192r1086b2268],
37	as	IN	O	as	_	0	SENT_26	[p3l1118t2212r1185b2253],
38	a	DT	O	a	det	39	SENT_26	[p3l1220t2212r1255b2252],
39	result	NN	O	result	nsubj	44	SENT_26	[p3l1286t2192r1490b2252],
40	of	IN	O	of	_	0	SENT_26	[p3l1521t2192r1599b2252],
41	the	DT	O	the	det	43	SENT_26	[p3l1620t2192r1732b2252],
42	aminoacid	JJ	O	aminoacid	amod	43	SENT_26	[p3l1766t2192r2144b2253],
43	substitution	NN	O	substitution	prep_of	39	SENT_26	[p3l13t2292r446b2352],
44	altering	VBG	O	alter	prepc_as	26	SENT_26	[p3l491t2292r764b2368],
45	the	DT	O	the	det	46	SENT_26	[p3l806t2292r918b2352],
46	interaction	NN	O	interaction	dobj	44	SENT_26	[p3l962t2292r1356b2352],
47	of	IN	O	of	_	0	SENT_26	[p3l1401t2291r1479b2352],
48	the	DT	O	the	det	49	SENT_26	[p3l1511t2292r1623b2352],
49	enzyme	NN	O	enzyme	prep_of	46	SENT_26	[p3l1669t2311r1942b2367],
50	with	IN	O	with	_	0	SENT_26	[p3l1986t2292r2145b2352],
51	cytochrome	NN	O	cytochrome	nn	53	SENT_26	[p3l13t2390r440b2466],
52	P450	NN	O	p450	nn	53	SENT_26	[p3l494t2391r682b2451],
53	oxidoreductase	NN	O	oxidoreductase	prep_with	26	SENT_26	[p3l737t2390r1430b2451],
54	.	.	O	.	_	0	SENT_26	[p3l737t2390r1430b2451],

1	“‘	RB	O	“‘	advmod	29	SENT_27	[p3l737t2390r1430b2451],
2	13	CD	NUMBER	13	dep	14	SENT_27	[p3l737t2390r1430b2451],
3	Because	IN	O	because	dep	14	SENT_27	[p3l1459t2391r1754b2451],
4	these	DT	O	these	det	6	SENT_27	[p3l1807t2390r1992b2451],
5	invitro	NN	O	invitro	nn	6	SENT_27	[p3l2045t2390r2143b2450, p3l10t2490r176b2550],
6	data	NNS	O	datum	nsubj	14	SENT_27	[p3l239t2490r392b2550],
7	and	CC	O	and	_	0	SENT_27	[p3l453t2490r587b2550],
8	some	DT	O	some	det	12	SENT_27	[p3l648t2509r834b2550],
9	preliminary	JJ	O	preliminary	amod	12	SENT_27	[p3l894t2490r1316b2566],
10	in-vivo	JJ	O	in-vivo	amod	12	SENT_27	[p3l1374t2490r1621b2550],
11	data	NNS	O	datum	nn	12	SENT_27	[p3l1684t2490r1919b2550],
12	“	NN	O	“	nsubj	14	SENT_27	[p3l1684t2490r1919b2550],
13	have	VBP	O	have	aux	14	SENT_27	[p3l1978t2490r2144b2550],
14	suggested	VBN	O	suggest	dep	29	SENT_27	[p3l14t2588r366b2664],
15	that	IN	O	that	complm	22	SENT_27	[p3l421t2588r563b2649],
16	the	DT	O	the	det	18	SENT_27	[p3l617t2588r729b2649],
17	known	JJ	O	known	amod	18	SENT_27	[p3l786t2588r1030b2649],
18	polymorphisms	NNS	O	polymorphism	nsubj	22	SENT_27	[p3l1084t2588r1647b2664],
19	in	IN	O	in	_	0	SENT_27	[p3l1703t2588r1772b2648],
20	CYPZC9	NN	O	cypzc9	prep_in	18	SENT_27	[p3l1829t2588r2147b2649],
21	signiﬁcantly	RB	O	signiﬁcantly	advmod	22	SENT_27	[p3l12t2687r449b2764],
22	impair	VBP	O	impair	ccomp	14	SENT_27	[p3l483t2688r720b2764],
23	S-warfarin	NN	MISC	s-warfarin	nn	24	SENT_27	[p3l756t2687r1136b2748],
24	metabolism	NN	O	metabolism	dobj	22	SENT_27	[p3l1171t2688r1618b2760],
25	,	,	O	,	_	0	SENT_27	[p3l1171t2688r1618b2760],
26	we	PRP	O	we	nsubj	29	SENT_27	[p3l1654t2707r1753b2748],
27	have	VBP	O	have	aux	29	SENT_27	[p3l1788t2688r1954b2748],
28	now	RB	DATE	now	advmod	29	SENT_27	[p3l1989t2707r2144b2748],
29	investigated	VBN	O	investigate	_	0	SENT_27	[p3l10t2786r443b2862],
30	whether	IN	O	whether	complm	37	SENT_27	[p3l490t2786r787b2847],
31	either	CC	O	either	dep	32	SENT_27	[p3l835t2786r1042b2847],
32	CYPZC9	NN	O	cypzc9	nsubj	51	SENT_27	[p3l1093t2786r1411b2847],
33	allelic	JJ	O	allelic	amod	34	SENT_27	[p3l1458t2786r1665b2847],
34	variant	NN	O	variant	dep	32	SENT_27	[p3l1712t2786r1964b2847],
35	was	VBD	O	be	cop	37	SENT_27	[p3l2011t2806r2143b2847],
36	more	RBR	O	more	advmod	37	SENT_27	[p3l10t2905r197b2946],
37	common	JJ	O	common	ccomp	29	SENT_27	[p3l254t2905r577b2946],
38	in	IN	O	in	_	0	SENT_27	[p3l632t2886r700b2945],
39	patients	NNS	O	patient	prep_in	37	SENT_27	[p3l753t2886r1039b2962],
40	with	IN	O	with	_	0	SENT_27	[p3l1094t2886r1254b2946],
41	a	DT	O	a	det	47	SENT_27	[p3l1310t2906r1345b2946],
42	lower	JJR	O	lower	amod	47	SENT_27	[p3l1400t2886r1601b2946],
43	than	IN	O	than	_	0	SENT_27	[p3l1653t2886r1816b2946],
44	average	JJ	O	average	amod	45	SENT_27	[p3l1873t2905r2142b2962],
45	warfarin	NN	O	warfarin	prep_than	42	SENT_27	[p3l9t2984r312b3045],
46	dose	NN	O	dose	nn	47	SENT_27	[p3l384t2984r546b3045],
47	requirement	NN	O	requirement	prep_with	39	SENT_27	[p3l618t2984r1067b3060],
48	and	CC	O	and	_	0	SENT_27	[p3l1140t2984r1272b3045],
49	have	VBP	O	have	aux	51	SENT_27	[p3l1342t2984r1508b3045],
50	also	RB	O	also	advmod	51	SENT_27	[p3l1581t2984r1718b3045],
51	examined	VBN	O	examine	conj_and	37	SENT_27	[p3l1792t2984r2143b3045],
52	whether	IN	O	whether	complm	59	SENT_27	[p3l9t3084r306b3144],
53	the	DT	O	the	det	54	SENT_27	[p3l377t3084r488b3144],
54	incidence	NN	O	incidence	nsubjpass	59	SENT_27	[p3l563t3084r909b3144],
55	of	IN	O	of	_	0	SENT_27	[p3l985t3084r1062b3144],
56	bleeding	VBG	O	bleed	amod	57	SENT_27	[p3l1124t3084r1436b3160],
57	complications	NNS	O	complication	prep_of	54	SENT_27	[p3l1510t3084r2015b3160],
58	is	VBZ	O	be	auxpass	59	SENT_27	[p3l2090t3084r2142b3144],
59	associated	VBN	O	associate	ccomp	51	SENT_27	[p3l13t3182r381b3243],
60	with	IN	O	with	_	0	SENT_27	[p3l407t3182r566b3243],
61	CYPZC9	NN	O	cypzc9	nn	62	SENT_27	[p3l594t3182r912b3243],
62	genotype	NN	O	genotype	prep_with	59	SENT_27	[p3l937t3196r1285b3258],
63	.	.	O	.	_	0	SENT_27	[p3l937t3196r1285b3258],

1	Methods	NNS	O	method	_	0	SENT_28	[p3l14t3372r401b3439],

1	The	DT	O	the	det	2	SENT_29	[p3l11t3483r143b3538],
2	investigation	NN	O	investigation	nsubjpass	4	SENT_29	[p3l184t3484r596b3551],
3	was	VBD	O	be	auxpass	4	SENT_29	[p3l635t3501r753b3538],
4	approved	VBN	O	approve	_	0	SENT_29	[p3l797t3483r1096b3551],
5	by	IN	O	by	_	0	SENT_29	[p3l1136t3483r1214b3551],
6	the	DT	O	the	det	7	SENT_29	[p3l1253t3483r1353b3538],
7	Newcastle	NNP	ORGANIZATION	Newcastle	agent	4	SENT_29	[p3l1393t3483r1726b3538],
8	upon	IN	O	upon	_	0	SENT_29	[p3l1768t3501r1935b3551],
9	Tyne	NNP	ORGANIZATION	Tyne	nn	12	SENT_29	[p3l1975t3484r2144b3551],
10	Joint	NNP	ORGANIZATION	Joint	nn	12	SENT_29	[p3l6t3573r164b3639],
11	Ethics	NNPS	ORGANIZATION	Ethics	nn	12	SENT_29	[p3l201t3573r400b3627],
12	Committee	NNP	ORGANIZATION	Committee	prep_upon	4	SENT_29	[p3l442t3573r806b3627],
13	and	CC	O	and	_	0	SENT_29	[p3l846t3573r964b3627],
14	all	PDT	O	all	predet	16	SENT_29	[p3l1002t3573r1074b3627],
15	the	DT	O	the	det	16	SENT_29	[p3l1112t3573r1211b3627],
16	participants	NNS	O	participant	nsubj	17	SENT_29	[p3l1248t3573r1629b3640],
17	gave	VBD	O	give	conj_and	4	SENT_29	[p3l1667t3590r1809b3640],
18	informed	VBN	O	inform	amod	19	SENT_29	[p3l1847t3572r2144b3627],
19	consent	NN	O	consent	dobj	17	SENT_29	[p3l13t3657r279b3698],
20	.	.	O	.	_	0	SENT_29	[p3l13t3657r279b3698],

1	Participants	NNS	O	participant	nn	2	SENT_30	[p4l15t47r473b119],
2	Patients	NNS	O	patient	nsubj	15	SENT_30	[p4l11t150r269b204],
3	whose	WP$	O	whose	dep	9	SENT_30	[p4l295t150r496b204],
4	warfarin	NN	O	warfarin	nn	6	SENT_30	[p4l522t150r791b204],
5	dose	NN	O	dose	nn	6	SENT_30	[p4l818t150r962b204],
6	requirement	NN	O	requirement	nsubj	9	SENT_30	[p4l989t150r1389b218],
7	was	VBD	O	be	cop	9	SENT_30	[p4l1413t168r1531b204],
8	1-5	CD	NUMBER	1-5	num	9	SENT_30	[p4l1566t152r1654b204],
9	mg	NN	O	mg	dep	2	SENT_30	[p4l1682t168r1783b218],
10	per	IN	O	per	_	0	SENT_30	[p4l1805t168r1910b218],
11	day	NN	DURATION	day	prep_per	9	SENT_30	[p4l1934t150r2046b218],
12	or	CC	O	or	_	0	SENT_30	[p4l2070t168r2136b204],
13	less	JJR	O	less	conj_or	11	SENT_30	[p4l12t241r143b306],
14	,	,	O	,	_	0	SENT_30	[p4l12t241r143b306],
15	had	VBD	O	have	_	0	SENT_30	[p4l184t241r304b296],
16	a	DT	O	a	det	20	SENT_30	[p4l345t259r376b296],
17	stable	JJ	O	stable	amod	20	SENT_30	[p4l417t241r601b296],
18	warfarin	NN	O	warfarin	nn	20	SENT_30	[p4l640t241r909b296],
19	dose	NN	O	dose	nn	20	SENT_30	[p4l949t241r1093b296],
20	requirement	NN	O	requirement	dobj	15	SENT_30	[p4l1134t242r1533b309],
21	for	IN	O	for	_	0	SENT_30	[p4l1572t241r1663b296],
22	at	IN	O	at	quantmod	24	SENT_30	[p4l1702t254r1760b296],
23	least	JJS	O	least	mwe	22	SENT_30	[p4l1798t241r1943b296],
24	three	CD	NUMBER	three	prep_for	20	SENT_30	[p4l1981t241r2144b296],

1	THE	DT	O	the	det	2	SENT_31	[p4l88t415r154b436],
2	LANCET	NN	O	lancet	_	0	SENT_31	[p4l163t415r293b436],
3	-	:	O	-	_	0	SENT_31	[p4l302t422r310b429],
4	Vol	NN	O	vol	dep	2	SENT_31	[p4l319t415r363b436],
5	353	CD	NUMBER	353	num	4	SENT_31	[p4l373t415r418b436],
6	-	:	O	-	_	0	SENT_31	[p4l430t422r437b429],
7	February	NNP	DATE	February	dep	4	SENT_31	[p4l447t415r562b441],
8	27	CD	DATE	27	num	7	SENT_31	[p4l572t415r610b440],
9	,	,	DATE	,	_	0	SENT_31	[p4l572t415r610b440],
10	1999	CD	DATE	1999	num	7	SENT_31	[p4l623t416r682b436],
11	717	CD	NUMBER	717	dep	7	SENT_31	[p4l2010t410r2068b436],

1	consecutive	JJ	O	consecutive	amod	3	SENT_32	[p4l13t616r387b670],
2	clinic	NN	O	clinic	nn	3	SENT_32	[p4l421t616r591b670],
3	visits	NNS	O	visit	nsubjpass	30	SENT_32	[p4l622t616r780b670],
4	with	IN	O	with	_	0	SENT_32	[p4l813t616r954b670],
5	a	DT	O	a	det	7	SENT_32	[p4l987t633r1018b670],
6	target	NN	O	target	nn	7	SENT_32	[p4l1050t628r1235b683],
7	INR	NN	O	inr	prep_with	3	SENT_32	[p4l1266t617r1413b670],
8	of	IN	O	of	_	0	SENT_32	[p4l1442t616r1511b670],
9	2-0	CD	NUMBER	2-0	number	11	SENT_32	[p4l1536t618r1631b670],
10	to	TO	O	to	dep	11	SENT_32	[p4l1665t628r1726b670],
11	3-0	CD	NUMBER	3-0	prep_of	7	SENT_32	[p4l1761t618r1878b681],
12	,	,	O	,	_	0	SENT_32	[p4l1761t618r1878b681],
13	and	CC	O	and	_	0	SENT_32	[p4l1913t616r2032b670],
14	no	DT	O	no	det	16	SENT_32	[p4l2062t633r2143b670],
15	apparent	JJ	O	apparent	amod	16	SENT_32	[p4l11t719r296b775],
16	cause	NN	O	cause	prep_of	7	SENT_32	[p4l331t725r506b761],
17	for	IN	O	for	_	0	SENT_32	[p4l541t707r632b761],
18	low-dose	JJ	O	low-dose	amod	20	SENT_32	[p4l666t707r954b761],
19	requirement	NN	O	requirement	nn	20	SENT_32	[p4l989t707r1389b775],
20	(	NN	O	(	prep_for	16	SENT_32	[p4l1428t707r1542b775],
21	eg	FW	O	eg	dep	20	SENT_32	[p4l1428t707r1542b775],
22	,	,	O	,	_	0	SENT_32	[p4l1428t707r1542b775],
23	drug	NN	O	drug	nn	24	SENT_32	[p4l1580t707r1729b775],
24	interactions	NNS	O	interaction	prep_for	16	SENT_32	[p4l1763t707r2141b761],
25	or	CC	O	or	_	0	SENT_32	[p4l12t816r79b852],
26	liver	NN	O	liver	nn	28	SENT_32	[p4l107t798r246b852],
27	disease	NN	O	disease	nn	28	SENT_32	[p4l275t798r525b865],
28	)	NN	O	)	prep_for	16	SENT_32	[p4l275t798r525b865],
29	were	VBD	O	be	auxpass	30	SENT_32	[p4l558t816r709b852],
30	recruited	VBN	O	recruit	_	0	SENT_32	[p4l739t798r1031b852],
31	from	IN	O	from	_	0	SENT_32	[p4l1060t798r1215b852],
32	an	DT	O	a	det	34	SENT_32	[p4l1247t816r1322b852],
33	anticoagulation	NN	O	anticoagulation	nn	34	SENT_32	[p4l1353t798r1852b866],
34	clinic	NN	O	clinic	prep_from	30	SENT_32	[p4l1883t798r2053b852],
35	in	IN	O	in	_	0	SENT_32	[p4l2083t798r2144b851],
36	north-east	NN	O	north-east	nn	37	SENT_32	[p4l9t889r341b944],
37	England	NNP	LOCATION	England	prep_in	34	SENT_32	[p4l366t889r655b957],
38	.	.	O	.	_	0	SENT_32	[p4l366t889r655b957],

1	Of	IN	O	of	_	0	SENT_33	[p4l687t889r776b944],
2	a	DT	O	a	det	3	SENT_33	[p4l794t907r825b943],
3	total	NN	O	total	prep_of	18	SENT_33	[p4l851t889r996b944],
4	of	IN	O	of	_	0	SENT_33	[p4l1023t889r1092b944],
5	828	CD	NUMBER	828	num	6	SENT_33	[p4l1111t892r1228b944],
6	patients	NNS	O	patient	prep_of	3	SENT_33	[p4l1256t890r1509b957],
7	registered	VBN	O	register	partmod	6	SENT_33	[p4l1536t889r1852b957],
8	with	IN	O	with	_	0	SENT_33	[p4l1876t889r2018b944],
9	the	DT	O	the	det	10	SENT_33	[p4l2043t889r2142b943],
10	clinic	NN	O	clinic	prep_with	7	SENT_33	[p4l13t980r182b1034],
11	at	IN	O	at	_	0	SENT_33	[p4l209t992r267b1034],
12	the	DT	O	the	det	13	SENT_33	[p4l291t980r390b1034],
13	time	NN	O	time	prep_at	10	SENT_33	[p4l416t980r558b1034],
14	of	IN	O	of	_	0	SENT_33	[p4l585t980r654b1034],
15	recruitment	NN	O	recruitment	prep_of	13	SENT_33	[p4l670t980r1071b1045],
16	,	,	O	,	_	0	SENT_33	[p4l670t980r1071b1045],
17	76	CD	NUMBER	76	nsubj	18	SENT_33	[p4l1101t982r1177b1034],
18	fulﬁlled	VBD	O	fulﬁlled	_	0	SENT_33	[p4l1204t980r1451b1034],
19	the	DT	O	the	det	20	SENT_33	[p4l1476t980r1575b1034],
20	requirements	NNS	O	requirement	dobj	18	SENT_33	[p4l1600t980r2028b1047],
21	for	IN	O	for	_	0	SENT_33	[p4l2054t980r2146b1034],
22	the	DT	O	the	det	23	SENT_33	[p4l9t1071r109b1125],
23	study	NN	O	study	prep_for	18	SENT_33	[p4l150t1071r341b1138],
24	.	.	O	.	_	0	SENT_33	[p4l150t1071r341b1138],

1	Of	IN	O	of	_	0	SENT_34	[p4l387t1071r475b1125],
2	these	DT	O	these	prep_of	7	SENT_34	[p4l505t1071r690b1136],
3	,	,	O	,	_	0	SENT_34	[p4l505t1071r690b1136],
4	57	CD	NUMBER	57	num	5	SENT_34	[p4l735t1073r808b1125],
5	patients	NNS	O	patient	nsubjpass	28	SENT_34	[p4l850t1071r1104b1139],
6	had	VBD	O	have	aux	7	SENT_34	[p4l1144t1071r1264b1125],
7	prescheduled	VBN	O	preschedule	_	0	SENT_34	[p4l1301t1071r1734b1139],
8	clinic	NN	O	clinic	nn	9	SENT_34	[p4l1774t1071r1944b1125],
9	visits	NNS	O	visit	dobj	7	SENT_34	[p4l1982t1071r2142b1125],
10	during	IN	O	during	_	0	SENT_34	[p4l12t1162r225b1230],
11	the	DT	O	the	det	13	SENT_34	[p4l257t1162r356b1216],
12	study	NN	O	study	nn	13	SENT_34	[p4l391t1162r566b1230],
13	period	NN	O	period	prep_during	7	SENT_34	[p4l596t1162r805b1230],
14	(	CD	NUMBER	(	dep	13	SENT_34	[p4l842t1162r991b1230],
15	July	NNP	DATE	July	tmod	13	SENT_34	[p4l842t1162r991b1230],
16	1	CD	DATE	1	num	15	SENT_34	[p4l1031t1164r1081b1227],
17	,	,	DATE	,	_	0	SENT_34	[p4l1031t1164r1081b1227],
18	1997	CD	DATE	1997	num	15	SENT_34	[p4l1125t1162r1449b1230],
19	—	CD	NUMBER	—	num	21	SENT_34	[p4l1125t1162r1449b1230],
20	]	NN	O	]	nn	21	SENT_34	[p4l1125t1162r1449b1230],
21	uly	NN	O	uly	dep	13	SENT_34	[p4l1125t1162r1449b1230],
22	31	CD	NUMBER	31	dep	21	SENT_34	[p4l1482t1164r1580b1227],
23	,	,	O	,	_	0	SENT_34	[p4l1482t1164r1580b1227],
24	1997	CD	DATE	1997	num	25	SENT_34	[p4l1624t1163r1803b1229],
25	)	NN	O	)	appos	13	SENT_34	[p4l1624t1163r1803b1229],
26	and	CC	O	and	_	0	SENT_34	[p4l1843t1162r1961b1216],
27	were	VBD	O	be	auxpass	28	SENT_34	[p4l1992t1180r2144b1216],
28	invited	VBN	O	invite	conj_and	7	SENT_34	[p4l10t1253r231b1308],
29	to	TO	O	to	aux	30	SENT_34	[p4l254t1266r316b1307],
30	take	VB	O	take	xcomp	28	SENT_34	[p4l341t1253r473b1308],
31	part	NN	O	part	dobj	30	SENT_34	[p4l496t1266r627b1321],
32	in	IN	O	in	_	0	SENT_34	[p4l650t1253r711b1307],
33	the	DT	O	the	det	34	SENT_34	[p4l734t1253r833b1307],
34	study	NN	O	study	prep_in	30	SENT_34	[p4l859t1253r1050b1321],
35	.	.	O	.	_	0	SENT_34	[p4l859t1253r1050b1321],

1	The	DT	O	the	det	4	SENT_35	[p4l1077t1253r1210b1307],
2	other	JJ	O	other	amod	4	SENT_35	[p4l1235t1253r1405b1307],
3	19	CD	NUMBER	19	num	4	SENT_35	[p4l1435t1256r1504b1308],
4	patients	NNS	O	patient	nsubj	6	SENT_35	[p4l1530t1254r1784b1321],
5	either	CC	O	either	preconj	6	SENT_35	[p4l1810t1253r1995b1307],
6	had	VBD	O	have	_	0	SENT_35	[p4l2015t1253r2135b1308],
7	clinic	NN	O	clinic	nn	8	SENT_35	[p4l13t1345r183b1399],
8	visits	NNS	O	visit	dobj	6	SENT_35	[p4l226t1345r385b1399],
9	prescheduled	VBD	O	preschedule	rcmod	8	SENT_35	[p4l429t1345r862b1412],
10	for	IN	O	for	_	0	SENT_35	[p4l905t1344r997b1399],
11	a	DT	O	a	det	15	SENT_35	[p4l1041t1362r1072b1399],
12	later	JJ	O	later	amod	15	SENT_35	[p4l1117t1345r1261b1399],
13	date	NN	O	date	nn	15	SENT_35	[p4l1304t1345r1439b1399],
14	(	NN	O	(	nn	15	SENT_35	[p4l1489t1345r1701b1411],
15	n	NN	O	n	prep_for	9	SENT_35	[p4l1489t1345r1701b1411],
16	=	JJ	O	=	amod	15	SENT_35	[p4l1489t1345r1701b1411],
17	14	CD	NUMBER	14	number	18	SENT_35	[p4l1489t1345r1701b1411],
18	)	CD	NUMBER	)	dep	16	SENT_35	[p4l1489t1345r1701b1411],
19	or	CC	O	or	_	0	SENT_35	[p4l1753t1362r1819b1399],
20	failed	VBD	O	fail	conj_or	9	SENT_35	[p4l1861t1344r2038b1399],
21	to	TO	O	to	aux	22	SENT_35	[p4l2081t1357r2143b1399],
22	attend	VB	O	attend	xcomp	20	SENT_35	[p4l12t1435r215b1489],
23	the	DT	O	the	det	25	SENT_35	[p4l257t1435r356b1489],
24	scheduled	VBN	O	schedule	amod	25	SENT_35	[p4l400t1435r724b1489],
25	visit	NN	O	visit	dobj	22	SENT_35	[p4l764t1435r896b1489],
26	during	IN	O	during	_	0	SENT_35	[p4l938t1435r1152b1502],
27	the	DT	O	the	det	31	SENT_35	[p4l1192t1435r1291b1489],
28	study	NN	O	study	nn	31	SENT_35	[p4l1336t1435r1510b1502],
29	period	NN	O	period	nn	31	SENT_35	[p4l1549t1435r1758b1502],
30	(	CD	NUMBER	(	num	31	SENT_35	[p4l1806t1435r1976b1502],
31	n	NN	O	n	prep_during	22	SENT_35	[p4l1806t1435r1976b1502],
32	=	JJ	O	=	amod	34	SENT_35	[p4l1806t1435r1976b1502],
33	5	CD	NUMBER	5	tmod	32	SENT_35	[p4l1806t1435r1976b1502],
34	)	NN	O	)	dobj	9	SENT_35	[p4l1806t1435r1976b1502],
35	and	CC	O	and	_	0	SENT_35	[p4l2025t1435r2144b1489],
36	were	VBD	O	be	auxpass	38	SENT_35	[p4l10t1544r161b1580],
37	not	RB	O	not	neg	38	SENT_35	[p4l188t1538r295b1580],
38	invited	VBN	O	invite	conj_and	6	SENT_35	[p4l322t1526r542b1580],
39	to	TO	O	to	aux	40	SENT_35	[p4l569t1538r630b1580],
40	take	VB	O	take	xcomp	38	SENT_35	[p4l658t1526r790b1580],
41	part	NN	O	part	dobj	40	SENT_35	[p4l816t1538r947b1594],
42	in	IN	O	in	_	0	SENT_35	[p4l973t1526r1034b1579],
43	the	DT	O	the	det	44	SENT_35	[p4l1060t1526r1159b1580],
44	study	NN	O	study	prep_in	40	SENT_35	[p4l1188t1526r1378b1593],
45	.	.	O	.	_	0	SENT_35	[p4l1188t1526r1378b1593],

1	Of	IN	O	of	_	0	SENT_36	[p4l1412t1526r1501b1580],
2	57	CD	NUMBER	57	num	3	SENT_36	[p4l1521t1528r1595b1580],
3	patients	NNS	O	patient	prep_of	30	SENT_36	[p4l1624t1526r1899b1594],
4	,	,	O	,	_	0	SENT_36	[p4l1624t1526r1899b1594],
5	36	CD	NUMBER	36	number	6	SENT_36	[p4l1930t1528r2006b1580],
6	(	CD	NUMBER	(	appos	3	SENT_36	[p4l2041t1526r2141b1593],
7	17	CD	NUMBER	17	num	8	SENT_36	[p4l2041t1526r2141b1593],
8	male	NN	O	male	dep	6	SENT_36	[p4l10t1617r184b1682],
9	,	,	O	,	_	0	SENT_36	[p4l10t1617r184b1682],
10	19	CD	NUMBER	19	nsubj	30	SENT_36	[p4l225t1619r294b1671],
11	female	JJ	O	female	amod	12	SENT_36	[p4l328t1617r564b1684],
12	)	JJ	O	)	amod	10	SENT_36	[p4l328t1617r564b1684],
13	aged	JJ	O	aged	advmod	10	SENT_36	[p4l603t1617r751b1685],
14	55-88	CD	NUMBER	55-88	num	16	SENT_36	[p4l784t1619r980b1671],
15	(	CD	NUMBER	(	num	16	SENT_36	[p4l1019t1617r1283b1684],
16	median	NN	O	median	dep	10	SENT_36	[p4l1019t1617r1283b1684],
17	73	CD	NUMBER	73	number	18	SENT_36	[p4l1316t1618r1418b1684],
18	)	CD	NUMBER	)	num	19	SENT_36	[p4l1316t1618r1418b1684],
19	years	NNS	NUMBER	year	tmod	16	SENT_36	[p4l1452t1635r1637b1685],
20	,	,	O	,	_	0	SENT_36	[p4l1452t1635r1637b1685],
21	who	WP	O	who	nsubj	22	SENT_36	[p4l1669t1617r1804b1671],
22	agreed	VBD	O	agree	rcmod	10	SENT_36	[p4l1838t1617r2049b1685],
23	to	TO	O	to	aux	24	SENT_36	[p4l2080t1629r2142b1671],
24	take	VB	O	take	xcomp	22	SENT_36	[p4l11t1708r143b1763],
25	part	NN	O	part	dobj	24	SENT_36	[p4l174t1721r305b1776],
26	in	IN	O	in	_	0	SENT_36	[p4l337t1709r398b1762],
27	the	DT	O	the	det	28	SENT_36	[p4l430t1708r529b1763],
28	study	NN	O	study	prep_in	24	SENT_36	[p4l564t1708r756b1776],
29	,	,	O	,	_	0	SENT_36	[p4l564t1708r756b1776],
30	formed	VBD	O	form	_	0	SENT_36	[p4l791t1708r1025b1763],
31	the	DT	O	the	det	33	SENT_36	[p4l1057t1708r1156b1763],
32	low-dose	JJ	O	low-dose	amod	33	SENT_36	[p4l1190t1708r1479b1763],
33	group	NN	O	group	dobj	30	SENT_36	[p4l1512t1726r1718b1776],
34	.	.	O	.	_	0	SENT_36	[p4l1512t1726r1718b1776],

1	Reasons	NNS	O	reason	nsubj	11	SENT_37	[p4l1756t1709r2021b1763],
2	for	IN	O	for	_	0	SENT_37	[p4l2054t1708r2146b1762],
3	refusing	VBG	O	refuse	prepc_for	1	SENT_37	[p4l10t1799r270b1867],
4	consent	NN	O	consent	dobj	3	SENT_37	[p4l307t1812r556b1854],
5	in	IN	O	in	_	0	SENT_37	[p4l591t1800r653b1853],
6	the	DT	O	the	det	9	SENT_37	[p4l688t1800r788b1854],
7	other	JJ	O	other	amod	9	SENT_37	[p4l827t1800r996b1854],
8	21	CD	NUMBER	21	num	9	SENT_37	[p4l1033t1802r1103b1853],
9	patients	NNS	O	patient	prep_in	3	SENT_37	[p4l1147t1800r1401b1867],
10	were	VBD	O	be	cop	11	SENT_37	[p4l1438t1817r1589b1854],
11	fear	NN	O	fear	_	0	SENT_37	[p4l1626t1799r1749b1854],
12	of	IN	O	of	_	0	SENT_37	[p4l1785t1799r1854b1854],
13	needles	NNS	O	needle	prep_of	11	SENT_37	[p4l1881t1800r2141b1864],
14	,	,	O	,	_	0	SENT_37	[p4l1881t1800r2141b1864],
15	lack	NN	O	lack	conj_and	11	SENT_37	[p4l12t1889r141b1942],
16	of	IN	O	of	_	0	SENT_37	[p4l164t1889r233b1942],
17	time	NN	O	time	prep_of	15	SENT_37	[p4l248t1889r410b1953],
18	,	,	O	,	_	0	SENT_37	[p4l248t1889r410b1953],
19	and	CC	O	and	_	0	SENT_37	[p4l438t1889r556b1942],
20	lack	NN	O	lack	conj_and	11	SENT_37	[p4l580t1889r709b1942],
21	of	IN	O	of	_	0	SENT_37	[p4l732t1889r802b1942],
22	interest	NN	O	interest	prep_of	20	SENT_37	[p4l816t1889r1057b1942],
23	in	IN	O	in	_	0	SENT_37	[p4l1080t1889r1141b1942],
24	research	NN	O	research	prep_in	22	SENT_37	[p4l1164t1889r1449b1942],
25	.	.	O	.	_	0	SENT_37	[p4l1164t1889r1449b1942],

1	From	IN	O	from	_	0	SENT_38	[p4l94t1981r275b2034],
2	a	DT	O	a	det	3	SENT_38	[p4l354t1998r385b2034],
3	group	NN	O	group	prep_from	22	SENT_38	[p4l462t1998r650b2048],
4	of	IN	O	of	_	0	SENT_38	[p4l730t1980r799b2034],
5	124	CD	NUMBER	124	num	7	SENT_38	[p4l875t1982r987b2033],
6	consecutive	JJ	O	consecutive	amod	7	SENT_38	[p4l1067t1980r1442b2034],
7	attendees	NNS	O	attendee	prep_of	3	SENT_38	[p4l1521t1980r1824b2034],
8	to	TO	O	to	_	0	SENT_38	[p4l1902t1992r1964b2034],
9	the	DT	O	the	det	11	SENT_38	[p4l2042t1980r2142b2034],
10	anticoagulant	JJ	O	anticoagulant	amod	11	SENT_38	[p4l12t2071r451b2139],
11	clinic	NN	O	clinic	prep_to	7	SENT_38	[p4l512t2071r682b2125],
12	invited	VBN	O	invite	partmod	11	SENT_38	[p4l743t2071r963b2125],
13	to	TO	O	to	aux	14	SENT_38	[p4l1023t2083r1084b2125],
14	take	VB	O	take	xcomp	12	SENT_38	[p4l1146t2071r1277b2125],
15	part	NN	O	part	dobj	14	SENT_38	[p4l1337t2083r1467b2139],
16	in	IN	O	in	_	0	SENT_38	[p4l1527t2071r1588b2124],
17	the	DT	O	the	det	18	SENT_38	[p4l1647t2071r1746b2125],
18	study	NN	O	study	prep_in	14	SENT_38	[p4l1808t2071r2001b2139],
19	,	,	O	,	_	0	SENT_38	[p4l1808t2071r2001b2139],
20	52	CD	NUMBER	52	num	21	SENT_38	[p4l2066t2073r2142b2125],
21	individuals	NNS	O	individual	nsubj	22	SENT_38	[p4l12t2162r363b2217],
22	(	VBP	O	(	_	0	SENT_38	[p4l417t2163r518b2229],
23	26	CD	NUMBER	26	num	24	SENT_38	[p4l417t2163r518b2229],
24	men	NNS	O	man	nsubjpass	48	SENT_38	[p4l567t2180r727b2227],
25	,	,	O	,	_	0	SENT_38	[p4l567t2180r727b2227],
26	26	CD	NUMBER	26	num	27	SENT_38	[p4l779t2165r855b2217],
27	women	NNS	O	woman	appos	24	SENT_38	[p4l902t2163r1163b2229],
28	)	JJ	O	)	amod	29	SENT_38	[p4l902t2163r1163b2229],
29	aged	JJ	O	aged	amod	27	SENT_38	[p4l1217t2162r1365b2230],
30	33-94	CD	NUMBER	33-94	number	31	SENT_38	[p4l1413t2165r1611b2217],
31	(	CD	NUMBER	(	dep	32	SENT_38	[p4l1665t2162r1929b2229],
32	median	NN	O	median	amod	27	SENT_38	[p4l1665t2162r1929b2229],
33	70-5	CD	NUMBER	70-5	num	32	SENT_38	[p4l1977t2163r2140b2229],
34	)	CD	NUMBER	)	num	35	SENT_38	[p4l1977t2163r2140b2229],
35	years	NNS	NUMBER	year	tmod	32	SENT_38	[p4l9t2271r193b2321],
36	,	,	O	,	_	0	SENT_38	[p4l9t2271r193b2321],
37	with	IN	O	with	_	0	SENT_38	[p4l218t2254r359b2308],
38	a	DT	O	a	det	40	SENT_38	[p4l384t2271r415b2308],
39	wide	JJ	O	wide	amod	40	SENT_38	[p4l439t2254r589b2308],
40	range	NN	O	range	prep_with	27	SENT_38	[p4l614t2271r791b2321],
41	of	IN	O	of	_	0	SENT_38	[p4l817t2253r886b2308],
42	daily	JJ	SET	daily	amod	45	SENT_38	[p4l902t2254r1056b2321],
43	warfarin	NN	O	warfarin	nn	45	SENT_38	[p4l1077t2253r1346b2308],
44	dose	NN	O	dose	nn	45	SENT_38	[p4l1371t2254r1515b2308],
45	requirement	NN	O	requirement	prep_of	40	SENT_38	[p4l1539t2254r1958b2321],
46	,	,	O	,	_	0	SENT_38	[p4l1539t2254r1958b2321],
47	were	VBD	O	be	auxpass	48	SENT_38	[p4l1983t2271r2135b2308],
48	recruited	VBN	O	recruit	ccomp	22	SENT_38	[p4l12t2344r303b2398],
49	to	TO	O	to	_	0	SENT_38	[p4l338t2356r400b2398],
50	the	DT	O	the	det	53	SENT_38	[p4l436t2344r536b2398],
51	clinic	NN	O	clinic	nn	53	SENT_38	[p4l573t2344r743b2398],
52	control	NN	O	control	nn	53	SENT_38	[p4l781t2344r1010b2398],
53	group	NN	O	group	prep_to	48	SENT_38	[p4l1045t2362r1233b2412],
54	during	IN	O	during	_	0	SENT_38	[p4l1271t2344r1484b2412],
55	the	DT	DATE	the	det	56	SENT_38	[p4l1518t2344r1617b2398],
56	month	NN	DATE	month	prep_during	48	SENT_38	[p4l1653t2344r1867b2398],
57	starting	VBG	O	start	partmod	56	SENT_38	[p4l1903t2344r2146b2412],
58	June	NNP	DATE	June	tmod	57	SENT_38	[p4l6t2436r155b2501],
59	5	CD	DATE	5	num	58	SENT_38	[p4l194t2437r249b2500],
60	,	,	DATE	,	_	0	SENT_38	[p4l194t2437r249b2500],
61	1998	CD	DATE	1998	num	58	SENT_38	[p4l296t2437r468b2489],
62	.	.	O	.	_	0	SENT_38	[p4l296t2437r468b2489],

1	One	CD	NUMBER	one	num	2	SENT_39	[p4l511t2435r644b2489],
2	patient	NN	O	patient	nsubjpass	10	SENT_39	[p4l679t2435r906b2503],
3	previously	RB	DATE	previously	advmod	4	SENT_39	[p4l939t2435r1272b2503],
4	included	VBN	O	include	partmod	2	SENT_39	[p4l1306t2435r1587b2489],
5	in	IN	O	in	_	0	SENT_39	[p4l1623t2435r1683b2488],
6	the	DT	O	the	det	8	SENT_39	[p4l1718t2435r1817b2489],
7	low-dose	JJ	O	low-dose	amod	8	SENT_39	[p4l1854t2435r2143b2489],
8	group	NN	O	group	prep_in	4	SENT_39	[p4l12t2544r199b2594],
9	was	VBD	O	be	auxpass	10	SENT_39	[p4l228t2544r346b2581],
10	excluded	VBN	O	exclude	_	0	SENT_39	[p4l377t2526r684b2581],
11	.	.	O	.	_	0	SENT_39	[p4l377t2526r684b2581],

1	The	DT	O	the	det	4	SENT_40	[p4l716t2526r848b2581],
2	community	NN	O	community	nn	4	SENT_40	[p4l879t2526r1250b2594],
3	control	NN	O	control	nn	4	SENT_40	[p4l1279t2526r1508b2581],
4	group	NN	O	group	nsubj	5	SENT_40	[p4l1537t2544r1724b2594],
5	consisted	VBD	O	consist	dep	9	SENT_40	[p4l1756t2526r2055b2581],
6	of	IN	O	of	_	0	SENT_40	[p4l2085t2526r2153b2580],
7	100	CD	NUMBER	100	num	8	SENT_40	[p4l19t2620r130b2672],
8	individuals	NNS	O	individual	prep_of	5	SENT_40	[p4l176t2618r528b2672],
9	(	VBP	O	(	_	0	SENT_40	[p4l578t2618r679b2685],
10	58	CD	NUMBER	58	num	11	SENT_40	[p4l578t2618r679b2685],
11	men	NNS	O	man	nsubj	9	SENT_40	[p4l724t2635r884b2682],
12	,	,	O	,	_	0	SENT_40	[p4l724t2635r884b2682],
13	42	CD	NUMBER	42	num	14	SENT_40	[p4l931t2620r1009b2671],
14	women	NNS	O	woman	appos	11	SENT_40	[p4l1053t2618r1314b2684],
15	)	JJ	O	)	amod	14	SENT_40	[p4l1053t2618r1314b2684],
16	aged	JJ	O	aged	amod	14	SENT_40	[p4l1364t2618r1512b2685],
17	38-91	CD	NUMBER	38-91	tmod	16	SENT_40	[p4l1557t2620r1748b2672],
18	(	CD	NUMBER	(	number	19	SENT_40	[p4l1805t2618r1933b2685],
19	69	CD	NUMBER	69	prep	16	SENT_40	[p4l1805t2618r1933b2685],
20	)	CD	NUMBER	)	num	21	SENT_40	[p4l1805t2618r1933b2685],
21	years	NNS	NUMBER	year	dep	19	SENT_40	[p4l1979t2635r2142b2685],
22	recruited	VBN	O	recruit	partmod	14	SENT_40	[p4l11t2708r303b2762],
23	from	IN	O	from	_	0	SENT_40	[p4l335t2708r490b2762],
24	the	DT	O	the	prep_from	22	SENT_40	[p4l520t2708r620b2762],
25	registers	VBZ	O	register	rcmod	24	SENT_40	[p4l651t2708r917b2775],
26	of	IN	O	of	_	0	SENT_40	[p4l951t2708r1020b2762],
27	general	JJ	O	general	amod	28	SENT_40	[p4l1042t2708r1275b2775],
28	practitioner	NN	O	practitioner	poss	30	SENT_40	[p4l1306t2708r1735b2775],
29	’s	POS	O	’s	_	0	SENT_40	[p4l1306t2708r1735b2775],
30	practices	NNS	O	practice	prep_of	25	SENT_40	[p4l1766t2708r2051b2775],
31	in	IN	O	in	_	0	SENT_40	[p4l2084t2708r2145b2761],
32	the	DT	O	the	det	34	SENT_40	[p4l10t2799r110b2853],
33	same	JJ	O	same	amod	34	SENT_40	[p4l148t2817r309b2853],
34	area	NN	O	area	prep_in	25	SENT_40	[p4l348t2817r479b2853],
35	of	IN	O	of	_	0	SENT_40	[p4l517t2799r586b2853],
36	north-east	NN	O	north-east	nn	37	SENT_40	[p4l613t2799r944b2853],
37	England	NNP	LOCATION	England	prep_of	34	SENT_40	[p4l980t2799r1269b2867],
38	.	.	O	.	_	0	SENT_40	[p4l980t2799r1269b2867],

1	The	DT	O	the	det	3	SENT_41	[p4l1309t2799r1441b2853],
2	recruitment	NN	O	recruitment	nn	3	SENT_41	[p4l1478t2799r1860b2853],
3	rate	NN	O	rate	nsubj	10	SENT_41	[p4l1896t2811r2017b2853],
4	for	IN	O	for	_	0	SENT_41	[p4l2054t2799r2145b2853],
5	the	DT	O	the	det	7	SENT_41	[p4l9t2890r109b2944],
6	community	NN	O	community	nn	7	SENT_41	[p4l135t2890r506b2958],
7	controls	NNS	O	control	prep_for	3	SENT_41	[p4l530t2890r788b2944],
8	was	VBD	O	be	cop	10	SENT_41	[p4l812t2908r929b2944],
9	50	CD	PERCENT	50	num	10	SENT_41	[p4l958t2890r1120b2946],
10	%	NN	PERCENT	%	_	0	SENT_41	[p4l958t2890r1120b2946],
11	.	.	O	.	_	0	SENT_41	[p4l958t2890r1120b2946],

1	Genotyping	VBG	O	genotype	partmod	14	SENT_42	[p4l17t2999r439b3075],
2	10	CD	NUMBER	10	num	3	SENT_42	[p4l19t3104r90b3156],
3	mL	NN	O	ml	nsubjpass	7	SENT_42	[p4l137t3103r254b3155],
4	of	IN	O	of	_	0	SENT_42	[p4l298t3101r367b3156],
5	blood	NN	O	blood	prep_of	3	SENT_42	[p4l402t3102r588b3156],
6	was	VBD	O	be	auxpass	7	SENT_42	[p4l633t3119r751b3156],
7	taken	VBN	O	take	ccomp	1	SENT_42	[p4l797t3102r973b3156],
8	from	IN	O	from	_	0	SENT_42	[p4l1018t3101r1173b3156],
9	each	DT	O	each	det	10	SENT_42	[p4l1221t3102r1366b3156],
10	individual	NN	O	individual	prep_from	7	SENT_42	[p4l1411t3102r1753b3167],
11	,	,	O	,	_	0	SENT_42	[p4l1411t3102r1753b3167],
12	DNA	NN	O	dna	nsubjpass	14	SENT_42	[p4l1802t3103r1982b3156],
13	was	VBD	O	be	auxpass	14	SENT_42	[p4l2025t3119r2143b3156],
14	extracted	VBN	O	extract	_	0	SENT_42	[p4l11t3191r349b3245],
15	”	NN	O	”	dobj	14	SENT_42	[p4l11t3191r349b3245],
16	and	CC	O	and	_	0	SENT_42	[p4l367t3191r485b3245],
17	analysed	VBN	O	analyse	conj_and	14	SENT_42	[p4l514t3191r789b3258],
18	by	IN	O	by	_	0	SENT_42	[p4l815t3191r893b3258],
19	PCR	NN	O	pcr	prep_by	17	SENT_42	[p4l920t3191r1094b3245],
20	.	.	O	.	_	0	SENT_42	[p4l920t3191r1094b3245],

1	Genotyping	VBG	O	genotype	_	0	SENT_43	[p4l1128t3191r1512b3258],
2	for	IN	O	for	_	0	SENT_43	[p4l1538t3191r1629b3245],
3	the	DT	O	the	det	5	SENT_43	[p4l1654t3191r1754b3245],
4	CYPZC9	NN	O	cypzc9	nn	5	SENT_43	[p4l1784t3191r2067b3245],
5	*	NN	O	*	prep_for	1	SENT_43	[p4l2078t3188r2144b3244],
6	2	CD	NUMBER	2	number	10	SENT_43	[p4l2078t3188r2144b3244],
7	and	CC	O	and	_	0	SENT_43	[p4l13t3281r131b3335],
8	CYPZC9	CD	NUMBER	cypzc9	num	11	SENT_43	[p4l159t3281r442b3335],
9	*	CD	NUMBER	*	number	10	SENT_43	[p4l453t3278r519b3335],
10	3	CD	NUMBER	3	num	11	SENT_43	[p4l453t3278r519b3335],
11	alleles	NNS	O	allele	dobj	1	SENT_43	[p4l547t3281r738b3335],
12	was	VBD	O	be	auxpass	13	SENT_43	[p4l765t3299r883b3335],
13	done	VBN	O	do	rcmod	11	SENT_43	[p4l912t3281r1070b3335],
14	by	IN	O	by	_	0	SENT_43	[p4l1095t3281r1174b3348],
15	AvaII	NN	O	avaius	nn	16	SENT_43	[p4l1194t3281r1384b3335],
16	digestion	NN	O	digestion	agent	13	SENT_43	[p4l1412t3281r1704b3349],
17	to	TO	O	to	aux	18	SENT_43	[p4l1730t3294r1792b3335],
18	detect	VB	O	detect	xcomp	13	SENT_43	[p4l1821t3281r2017b3335],
19	the	DT	O	the	det	23	SENT_43	[p4l2042t3281r2142b3335],
20	CYPZC9	NN	O	cypzc9	nn	23	SENT_43	[p4l12t3372r295b3425],
21	*	NN	O	*	nn	23	SENT_43	[p4l306t3368r372b3425],
22	2	CD	NUMBER	2	num	23	SENT_43	[p4l306t3368r372b3425],
23	allele	NN	O	allele	dobj	18	SENT_43	[p4l397t3371r560b3425],
24	and	CC	O	and	_	0	SENT_43	[p4l586t3371r704b3425],
25	N321	NN	O	n321	nn	26	SENT_43	[p4l726t3372r860b3425],
26	digestion	NN	O	digestion	dobj	18	SENT_43	[p4l885t3371r1178b3439],
27	for	IN	O	for	_	0	SENT_43	[p4l1200t3371r1292b3425],
28	CYP2C9	NN	O	cyp2c9	prep_for	23	SENT_43	[p4l1317t3368r1741b3425],
29	*	CD	NUMBER	*	number	30	SENT_43	[p4l1317t3368r1741b3425],
30	3.16	CD	NUMBER	3.16	num	28	SENT_43	[p4l1317t3368r1741b3425],

1	Assessment	NNP	O	Assessment	nsubjpass	30	SENT_44	[p4l10t3506r473b3566],
2	of	IN	O	of	_	0	SENT_44	[p4l504t3505r583b3566],
3	complications	NNS	O	complication	prep_of	1	SENT_44	[p4l600t3506r1127b3579],
4	of	IN	O	of	_	0	SENT_44	[p4l1157t3505r1236b3566],
5	anticoagulation	NN	O	anticoagulation	prep_of	3	SENT_44	[p4l1253t3506r1837b3581],
6	All	DT	O	all	det	7	SENT_44	[p4l9t3603r102b3656],
7	records	NNS	O	record	dep	3	SENT_44	[p4l173t3603r410b3657],
8	from	IN	O	from	_	0	SENT_44	[p4l482t3603r637b3657],
9	inpatient	JJ	O	inpatient	amod	10	SENT_44	[p4l707t3603r996b3670],
10	admissions	NNS	O	admission	prep_from	7	SENT_44	[p4l1067t3603r1420b3657],
11	and	CC	O	and	_	0	SENT_44	[p4l1493t3603r1611b3657],
12	visits	NNS	O	visit	conj_and	3	SENT_44	[p4l1679t3603r1839b3657],
13	to	TO	O	to	_	0	SENT_44	[p4l1910t3615r1972b3657],
14	the	DT	O	the	det	16	SENT_44	[p4l2043t3603r2143b3657],
15	anticoagulation	NN	O	anticoagulation	nn	16	SENT_44	[p4l14t3694r513b3762],
16	clinic	NN	O	clinic	prep_to	12	SENT_44	[p4l543t3694r713b3748],
17	for	IN	O	for	_	0	SENT_44	[p4l742t3694r833b3748],
18	the	DT	O	the	det	19	SENT_44	[p4l860t3694r959b3748],
19	patients	NNS	O	patient	prep_for	16	SENT_44	[p4l988t3694r1241b3762],
20	in	IN	O	in	_	0	SENT_44	[p4l1271t3694r1333b3747],
21	the	DT	O	the	det	23	SENT_44	[p4l1360t3694r1459b3748],
22	low-dose	JJ	O	low-dose	amod	23	SENT_44	[p4l1489t3694r1778b3748],
23	group	NN	O	group	prep_in	19	SENT_44	[p4l1807t3712r1995b3762],
24	and	CC	O	and	_	0	SENT_44	[p4l2027t3694r2145b3748],
25	the	DT	O	the	det	28	SENT_44	[p5l10t18r110b72],
26	clinic	NN	O	clinic	nn	28	SENT_44	[p5l169t18r339b72],
27	control	NN	O	control	nn	28	SENT_44	[p5l399t18r628b72],
28	group	NN	O	group	conj_and	23	SENT_44	[p5l686t36r873b86],
29	were	VBD	O	be	auxpass	30	SENT_44	[p5l931t36r1082b72],
30	reviewed	VBN	O	review	_	0	SENT_44	[p5l1140t18r1443b72],
31	.	.	O	.	_	0	SENT_44	[p5l1140t18r1443b72],

1	To	TO	O	to	aux	2	SENT_45	[p5l1505t19r1599b72],
2	determine	VB	O	determine	purpcl	31	SENT_45	[p5l1659t18r1986b72],
3	the	DT	O	the	det	4	SENT_45	[p5l2043t18r2143b72],
4	presence	NN	O	presence	dobj	2	SENT_45	[p5l11t127r293b177],
5	of	IN	O	of	_	0	SENT_45	[p5l330t109r399b163],
6	difﬁculties	NNS	O	difﬁculties	prep_of	4	SENT_45	[p5l426t109r761b164],
7	during	IN	O	during	_	0	SENT_45	[p5l798t109r1011b177],
8	the	DT	O	the	det	9	SENT_45	[p5l1044t109r1144b164],
9	induction	NN	O	induction	prep_during	2	SENT_45	[p5l1179t109r1491b164],
10	of	IN	O	of	_	0	SENT_45	[p5l1527t109r1596b164],
11	anticoagulation	NN	O	anticoagulation	prep_of	9	SENT_45	[p5l1623t109r2142b177],
12	,	,	O	,	_	0	SENT_45	[p5l1623t109r2142b177],
13	the	DT	O	the	det	14	SENT_45	[p5l10t201r110b255],
14	details	NNS	O	detail	nsubj	31	SENT_45	[p5l150t201r354b255],
15	of	IN	O	of	_	0	SENT_45	[p5l396t200r465b255],
16	dosage	NN	O	dosage	nn	17	SENT_45	[p5l495t201r713b268],
17	regimen	NNS	O	regimen	prep_of	14	SENT_45	[p5l752t201r1015b268],
18	used	VBN	O	use	partmod	17	SENT_45	[p5l1052t201r1221b265],
19	,	,	O	,	_	0	SENT_45	[p5l1052t201r1221b265],
20	peak	JJ	O	peak	amod	21	SENT_45	[p5l1260t201r1413b268],
21	INR	NN	O	inr	prep_of	14	SENT_45	[p5l1449t201r1596b255],
22	during	IN	O	during	_	0	SENT_45	[p5l1632t201r1845b268],
23	the	DT	DURATION	the	det	25	SENT_45	[p5l1881t201r1980b255],
24	first	JJ	DURATION	first	amod	25	SENT_45	[p5l2019t200r2144b255],
25	week	NN	DURATION	week	prep_during	21	SENT_45	[p5l10t291r192b356],
26	,	,	O	,	_	0	SENT_45	[p5l10t291r192b356],
27	and	CC	O	and	_	0	SENT_45	[p5l263t291r381b345],
28	the	DT	O	the	det	30	SENT_45	[p5l447t291r546b345],
29	medical	JJ	O	medical	amod	30	SENT_45	[p5l613t291r866b345],
30	consequences	NNS	O	consequence	conj_and	17	SENT_45	[p5l934t308r1378b358],
31	(	VBP	O	(	_	0	SENT_45	[p5l1451t291r1721b358],
32	delayed	VBN	O	delay	amod	33	SENT_45	[p5l1451t291r1721b358],
33	discharges	NNS	O	discharge	dobj	31	SENT_45	[p5l1789t291r2142b358],
34	,	,	O	,	_	0	SENT_45	[p5l1789t291r2142b358],
35	outpatient	NN	O	outpatient	nn	36	SENT_45	[p5l12t382r345b450],
36	visits	NNS	O	visit	dobj	31	SENT_45	[p5l368t382r548b447],
37	,	,	O	,	_	0	SENT_45	[p5l368t382r548b447],
38	and	CC	O	and	_	0	SENT_45	[p5l578t382r696b436],
39	referrals	NNS	O	referral	dobj	31	SENT_45	[p5l721t382r1007b449],
40	)	CD	NUMBER	)	nsubjpass	50	SENT_45	[p5l721t382r1007b449],
41	of	IN	O	of	_	0	SENT_45	[p5l1039t382r1108b436],
42	poor	JJ	O	poor	amod	43	SENT_45	[p5l1123t400r1275b450],
43	control	NN	O	control	prep_of	40	SENT_45	[p5l1301t382r1530b436],
44	of	IN	O	of	_	0	SENT_45	[p5l1557t382r1626b436],
45	anticoagulation	NN	O	anticoagulation	prep_of	43	SENT_45	[p5l1644t382r2144b450],
46	during	IN	O	during	_	0	SENT_45	[p5l13t473r226b541],
47	the	DT	O	the	det	48	SENT_45	[p5l249t473r347b527],
48	induction	NN	O	induction	prep_during	45	SENT_45	[p5l372t473r684b527],
49	were	VBD	O	be	auxpass	50	SENT_45	[p5l706t491r858b527],
50	noted	VBN	O	note	rcmod	39	SENT_45	[p5l882t473r1084b527],
51	.	.	O	.	_	0	SENT_45	[p5l882t473r1084b527],

1	Bleeding	VBG	O	bleed	dep	17	SENT_46	[p5l95t564r380b632],
2	complications	NNS	O	complication	dobj	1	SENT_46	[p5l412t564r861b632],
3	associated	VBN	O	associate	partmod	2	SENT_46	[p5l896t564r1224b619],
4	with	IN	O	with	_	0	SENT_46	[p5l1254t564r1396b619],
5	raised	VBN	O	raise	amod	6	SENT_46	[p5l1426t564r1617b619],
6	INR	NN	O	inr	prep_with	3	SENT_46	[p5l1649t565r1795b618],
7	above	IN	O	above	_	0	SENT_46	[p5l1825t564r2010b619],
8	the	DT	O	the	det	10	SENT_46	[p5l2042t564r2142b619],
9	therapeutic	JJ	O	therapeutic	amod	10	SENT_46	[p5l10t656r376b723],
10	range	NN	O	range	prep_above	6	SENT_46	[p5l414t673r591b723],
11	of	IN	O	of	prep	10	SENT_46	[p5l631t655r699b710],
12	greater	JJR	O	greater	quantmod	13	SENT_46	[p5l728t668r953b723],
13	than	IN	O	than	pobj	11	SENT_46	[p5l988t656r1133b710],
14	4-0	JJ	O	4-0	dep	13	SENT_46	[p5l1171t658r1291b720],
15	,	,	O	,	_	0	SENT_46	[p5l1171t658r1291b720],
16	were	VBD	O	be	auxpass	17	SENT_46	[p5l1330t673r1482b710],
17	classiﬁed	VBN	O	classiﬁed	_	0	SENT_46	[p5l1521t655r1811b710],
18	as	IN	O	as	mark	85	SENT_46	[p5l1850t673r1910b710],
19	minor	JJ	O	minor	amod	20	SENT_46	[p5l1948t656r2146b710],
20	(	NN	O	(	nsubjpass	85	SENT_46	[p5l15t746r336b814],
21	requiring	VBG	O	require	partmod	20	SENT_46	[p5l15t746r336b814],
22	no	DT	O	no	det	24	SENT_46	[p5l377t764r457b800],
23	additional	JJ	O	additional	amod	24	SENT_46	[p5l503t746r828b800],
24	testing	NN	O	testing	dobj	21	SENT_46	[p5l870t746r1104b814],
25	,	,	O	,	_	0	SENT_46	[p5l870t746r1104b814],
26	referral	NN	O	referral	dobj	21	SENT_46	[p5l1149t746r1402b811],
27	,	,	O	,	_	0	SENT_46	[p5l1149t746r1402b811],
28	or	CC	O	or	_	0	SENT_46	[p5l1448t764r1515b800],
29	outpatient	NN	O	outpatient	nn	30	SENT_46	[p5l1558t746r1891b814],
30	visits	NNS	O	visit	dobj	21	SENT_46	[p5l1931t746r2140b813],
31	)	VBP	O	)	rcmod	30	SENT_46	[p5l1931t746r2140b813],
32	,	,	O	,	_	0	SENT_46	[p5l1931t746r2140b813],
33	serious	JJ	O	serious	amod	34	SENT_46	[p5l12t837r234b891],
34	(	NN	O	(	conj_or	30	SENT_46	[p5l277t837r598b905],
35	requiring	VBG	O	require	partmod	34	SENT_46	[p5l277t837r598b905],
36	medical	JJ	O	medical	amod	37	SENT_46	[p5l632t837r885b891],
37	evaluation	NN	O	evaluation	dobj	35	SENT_46	[p5l922t837r1274b902],
38	,	,	O	,	_	0	SENT_46	[p5l922t837r1274b902],
39	blood	NN	O	blood	nn	40	SENT_46	[p5l1311t837r1497b891],
40	transfusion	NN	O	transfusion	conj_or	30	SENT_46	[p5l1532t837r1893b891],
41	of	IN	O	of	_	0	SENT_46	[p5l1930t837r1999b891],
42	two	CD	NUMBER	two	num	43	SENT_46	[p5l2025t849r2142b891],
43	units	NNS	O	unit	prep_of	40	SENT_46	[p5l9t929r167b983],
44	or	CC	O	or	_	0	SENT_46	[p5l242t946r308b983],
45	less	JJR	O	less	amod	46	SENT_46	[p5l378t928r539b995],
46	)	NN	O	)	prep_of	40	SENT_46	[p5l378t928r539b995],
47	,	,	O	,	_	0	SENT_46	[p5l378t928r539b995],
48	or	CC	O	or	_	0	SENT_46	[p5l615t946r681b982],
49	life	NN	O	life	nn	51	SENT_46	[p5l751t928r847b982],
50	threatening	JJ	O	threatening	amod	51	SENT_46	[p5l919t928r1290b996],
51	(	NN	O	(	conj_or	30	SENT_46	[p5l1365t929r1686b996],
52	requiring	VBG	O	require	partmod	51	SENT_46	[p5l1365t929r1686b996],
53	surgical	JJ	O	surgical	amod	56	SENT_46	[p5l1758t928r2004b996],
54	or	CC	O	or	_	0	SENT_46	[p5l2078t946r2144b983],
55	angiographic	JJ	O	angiographic	amod	56	SENT_46	[p5l13t1020r428b1087],
56	intervention	NN	O	intervention	nsubj	67	SENT_46	[p5l461t1020r874b1084],
57	,	,	O	,	_	0	SENT_46	[p5l461t1020r874b1084],
58	transfusion	NN	O	transfusion	appos	56	SENT_46	[p5l909t1019r1270b1074],
59	of	IN	O	of	_	0	SENT_46	[p5l1304t1019r1372b1074],
60	three	CD	NUMBER	three	num	63	SENT_46	[p5l1396t1020r1559b1074],
61	or	CC	O	or	_	0	SENT_46	[p5l1594t1037r1660b1074],
62	more	JJR	O	more	num	63	SENT_46	[p5l1691t1037r1857b1074],
63	units	NNS	O	unit	prep_of	58	SENT_46	[p5l1891t1020r2048b1074],
64	of	IN	O	of	_	0	SENT_46	[p5l2084t1019r2153b1074],
65	blood	NN	O	blood	prep_of	63	SENT_46	[p5l8t1110r213b1175],
66	,	,	O	,	_	0	SENT_46	[p5l8t1110r213b1175],
67	leading	VBG	O	lead	dep	52	SENT_46	[p5l251t1110r485b1177],
68	to	TO	O	to	_	0	SENT_46	[p5l519t1122r580b1164],
69	irreversible	JJ	O	irreversible	amod	70	SENT_46	[p5l616t1110r973b1164],
70	seque1ae	NN	O	seque1a	prep_to	67	SENT_46	[p5l1009t1110r1354b1177],
71	)	CD	NUMBER	)	num	74	SENT_46	[p5l1009t1110r1354b1177],
72	.3	NN	NUMBER	.3	nn	74	SENT_46	[p5l1009t1110r1354b1177],
73	Bleeding	NN	O	bleeding	nn	74	SENT_46	[p5l1391t1110r1677b1177],
74	episodes	NNS	O	episode	dobj	67	SENT_46	[p5l1711t1110r1983b1177],
75	that	WDT	O	that	nsubj	76	SENT_46	[p5l2018t1110r2145b1164],
76	occurred	VBD	O	occur	rcmod	74	SENT_46	[p5l11t1201r297b1255],
77	within	IN	O	within	_	0	SENT_46	[p5l355t1201r560b1255],
78	the	DT	O	the	det	79	SENT_46	[p5l619t1201r718b1255],
79	ﬁrst	NN	O	ﬁrst	prep_within	76	SENT_46	[p5l778t1201r903b1255],
80	4	CD	DURATION	4	num	81	SENT_46	[p5l963t1203r999b1254],
81	weeks	NNS	NUMBER	week	tmod	79	SENT_46	[p5l1059t1201r1249b1255],
82	of	IN	O	of	_	0	SENT_46	[p5l1312t1201r1381b1255],
83	anticoagulation	NN	O	anticoagulation	prep_of	79	SENT_46	[p5l1433t1201r1933b1268],
84	were	VBD	O	be	auxpass	85	SENT_46	[p5l1990t1218r2142b1255],
85	classiﬁed	VBN	O	classiﬁed	advcl	17	SENT_46	[p5l13t1292r302b1346],
86	as	RB	O	as	advmod	87	SENT_46	[p5l328t1310r388b1346],
87	early	RB	O	early	nsubjpass	17	SENT_46	[p5l414t1292r586b1360],
88	,	,	O	,	_	0	SENT_46	[p5l414t1292r586b1360],
89	the	DT	O	the	det	90	SENT_46	[p5l612t1292r711b1346],
90	rest	NN	O	rest	appos	87	SENT_46	[p5l736t1304r852b1346],
91	as	IN	O	as	_	0	SENT_46	[p5l877t1310r937b1346],
92	late	JJ	O	late	prep_as	90	SENT_46	[p5l962t1292r1093b1346],
93	.	.	O	.	_	0	SENT_46	[p5l962t1292r1093b1346],

1	Statistical	JJ	O	statistical	amod	3	SENT_47	[p5l16t1485r406b1546],
2	analysis	NN	O	analysis	nn	3	SENT_47	[p5l435t1486r738b1561],
3	Comparisons	NNS	O	comparison	nsubjpass	17	SENT_47	[p5l14t1583r442b1650],
4	of	IN	O	of	_	0	SENT_47	[p5l533t1583r602b1637],
5	genotype	NN	O	genotype	nn	6	SENT_47	[p5l681t1595r973b1650],
6	frequency	NN	O	frequency	prep_of	3	SENT_47	[p5l1061t1583r1382b1650],
7	and	CC	O	and	_	0	SENT_47	[p5l1470t1583r1588b1637],
8	frequency	NN	O	frequency	prep_of	3	SENT_47	[p5l1675t1583r1997b1650],
9	of	IN	O	of	_	0	SENT_47	[p5l2084t1583r2153b1637],
10	complications	NNS	O	complication	prep_of	6	SENT_47	[p5l11t1674r461b1742],
11	of	IN	O	of	_	0	SENT_47	[p5l493t1674r562b1728],
12	anticoagulation	NN	O	anticoagulation	prep_of	10	SENT_47	[p5l583t1674r1083b1742],
13	between	IN	O	between	_	0	SENT_47	[p5l1111t1674r1380b1728],
14	the	DT	O	the	det	15	SENT_47	[p5l1409t1674r1508b1728],
15	groups	NNS	O	group	prep_between	12	SENT_47	[p5l1538t1692r1756b1742],
16	were	VBD	O	be	auxpass	17	SENT_47	[p5l1785t1692r1936b1728],
17	made	VBN	O	make	_	0	SENT_47	[p5l1966t1674r2142b1728],
18	using	VBG	O	use	xcomp	17	SENT_47	[p5l11t1765r184b1833],
19	Fisher	NNP	PERSON	Fisher	poss	22	SENT_47	[p5l211t1765r464b1819],
20	’s	POS	O	’s	_	0	SENT_47	[p5l211t1765r464b1819],
21	exact	JJ	O	exact	amod	22	SENT_47	[p5l495t1777r661b1819],
22	test	NN	O	test	dobj	18	SENT_47	[p5l688t1777r819b1819],
23	.	.	O	.	_	0	SENT_47	[p5l688t1777r819b1819],

1	Odds	NNS	O	odds	nsubjpass	10	SENT_48	[p5l854t1765r1025b1819],
2	or	CC	O	or	_	0	SENT_48	[p5l1056t1783r1123b1819],
3	rate	NN	O	rate	nn	4	SENT_48	[p5l1149t1777r1271b1819],
4	ratios	NNS	O	ratio	nsubjpass	10	SENT_48	[p5l1300t1765r1476b1819],
5	with	IN	O	with	_	0	SENT_48	[p5l1504t1765r1646b1819],
6	95	CD	PERCENT	95	number	7	SENT_48	[p5l1676t1765r1819b1821],
7	%	NN	PERCENT	%	amod	8	SENT_48	[p5l1676t1765r1819b1821],
8	CIs	NNS	O	ci	prep_with	1	SENT_48	[p5l1854t1765r1963b1819],
9	were	VBD	O	be	auxpass	10	SENT_48	[p5l1992t1783r2143b1819],
10	calculated	VBN	O	calculate	_	0	SENT_48	[p5l12t1856r338b1911],
11	where	WRB	O	where	advmod	12	SENT_48	[p5l369t1856r563b1911],
12	appropriate	JJ	O	appropriate	advcl	10	SENT_48	[p5l598t1857r988b1924],
13	.	.	O	.	_	0	SENT_48	[p5l598t1857r988b1924],

1	Age	NNP	O	Age	nsubjpass	15	SENT_49	[p5l1024t1857r1149b1924],
2	and	CC	O	and	_	0	SENT_49	[p5l1184t1856r1302b1911],
3	duration	NN	O	duration	conj_and	1	SENT_49	[p5l1336t1856r1612b1911],
4	of	IN	O	of	_	0	SENT_49	[p5l1646t1856r1715b1911],
5	follow-up	NN	O	follow-up	prep_of	3	SENT_49	[p5l1739t1856r2048b1924],
6	in	IN	O	in	_	0	SENT_49	[p5l2083t1856r2143b1909],
7	the	DT	O	the	det	9	SENT_49	[p5l11t1948r110b2002],
8	low-dose	JJ	O	low-dose	amod	9	SENT_49	[p5l154t1948r443b2002],
9	group	NN	O	group	prep_in	5	SENT_49	[p5l487t1965r675b2015],
10	and	CC	O	and	_	0	SENT_49	[p5l721t1948r839b2002],
11	random	JJ	O	random	amod	13	SENT_49	[p5l882t1948r1136b2002],
12	clinic	NN	O	clinic	nn	13	SENT_49	[p5l1181t1948r1351b2002],
13	group	NN	O	group	prep_in	5	SENT_49	[p5l1395t1965r1582b2015],
14	were	VBD	O	be	auxpass	15	SENT_49	[p5l1625t1965r1777b2002],
15	compared	VBN	O	compare	_	0	SENT_49	[p5l1822t1948r2144b2015],
16	with	IN	O	with	_	0	SENT_49	[p5l9t2038r151b2092],
17	the	DT	O	the	det	20	SENT_49	[p5l173t2038r273b2092],
18	Mann-Whitney	NNP	O	Mann-Whitney	nn	20	SENT_49	[p5l297t2038r800b2105],
19	U	NNP	O	U	nn	20	SENT_49	[p5l822t2039r882b2092],
20	test	NN	O	test	prep_with	15	SENT_49	[p5l905t2050r1036b2092],
21	.	.	O	.	_	0	SENT_49	[p5l905t2050r1036b2092],

1	Results	NNS	O	result	nsubjpass	20	SENT_50	[p5l13t2247r353b2313],
2	CYPZC9	NN	O	cypzc9	nn	4	SENT_50	[p5l13t2353r331b2413],
3	genotype	NN	O	genotype	nn	4	SENT_50	[p5l367t2367r696b2429],
4	distributions	NNS	O	distribution	npadvmod	1	SENT_50	[p5l735t2353r1192b2413],
5	in	IN	O	in	_	0	SENT_50	[p5l1230t2353r1298b2412],
6	the	DT	O	the	det	9	SENT_50	[p5l1333t2353r1445b2413],
7	low-dose	JJ	O	low-dose	amod	9	SENT_50	[p5l1483t2353r1807b2413],
8	warfarin	NN	O	warfarin	nn	9	SENT_50	[p5l1843t2352r2146b2413],
9	group	NN	O	group	prep_in	1	SENT_50	[p5l11t2472r222b2528],
10	compared	VBN	O	compare	_	0	SENT_50	[p5l304t2452r667b2528],
11	with	IN	O	with	prepc_compared_with	9	SENT_50	[p5l744t2452r903b2513],
12	the	DT	O	the	det	14	SENT_50	[p5l981t2452r1093b2513],
13	clinic	NN	O	clinic	nn	14	SENT_50	[p5l1174t2452r1366b2513],
14	controls	NNS	O	control	pobj	9	SENT_50	[p5l1447t2452r1737b2513],
15	and	CC	O	and	_	0	SENT_50	[p5l1820t2452r1952b2513],
16	the	DT	O	the	det	18	SENT_50	[p5l2031t2452r2142b2513],
17	community	NN	O	community	nn	18	SENT_50	[p5l13t2553r431b2629],
18	controls	NNS	O	control	pobj	9	SENT_50	[p5l477t2553r767b2613],
19	are	VBP	O	be	auxpass	20	SENT_50	[p5l816t2572r923b2613],
20	summarised	VBN	O	summarise	_	0	SENT_50	[p5l971t2553r1412b2613],
21	in	IN	O	in	_	0	SENT_50	[p5l1458t2553r1527b2612],
22	table	NN	O	table	prep_in	20	SENT_50	[p5l1572t2553r1747b2613],
23	1	CD	NUMBER	1	num	22	SENT_50	[p5l1803t2555r1857b2613],
24	.	.	O	.	_	0	SENT_50	[p5l1803t2555r1857b2613],

1	In	IN	O	in	_	0	SENT_51	[p5l1909t2554r1986b2612],
2	the	DT	O	the	det	5	SENT_51	[p5l2031t2553r2143b2613],
3	low-dose	JJ	O	low-dose	amod	5	SENT_51	[p5l12t2652r337b2713],
4	warfarin	NN	O	warfarin	nn	5	SENT_51	[p5l364t2652r667b2713],
5	group	NN	O	group	prep_in	16	SENT_51	[p5l695t2672r929b2728],
6	,	,	O	,	_	0	SENT_51	[p5l695t2672r929b2728],
7	29	CD	PERCENT	29	nsubj	16	SENT_51	[p5l963t2655r1048b2713],
8	(	CD	PERCENT	(	num	10	SENT_51	[p5l1085t2653r1306b2728],
9	81	CD	PERCENT	81	num	10	SENT_51	[p5l1085t2653r1306b2728],
10	%	NN	PERCENT	%	dep	7	SENT_51	[p5l1085t2653r1306b2728],
11	)	CD	NUMBER	)	dep	7	SENT_51	[p5l1085t2653r1306b2728],
12	of	IN	O	of	_	0	SENT_51	[p5l1342t2652r1419b2713],
13	the	DT	O	the	det	15	SENT_51	[p5l1437t2652r1549b2713],
14	36	CD	NUMBER	36	num	15	SENT_51	[p5l1580t2655r1665b2713],
15	patients	NNS	O	patient	prep_of	11	SENT_51	[p5l1695t2653r1980b2728],
16	had	VBD	O	have	_	0	SENT_51	[p5l2009t2652r2144b2713],
17	one	CD	NUMBER	one	nsubj	24	SENT_51	[p5l13t2772r142b2813],
18	or	CC	O	or	_	0	SENT_51	[p5l178t2772r253b2813],
19	more	JJR	O	more	conj_or	17	SENT_51	[p5l284t2772r471b2813],
20	of	IN	O	of	_	0	SENT_51	[p5l507t2753r584b2813],
21	the	DT	O	the	det	23	SENT_51	[p5l607t2753r719b2813],
22	variant	JJ	O	variant	amod	23	SENT_51	[p5l752t2753r1004b2813],
23	alleles	NNS	O	allele	prep_of	17	SENT_51	[p5l1039t2753r1255b2813],
24	present	JJ	DATE	present	xcomp	16	SENT_51	[p5l1289t2767r1557b2829],
25	compared	VBN	O	compare	_	0	SENT_51	[p5l1591t2753r1953b2829],
26	with	IN	O	with	prepc_compared_with	24	SENT_51	[p5l1986t2753r2145b2813],
27	40	CD	PERCENT	40	num	28	SENT_51	[p5l13t2855r100b2913],
28	(	CD	PERCENT	(	pobj	24	SENT_51	[p5l139t2853r359b2928],
29	40	CD	PERCENT	40	num	30	SENT_51	[p5l139t2853r359b2928],
30	%	NN	PERCENT	%	tmod	16	SENT_51	[p5l139t2853r359b2928],
31	)	CD	NUMBER	)	number	33	SENT_51	[p5l139t2853r359b2928],
32	of	IN	O	of	quantmod	33	SENT_51	[p5l397t2852r475b2913],
33	100	CD	NUMBER	100	num	30	SENT_51	[p5l504t2855r630b2913],
34	in	IN	O	in	_	0	SENT_51	[p5l663t2853r732b2912],
35	the	DT	O	the	det	37	SENT_51	[p5l762t2852r873b2913],
36	control	NN	O	control	nn	37	SENT_51	[p5l906t2852r1164b2913],
37	group	NN	O	group	prep_in	30	SENT_51	[p5l1196t2872r1428b2928],
38	.	.	O	.	_	0	SENT_51	[p5l1196t2872r1428b2928],

1	The	DT	O	the	det	3	SENT_52	[p5l1463t2852r1611b2913],
2	odds	NNS	O	odds	nn	3	SENT_52	[p5l1644t2852r1814b2913],
3	ratio	NN	O	ratio	nsubj	29	SENT_52	[p5l1847t2853r2011b2913],
4	for	IN	O	for	_	0	SENT_52	[p5l2043t2852r2146b2913],
5	individuals	NNS	O	individual	prep_for	3	SENT_52	[p5l12t2952r408b3013],
6	with	IN	O	with	_	0	SENT_52	[p5l445t2952r604b3013],
7	a	DT	O	a	det	11	SENT_52	[p5l642t2972r677b3012],
8	low	JJ	O	low	amod	11	SENT_52	[p5l715t2952r844b3013],
9	warfarin	NN	O	warfarin	nn	11	SENT_52	[p5l878t2952r1181b3013],
10	dose	NN	O	dose	nn	11	SENT_52	[p5l1219t2952r1381b3013],
11	requirement	NN	O	requirement	prep_with	5	SENT_52	[p5l1419t2952r1869b3028],
12	having	VBG	O	have	partmod	11	SENT_52	[p5l1904t2952r2146b3028],
13	one	CD	NUMBER	one	num	16	SENT_52	[p5l11t3072r140b3113],
14	or	CC	O	or	_	0	SENT_52	[p5l182t3072r257b3113],
15	more	JJR	O	more	num	16	SENT_52	[p5l295t3072r482b3113],
16	CYPZC9	NN	O	cypzc9	npadvmod	17	SENT_52	[p5l527t3053r845b3113],
17	variant	JJ	O	variant	amod	18	SENT_52	[p5l880t3052r1133b3113],
18	alleles	NNS	O	allele	dobj	12	SENT_52	[p5l1174t3052r1390b3113],
19	compared	VBN	O	compare	_	0	SENT_52	[p5l1433t3052r1796b3128],
20	with	IN	O	with	prepc_compared_with	18	SENT_52	[p5l1834t3052r1993b3113],
21	the	DT	O	the	det	23	SENT_52	[p5l2032t3052r2144b3113],
22	normal	JJ	O	normal	amod	23	SENT_52	[p5l9t3152r269b3212],
23	population	NN	O	population	pobj	18	SENT_52	[p5l305t3152r702b3228],
24	was	VBD	O	be	cop	29	SENT_52	[p5l737t3172r869b3213],
25	6-21	CD	PERCENT	6-21	num	29	SENT_52	[p5l911t3154r1056b3213],
26	(	CD	PERCENT	(	number	27	SENT_52	[p5l1108t3152r1297b3227],
27	95	CD	PERCENT	95	dep	28	SENT_52	[p5l1108t3152r1297b3227],
28	%	NN	PERCENT	%	dep	29	SENT_52	[p5l1108t3152r1297b3227],
29	CI	NN	O	ci	_	0	SENT_52	[p5l1341t3152r1432b3213],
30	2-48-15-6	CD	NUMBER	2-48-15-6	num	31	SENT_52	[p5l1471t3152r1883b3227],
31	)	NN	O	)	dep	29	SENT_52	[p5l1471t3152r1883b3227],
32	.	.	O	.	_	0	SENT_52	[p5l1471t3152r1883b3227],

1	When	WRB	O	when	advmod	10	SENT_53	[p5l1923t3152r2143b3213],
2	possession	NN	O	possession	nsubj	10	SENT_53	[p5l9t3253r392b3329],
3	of	IN	O	of	_	0	SENT_53	[p5l460t3252r538b3313],
4	either	DT	O	either	preconj	5	SENT_53	[p5l596t3253r804b3313],
5	one	CD	NUMBER	one	prep_of	2	SENT_53	[p5l870t3272r998b3313],
6	or	CC	O	or	_	0	SENT_53	[p5l1068t3272r1143b3313],
7	two	CD	NUMBER	two	num	9	SENT_53	[p5l1207t3267r1338b3313],
8	variant	JJ	O	variant	amod	9	SENT_53	[p5l1405t3253r1658b3313],
9	alleles	NNS	O	allele	prep_of	2	SENT_53	[p5l1726t3253r1942b3313],
10	was	VBD	O	be	_	0	SENT_53	[p5l2009t3272r2141b3313],

1	Genotype	NN	O	genotype	nn	3	SENT_54	[p5l11t3532r241b3586],
2	Low-dose	NN	O	low-dose	nn	3	SENT_54	[p5l549t3533r773b3576],
3	group	NN	O	group	_	0	SENT_54	[p5l791t3539r929b3586],
4	Random	NNP	O	Random	dep	3	SENT_54	[p5l1030t3533r1224b3576],
5	clinic	NN	O	clinic	nn	6	SENT_54	[p5l1245t3532r1374b3576],
6	community	NN	O	community	dep	3	SENT_54	[p5l1597t3532r1873b3586],

1	(	NN	O	(	nn	2	SENT_55	[p5l549t3601r715b3654],
2	n	NN	O	n	_	0	SENT_55	[p5l549t3601r715b3654],
3	=	JJ	O	=	quantmod	5	SENT_55	[p5l549t3601r715b3654],
4	36	CD	NUMBER	36	number	5	SENT_55	[p5l549t3601r715b3654],
5	)	CD	NUMBER	)	num	9	SENT_55	[p5l549t3601r715b3654],
6	control	NN	O	control	nn	9	SENT_55	[p5l1028t3601r1197b3644],
7	group	NN	O	group	nn	9	SENT_55	[p5l1217t3607r1354b3655],
8	(	CD	NUMBER	(	num	9	SENT_55	[p5l1374t3601r1539b3654],
9	n	NN	O	n	dep	2	SENT_55	[p5l1374t3601r1539b3654],
10	=	JJ	O	=	quantmod	12	SENT_55	[p5l1374t3601r1539b3654],
11	52	CD	NUMBER	52	number	12	SENT_55	[p5l1374t3601r1539b3654],
12	)	CD	NUMBER	)	num	16	SENT_55	[p5l1374t3601r1539b3654],
13	control	NN	O	control	nn	16	SENT_55	[p5l1597t3601r1766b3644],
14	group	NN	O	group	nn	16	SENT_55	[p5l1785t3607r1923b3655],
15	(	CD	NUMBER	(	num	16	SENT_55	[p5l1942t3601r2140b3654],
16	n	NN	O	n	dep	2	SENT_55	[p5l1942t3601r2140b3654],
17	=	JJ	O	=	amod	16	SENT_55	[p5l1942t3601r2140b3654],
18	100	CD	NUMBER	100	number	19	SENT_55	[p5l1942t3601r2140b3654],
19	)	CD	NUMBER	)	dep	17	SENT_55	[p5l1942t3601r2140b3654],

1	CYP2C9	NN	O	cyp2c9	nn	2	SENT_56	[p5l16t3731r381b3784],
2	*	NN	O	*	_	0	SENT_56	[p5l16t3731r381b3784],
3	1	CD	NUMBER	1	dep	2	SENT_56	[p5l16t3731r381b3784],
4	/	:	O	/	punct	2	SENT_56	[p5l16t3731r381b3784],
5	*	CD	NUMBER	*	dep	14	SENT_56	[p5l16t3731r381b3784],
6	1	CD	NUMBER	1	number	7	SENT_56	[p5l16t3731r381b3784],
7	7	CD	NUMBER	7	num	8	SENT_56	[p5l550t3731r576b3774],
8	(	NN	O	(	dep	5	SENT_56	[p5l598t3731r746b3784],
9	0-19	CD	NUMBER	0-19	num	10	SENT_56	[p5l598t3731r746b3784],
10	)	CD	NUMBER	)	dep	8	SENT_56	[p5l598t3731r746b3784],
11	32	CD	NUMBER	32	num	12	SENT_56	[p5l1031t3731r1092b3775],
12	(	NN	O	(	dep	14	SENT_56	[p5l1113t3731r1262b3784],
13	0-62	CD	NUMBER	0-62	num	14	SENT_56	[p5l1113t3731r1262b3784],
14	)	CD	NUMBER	)	dep	18	SENT_56	[p5l1113t3731r1262b3784],
15	60	CD	NUMBER	60	num	16	SENT_56	[p5l1597t3731r1658b3775],
16	(	NN	O	(	dep	14	SENT_56	[p5l1679t3731r1828b3784],
17	0-60	CD	NUMBER	0-60	num	18	SENT_56	[p5l1679t3731r1828b3784],
18	)	NN	O	)	dep	2	SENT_56	[p5l1679t3731r1828b3784],

1	CYP2C9	NN	O	cyp2c9	nn	2	SENT_57	[p6l16t25r385b78],
2	*	NN	O	*	_	0	SENT_57	[p6l16t25r385b78],
3	1	CD	NUMBER	1	dep	2	SENT_57	[p6l16t25r385b78],
4	/	:	O	/	punct	2	SENT_57	[p6l16t25r385b78],
5	*	CD	NUMBER	*	dep	14	SENT_57	[p6l16t25r385b78],
6	2	CD	NUMBER	2	number	7	SENT_57	[p6l16t25r385b78],
7	12	CD	NUMBER	12	num	8	SENT_57	[p6l552t25r612b68],
8	(	NN	O	(	dep	5	SENT_57	[p6l633t25r781b78],
9	0-33	CD	NUMBER	0-33	num	10	SENT_57	[p6l633t25r781b78],
10	)	CD	NUMBER	)	dep	8	SENT_57	[p6l633t25r781b78],
11	9	CD	NUMBER	9	num	12	SENT_57	[p6l1030t25r1058b68],
12	(	NN	O	(	dep	14	SENT_57	[p6l1079t25r1228b78],
13	0-17	CD	NUMBER	0-17	num	14	SENT_57	[p6l1079t25r1228b78],
14	)	CD	NUMBER	)	dep	21	SENT_57	[p6l1079t25r1228b78],
15	20	CD	NUMBER	20	num	16	SENT_57	[p6l1597t25r1658b68],
16	(	NN	O	(	dep	14	SENT_57	[p6l1679t25r1828b78],
17	0-20	CD	NUMBER	0-20	number	18	SENT_57	[p6l1679t25r1828b78],
18	)	CD	NUMBER	)	num	20	SENT_57	[p6l1679t25r1828b78],
19	CYP2C9	NN	O	cyp2c9	nn	20	SENT_57	[p6l16t113r384b167],
20	*	NN	O	*	dep	16	SENT_57	[p6l16t113r384b167],
21	1	CD	NUMBER	1	dep	2	SENT_57	[p6l16t113r384b167],
22	/	:	O	/	punct	21	SENT_57	[p6l16t113r384b167],
23	*	CD	NUMBER	*	dep	32	SENT_57	[p6l16t113r384b167],
24	3	CD	NUMBER	3	number	25	SENT_57	[p6l16t113r384b167],
25	10	CD	NUMBER	10	num	26	SENT_57	[p6l552t113r612b157],
26	(	NN	O	(	dep	23	SENT_57	[p6l633t113r781b167],
27	0-28	CD	NUMBER	0-28	num	28	SENT_57	[p6l633t113r781b167],
28	)	CD	NUMBER	)	dep	26	SENT_57	[p6l633t113r781b167],
29	10	CD	NUMBER	10	num	30	SENT_57	[p6l1031t113r1091b157],
30	(	NN	O	(	dep	32	SENT_57	[p6l1112t113r1260b167],
31	0-19	CD	NUMBER	0-19	num	32	SENT_57	[p6l1112t113r1260b167],
32	)	CD	NUMBER	)	dep	39	SENT_57	[p6l1112t113r1260b167],
33	17	CD	NUMBER	17	num	34	SENT_57	[p6l1599t114r1658b156],
34	(	NN	O	(	dep	32	SENT_57	[p6l1680t113r1829b167],
35	0-17	CD	NUMBER	0-17	number	36	SENT_57	[p6l1680t113r1829b167],
36	)	CD	NUMBER	)	num	38	SENT_57	[p6l1680t113r1829b167],
37	CYP2C9	NN	O	cyp2c9	nn	38	SENT_57	[p6l15t201r383b254],
38	*	NN	O	*	dep	34	SENT_57	[p6l15t201r383b254],
39	2	CD	NUMBER	2	dep	21	SENT_57	[p6l15t201r383b254],
40	/	:	O	/	punct	39	SENT_57	[p6l15t201r383b254],
41	*	CD	NUMBER	*	dep	50	SENT_57	[p6l15t201r383b254],
42	3	CD	NUMBER	3	number	43	SENT_57	[p6l15t201r383b254],
43	5	CD	NUMBER	5	dep	41	SENT_57	[p6l549t201r578b245],
44	(	NN	O	(	nn	47	SENT_57	[p6l599t201r747b254],
45	0-14	CD	NUMBER	0-14	num	47	SENT_57	[p6l599t201r747b254],
46	)	NN	O	)	nn	47	SENT_57	[p6l599t201r747b254],
47	o	NN	O	o	dep	43	SENT_57	[p6l1028t201r1058b245],
48	(	CD	NUMBER	(	dep	50	SENT_57	[p6l1079t201r1227b254],
49	o-oo	JJ	O	o-oo	amod	50	SENT_57	[p6l1079t201r1227b254],
50	)	NN	O	)	dep	56	SENT_57	[p6l1079t201r1227b254],
51	2	CD	NUMBER	2	number	52	SENT_57	[p6l1599t201r1626b244],
52	(	CD	NUMBER	(	dep	50	SENT_57	[p6l1648t201r1796b254],
53	0-02	CD	NUMBER	0-02	num	54	SENT_57	[p6l1648t201r1796b254],
54	)	CD	NUMBER	)	dep	52	SENT_57	[p6l1648t201r1796b254],
55	CYP2C9	NN	O	cyp2c9	nn	56	SENT_57	[p6l16t289r385b342],
56	*	NN	O	*	dep	57	SENT_57	[p6l16t289r385b342],
57	2	CD	NUMBER	2	dep	39	SENT_57	[p6l16t289r385b342],
58	/	:	O	/	punct	57	SENT_57	[p6l16t289r385b342],
59	*	CD	NUMBER	*	dep	66	SENT_57	[p6l16t289r385b342],
60	2	CD	NUMBER	2	number	61	SENT_57	[p6l16t289r385b342],
61	2	CD	NUMBER	2	dep	59	SENT_57	[p6l551t289r579b332],
62	(	CD	NUMBER	(	num	63	SENT_57	[p6l600t289r749b342],
63	0-06	CD	NUMBER	0-06	dep	61	SENT_57	[p6l600t289r749b342],
64	)	NN	O	)	dep	66	SENT_57	[p6l600t289r749b342],
65	1	CD	NUMBER	1	num	64	SENT_57	[p6l1032t289r1059b332],
66	(	CD	NUMBER	(	dep	75	SENT_57	[p6l1080t289r1229b342],
67	0-02	CD	NUMBER	0-02	num	69	SENT_57	[p6l1080t289r1229b342],
68	)	NN	O	)	nn	69	SENT_57	[p6l1080t289r1229b342],
69	o	NN	O	o	dep	66	SENT_57	[p6l1597t289r1626b332],
70	(	CD	NUMBER	(	num	73	SENT_57	[p6l1647t289r1795b342],
71	o-oo	JJ	O	o-oo	amod	73	SENT_57	[p6l1647t289r1795b342],
72	)	NN	O	)	nn	73	SENT_57	[p6l1647t289r1795b342],
73	CYP2C9	NN	O	cyp2c9	dep	69	SENT_57	[p6l15t377r384b431],
74	*	CD	NUMBER	*	num	75	SENT_57	[p6l15t377r384b431],
75	3	CD	NUMBER	3	dep	57	SENT_57	[p6l15t377r384b431],
76	/	:	O	/	punct	75	SENT_57	[p6l15t377r384b431],
77	*	CD	NUMBER	*	num	79	SENT_57	[p6l15t377r384b431],
78	3	CD	NUMBER	3	num	79	SENT_57	[p6l15t377r384b431],
79	o	NN	O	o	dep	86	SENT_57	[p6l549t377r579b421],
80	(	CD	NUMBER	(	num	82	SENT_57	[p6l599t377r748b431],
81	o-oo	JJ	O	o-oo	amod	82	SENT_57	[p6l599t377r748b431],
82	)	NN	O	)	dep	79	SENT_57	[p6l599t377r748b431],
83	o	NN	O	o	dep	86	SENT_57	[p6l1029t377r1058b421],
84	(	CD	NUMBER	(	num	83	SENT_57	[p6l1079t377r1228b431],
85	o-oo	JJ	O	o-oo	amod	86	SENT_57	[p6l1079t377r1228b431],
86	)	NN	O	)	dep	90	SENT_57	[p6l1079t377r1228b431],
87	1	CD	NUMBER	1	num	88	SENT_57	[p6l1598t378r1625b420],
88	(	CD	NUMBER	(	dep	86	SENT_57	[p6l1646t377r1795b431],
89	0-01	CD	NUMBER	0-01	num	90	SENT_57	[p6l1646t377r1795b431],
90	)	NN	O	)	dep	75	SENT_57	[p6l1646t377r1795b431],

1	Table	NNP	O	Table	_	0	SENT_58	[p6l10t544r188b598],
2	1	CD	NUMBER	1	num	1	SENT_58	[p6l219t544r276b597],
3	:	:	O	:	_	0	SENT_58	[p6l219t544r276b597],
4	CYP2C9	CD	NUMBER	cyp2c9	num	6	SENT_58	[p6l313t544r592b598],
5	genotype	NN	O	genotype	nn	6	SENT_58	[p6l610t546r918b610],
6	distribution	NN	O	distribution	dep	1	SENT_58	[p6l945t544r1323b598],
7	considered	VBN	O	consider	partmod	6	SENT_58	[p6l11t644r405b704],
8	separately	RB	O	separately	advmod	7	SENT_58	[p6l435t644r817b720],
9	,	,	O	,	_	0	SENT_58	[p6l435t644r817b720],
10	the	DT	O	the	det	12	SENT_58	[p6l849t644r961b704],
11	odds	NNS	O	odds	nn	12	SENT_58	[p6l992t644r1162b704],
12	ratio	NN	O	ratio	nsubj	34	SENT_58	[p6l1192t644r1357b704],
13	for	IN	O	for	_	0	SENT_58	[p6l1387t643r1490b704],
14	a	DT	O	a	det	15	SENT_58	[p6l1519t663r1553b704],
15	patient	NN	O	patient	prep_for	12	SENT_58	[p6l1581t644r1836b720],
16	on	IN	O	on	_	0	SENT_58	[p6l1866t663r1955b704],
17	lowdose	NN	O	lowdose	nn	18	SENT_58	[p6l1984t644r2142b704, p6l11t743r173b804],
18	warfarin	NN	O	warfarin	prep_on	15	SENT_58	[p6l206t743r509b804],
19	with	IN	O	with	_	0	SENT_58	[p6l540t743r700b804],
20	one	CD	NUMBER	one	num	22	SENT_58	[p6l734t763r863b803],
21	Variant	JJ	O	variant	amod	22	SENT_58	[p6l895t743r1148b804],
22	allele	NN	O	allele	prep_with	18	SENT_58	[p6l1182t743r1365b803],
23	only	RB	O	only	advmod	24	SENT_58	[p6l1401t743r1556b819],
24	compared	VBN	O	compare	partmod	22	SENT_58	[p6l1589t743r1952b819],
25	with	IN	O	with	_	0	SENT_58	[p6l1983t743r2143b804],
26	the	DT	O	the	det	28	SENT_58	[p6l9t844r121b904],
27	general	JJ	O	general	amod	28	SENT_58	[p6l153t844r415b920],
28	population	NN	O	population	prep_with	24	SENT_58	[p6l445t844r842b920],
29	was	VBD	O	be	cop	34	SENT_58	[p6l871t863r1004b904],
30	2-68	CD	PERCENT	2-68	num	34	SENT_58	[p6l1039t846r1192b904],
31	(	CD	PERCENT	(	number	32	SENT_58	[p6l1232t844r1421b919],
32	95	CD	PERCENT	95	dep	33	SENT_58	[p6l1232t844r1421b919],
33	%	NN	PERCENT	%	dep	34	SENT_58	[p6l1232t844r1421b919],
34	CI	NN	O	ci	dep	7	SENT_58	[p6l1460t844r1551b904],
35	1-22-5-86	CD	NUMBER	1-22-5-86	num	36	SENT_58	[p6l1591t844r1970b919],
36	)	NN	O	)	dep	34	SENT_58	[p6l1591t844r1970b919],
37	and	CC	O	and	_	0	SENT_58	[p6l2005t844r2138b904],
38	with	IN	O	with	mark	47	SENT_58	[p6l8t943r168b1004],
39	two	CD	NUMBER	two	num	41	SENT_58	[p6l193t957r325b1004],
40	variant	JJ	O	variant	amod	41	SENT_58	[p6l351t943r604b1004],
41	alleles	NNS	O	allele	nsubj	47	SENT_58	[p6l632t943r848b1004],
42	was	VBD	O	be	cop	47	SENT_58	[p6l875t963r1008b1004],
43	7-8	CD	PERCENT	7-8	num	47	SENT_58	[p6l1038t946r1144b1004],
44	(	CD	PERCENT	(	number	45	SENT_58	[p6l1180t943r1369b1018],
45	95	CD	PERCENT	95	dep	46	SENT_58	[p6l1180t943r1369b1018],
46	%	NN	PERCENT	%	dep	47	SENT_58	[p6l1180t943r1369b1018],
47	CI	NN	O	ci	conj_and	34	SENT_58	[p6l1404t943r1495b1004],
48	1-90-32-1	CD	NUMBER	1-90-32-1	num	49	SENT_58	[p6l1531t944r1936b1018],
49	)	NN	O	)	dep	47	SENT_58	[p6l1531t944r1936b1018],
50	.	.	O	.	_	0	SENT_58	[p6l1531t944r1936b1018],

1	Genotype	NN	O	genotype	nn	4	SENT_59	[p6l96t1044r451b1120],
2	and	CC	O	and	_	0	SENT_59	[p6l489t1044r622b1104],
3	allele	NN	O	allele	conj_and	1	SENT_59	[p6l660t1044r843b1104],
4	frequencies	NNS	O	frequency	nsubjpass	6	SENT_59	[p6l880t1044r1293b1120],
5	were	VBD	O	be	auxpass	6	SENT_59	[p6l1330t1064r1500b1104],
6	measured	VBN	O	measure	_	0	SENT_59	[p6l1537t1044r1890b1104],
7	in	IN	O	in	_	0	SENT_59	[p6l1926t1044r1994b1103],
8	the	DT	O	the	det	9	SENT_59	[p6l2029t1044r2141b1104],
9	clinic	NN	O	clinic	prep_in	6	SENT_59	[p6l11t1143r203b1204],
10	controls	VBZ	O	control	rcmod	9	SENT_59	[p6l286t1143r576b1204],
11	to	TO	O	to	aux	12	SENT_59	[p6l658t1158r728b1204],
12	test	VB	O	test	xcomp	10	SENT_59	[p6l810t1158r937b1204],
13	whether	IN	O	whether	complm	18	SENT_59	[p6l1016t1143r1313b1204],
14	particular	JJ	O	particular	amod	16	SENT_59	[p6l1390t1143r1745b1219],
15	CYPZC9	NN	O	cypzc9	nn	16	SENT_59	[p6l1826t1144r2144b1204],
16	genotypes	NNS	O	genotype	nsubjpass	18	SENT_59	[p6l10t1258r371b1320],
17	were	VBD	O	be	auxpass	18	SENT_59	[p6l435t1263r606b1304],
18	associated	VBN	O	associate	ccomp	12	SENT_59	[p6l672t1244r1041b1304],
19	with	IN	O	with	_	0	SENT_59	[p6l1103t1244r1262b1304],
20	an	DT	O	a	det	22	SENT_59	[p6l1328t1263r1412b1304],
21	increased	VBN	O	increase	amod	22	SENT_59	[p6l1476t1244r1817b1304],
22	risk	NN	O	risk	prep_with	18	SENT_59	[p6l1881t1244r2012b1304],
23	of	IN	O	of	_	0	SENT_59	[p6l2075t1244r2153b1304],
24	requiring	VBG	O	require	prepc_of	22	SENT_59	[p6l10t1344r345b1419],
25	anticoagulant	JJ	O	anticoagulant	amod	26	SENT_59	[p6l441t1343r935b1419],
26	treatment	NN	O	treatment	dobj	24	SENT_59	[p6l1030t1358r1405b1404],
27	.	.	O	.	_	0	SENT_59	[p6l1030t1358r1405b1404],

1	There	EX	O	there	expl	2	SENT_60	[p6l1505t1343r1726b1404],
2	was	VBD	O	be	_	0	SENT_60	[p6l1821t1363r1953b1404],
3	no	DT	O	no	det	5	SENT_60	[p6l2051t1363r2141b1404],
4	significant	JJ	O	significant	amod	5	SENT_60	[p6l11t1443r385b1519],
5	difference	NN	O	difference	nsubj	2	SENT_60	[p6l439t1443r797b1504],
6	in	IN	O	in	_	0	SENT_60	[p6l851t1443r920b1503],
7	C	NN	O	c	nn	10	SENT_60	[p6l974t1443r1033b1503],
8	YPZC9	NN	O	ypzc9	nn	10	SENT_60	[p6l1040t1443r1293b1503],
9	genotype	NN	O	genotype	nn	10	SENT_60	[p6l1344t1457r1672b1519],
10	frequencies	NNS	O	frequency	prep_in	5	SENT_60	[p6l1727t1443r2140b1519],
11	between	IN	O	between	_	0	SENT_60	[p6l8t1543r312b1604],
12	the	DT	O	the	det	14	SENT_60	[p6l355t1543r467b1604],
13	clinic	NN	O	clinic	nn	14	SENT_60	[p6l513t1543r704b1604],
14	controls	NNS	O	control	prep_between	10	SENT_60	[p6l751t1543r1041b1604],
15	and	CC	O	and	_	0	SENT_60	[p6l1088t1543r1221b1604],
16	the	DT	O	the	det	19	SENT_60	[p6l1264t1543r1376b1604],
17	community	NN	O	community	nn	19	SENT_60	[p6l1422t1544r1840b1619],
18	control	NN	O	control	nn	19	SENT_60	[p6l1884t1543r2142b1604],
19	group	NN	O	group	prep_between	10	SENT_60	[p6l10t1663r242b1719],
20	.	.	O	.	_	0	SENT_60	[p6l10t1663r242b1719],

1	Age	NNP	O	Age	nsubj	6	SENT_61	[p6l289t1644r430b1719],
2	and	CC	O	and	_	0	SENT_61	[p6l477t1643r609b1704],
3	sex	NN	O	sex	conj_and	1	SENT_61	[p6l654t1663r767b1703],
4	were	VBD	O	be	cop	6	SENT_61	[p6l808t1663r978b1704],
5	not	RB	O	not	neg	6	SENT_61	[p6l1023t1657r1143b1703],
6	confounders	NNS	O	confounder	_	0	SENT_61	[p6l1188t1643r1639b1703],
7	between	IN	O	between	_	0	SENT_61	[p6l1683t1643r1987b1704],
8	the	DT	O	the	det	10	SENT_61	[p6l2030t1643r2142b1703],
9	low-dose	JJ	O	low-dose	amod	10	SENT_61	[p6l10t1744r335b1804],
10	group	NN	O	group	prep_between	6	SENT_61	[p6l383t1763r594b1820],
11	and	CC	O	and	_	0	SENT_61	[p6l644t1744r777b1804],
12	clinic	NN	O	clinic	nn	13	SENT_61	[p6l825t1744r1016b1804],
13	controls	NNS	O	control	conj_and	10	SENT_61	[p6l1066t1744r1356b1804],
14	because	IN	O	because	mark	20	SENT_61	[p6l1403t1744r1690b1804],
15	the	DT	O	the	det	16	SENT_61	[p6l1737t1744r1848b1804],
16	groups	NNS	O	group	nsubj	20	SENT_61	[p6l1896t1763r2141b1820],
17	were	VBD	O	be	cop	20	SENT_61	[p6l9t1863r179b1904],
18	not	RB	O	not	neg	20	SENT_61	[p6l240t1857r361b1904],
19	signiﬁcantly	RB	O	signiﬁcantly	advmod	20	SENT_61	[p6l423t1843r860b1919],
20	different	JJ	O	different	advcl	6	SENT_61	[p6l921t1843r1229b1904],
21	with	IN	O	with	_	0	SENT_61	[p6l1288t1843r1447b1904],
22	respect	NN	O	respect	prep_with	20	SENT_61	[p6l1507t1857r1765b1919],
23	to	TO	O	to	_	0	SENT_61	[p6l1825t1857r1894b1904],
24	these	DT	O	these	det	25	SENT_61	[p6l1957t1843r2142b1904],
25	factors	NNS	O	factor	prep_to	20	SENT_61	[p6l10t1944r273b2004],
26	.	.	O	.	_	0	SENT_61	[p6l10t1944r273b2004],

1	A	DT	O	a	det	4	SENT_62	[p6l312t1945r373b2003],
2	further	JJ	O	further	amod	4	SENT_62	[p6l408t1944r661b2004],
3	control	NN	O	control	nn	4	SENT_62	[p6l696t1944r954b2004],
4	group	NN	O	group	nsubj	20	SENT_62	[p6l991t1963r1202b2020],
5	of	IN	O	of	_	0	SENT_62	[p6l1242t1944r1319b2004],
6	37	CD	NUMBER	37	num	7	SENT_62	[p6l1347t1946r1432b2004],
7	patients	NNS	O	patient	prep_of	4	SENT_62	[p6l1470t1944r1756b2020],
8	randomly	RB	O	randomly	advmod	9	SENT_62	[p6l1794t1944r2145b2020],
9	selected	VBN	O	select	partmod	7	SENT_62	[p6l12t2043r300b2104],
10	from	IN	O	from	_	0	SENT_62	[p6l353t2043r527b2104],
11	patients	NNS	O	patient	prep_from	9	SENT_62	[p6l579t2043r864b2119],
12	attending	VBG	O	attend	partmod	11	SENT_62	[p6l921t2043r1265b2119],
13	another	DT	O	another	det	15	SENT_62	[p6l1318t2043r1598b2104],
14	anticoagulant	JJ	O	anticoagulant	amod	15	SENT_62	[p6l1650t2043r2144b2119],
15	clinic	NN	O	clinic	dobj	12	SENT_62	[p6l12t2144r204b2204],
16	in	IN	O	in	_	0	SENT_62	[p6l234t2144r303b2203],
17	the	DT	O	the	det	19	SENT_62	[p6l332t2144r444b2204],
18	same	JJ	O	same	amod	19	SENT_62	[p6l476t2163r658b2204],
19	region	NN	O	region	prep_in	15	SENT_62	[p6l688t2144r917b2220],
20	had	VBD	O	have	_	0	SENT_62	[p6l945t2144r1080b2204],
21	the	DT	O	the	det	25	SENT_62	[p6l1110t2144r1221b2204],
22	same	JJ	O	same	amod	25	SENT_62	[p6l1253t2163r1435b2204],
23	CYPZC9	NN	O	cypzc9	nn	25	SENT_62	[p6l1468t2144r1786b2204],
24	genotype	NN	O	genotype	nn	25	SENT_62	[p6l1814t2158r2142b2220],
25	frequencies	NNS	O	frequency	dobj	20	SENT_62	[p6l9t2243r422b2319],
26	as	IN	O	as	_	0	SENT_62	[p6l494t2263r562b2304],
27	the	DT	O	the	det	30	SENT_62	[p6l632t2243r744b2304],
28	community	NN	O	community	nn	30	SENT_62	[p6l815t2244r1233b2319],
29	control	NN	O	control	nn	30	SENT_62	[p6l1302t2243r1560b2304],
30	group	NN	O	group	prep_as	25	SENT_62	[p6l1629t2263r1861b2319],
31	.	.	O	.	_	0	SENT_62	[p6l1629t2263r1861b2319],

1	Allele	NN	O	allele	nn	2	SENT_63	[p6l1933t2243r2141b2304],
2	frequencies	NNS	O	frequency	nsubj	27	SENT_63	[p6l9t2342r422b2418],
3	of	IN	O	of	_	0	SENT_63	[p6l527t2342r604b2403],
4	0-785	NN	O	0-785	prep_of	2	SENT_63	[p6l697t2345r895b2403],
5	for	IN	O	for	_	0	SENT_63	[p6l1000t2342r1103b2403],
6	CYP2C9	NN	O	cyp2c9	nn	7	SENT_63	[p6l1205t2338r1630b2415],
7	*	NN	O	*	prep_for	4	SENT_63	[p6l1205t2338r1630b2415],
8	1	CD	NUMBER	1	num	7	SENT_63	[p6l1205t2338r1630b2415],
9	,	,	O	,	_	0	SENT_63	[p6l1205t2338r1630b2415],
10	0-110	CD	NUMBER	0-110	conj_and	4	SENT_63	[p6l1736t2345r1940b2403],
11	for	IN	O	for	_	0	SENT_63	[p6l2043t2342r2146b2403],
12	CYP2C9	NN	O	cyp2c9	nn	13	SENT_63	[p6l11t2439r436b2515],
13	*	NN	O	*	prep_for	10	SENT_63	[p6l11t2439r436b2515],
14	2	CD	NUMBER	2	num	13	SENT_63	[p6l11t2439r436b2515],
15	,	,	O	,	_	0	SENT_63	[p6l11t2439r436b2515],
16	and	CC	O	and	_	0	SENT_63	[p6l501t2443r634b2504],
17	O-105	NN	O	o-105	conj_and	4	SENT_63	[p6l693t2446r894b2504],
18	for	IN	O	for	_	0	SENT_63	[p6l956t2442r1058b2504],
19	CYP2C9	NN	O	cyp2c9	prep_for	17	SENT_63	[p6l1116t2439r1522b2504],
20	*	CD	NUMBER	*	number	21	SENT_63	[p6l1116t2439r1522b2504],
21	3	CD	NUMBER	3	num	19	SENT_63	[p6l1116t2439r1522b2504],
22	in	IN	O	in	_	0	SENT_63	[p6l1578t2443r1647b2503],
23	our	PRP$	O	we	poss	25	SENT_63	[p6l1705t2463r1828b2504],
24	control	NN	O	control	nn	25	SENT_63	[p6l1886t2443r2143b2504],
25	groups	NNS	O	group	prep_in	17	SENT_63	[p6l9t2562r254b2618],
26	are	VBP	O	be	cop	27	SENT_63	[p6l287t2562r394b2602],
27	comparable	JJ	O	comparable	_	0	SENT_63	[p6l426t2542r849b2618],
28	to	TO	O	to	_	0	SENT_63	[p6l880t2556r950b2602],
29	those	DT	O	those	prep_to	27	SENT_63	[p6l980t2542r1171b2602],
30	of	IN	O	of	_	0	SENT_63	[p6l1204t2542r1281b2603],
31	0-79	CD	NUMBER	0-79	prep_of	29	SENT_63	[p6l1303t2544r1483b2615],
32	,	,	O	,	_	0	SENT_63	[p6l1303t2544r1483b2615],
33	0-125	CD	NUMBER	0-125	prep_to	27	SENT_63	[p6l1515t2544r1742b2615],
34	,	,	O	,	_	0	SENT_63	[p6l1515t2544r1742b2615],
35	and	CC	O	and	_	0	SENT_63	[p6l1774t2542r1907b2603],
36	0-085	NN	O	0-085	conj_and	29	SENT_63	[p6l1936t2544r2140b2603],
37	for	IN	O	for	_	0	SENT_63	[p6l9t2642r112b2702],
38	CYPZC9	NN	O	cypzc9	nn	39	SENT_63	[p6l144t2642r462b2702],
39	*	NN	O	*	prep_for	36	SENT_63	[p6l475t2638r569b2714],
40	1	CD	NUMBER	1	num	39	SENT_63	[p6l475t2638r569b2714],
41	,	,	O	,	_	0	SENT_63	[p6l475t2638r569b2714],
42	*	CD	NUMBER	*	num	43	SENT_63	[p6l589t2638r664b2701],
43	2	CD	NUMBER	2	appos	36	SENT_63	[p6l589t2638r664b2701],
44	and	CC	O	and	_	0	SENT_63	[p6l696t2642r829b2702],
45	*	CD	NUMBER	*	num	47	SENT_63	[p6l861t2639r942b2702],
46	3	CD	NUMBER	3	num	47	SENT_63	[p6l861t2639r942b2702],
47	alleles	NNS	O	allele	appos	36	SENT_63	[p6l979t2642r1218b2714],
48	,	,	O	,	_	0	SENT_63	[p6l979t2642r1218b2714],
49	respectively	RB	O	respectively	amod	36	SENT_63	[p6l1252t2642r1698b2718],
50	,	,	O	,	_	0	SENT_63	[p6l1252t2642r1698b2718],
51	reported	VBN	O	report	partmod	36	SENT_63	[p6l1732t2642r2043b2718],
52	in	IN	O	in	_	0	SENT_63	[p6l2074t2642r2143b2701],
53	a	DT	O	a	det	54	SENT_63	[p6l11t2761r47b2802],
54	study	NN	O	study	prep_in	51	SENT_63	[p6l76t2741r272b2817],
55	of	IN	O	of	_	0	SENT_63	[p6l299t2741r376b2802],
56	a	DT	O	a	det	59	SENT_63	[p6l395t2761r430b2802],
57	white	JJ	O	white	amod	59	SENT_63	[p6l456t2741r653b2802],
58	British	JJ	MISC	british	amod	59	SENT_63	[p6l682t2741r924b2802],
59	population	NN	O	population	prep_of	54	SENT_63	[p6l949t2741r1416b2817],
60	.	.	O	.	_	0	SENT_63	[p6l949t2741r1416b2817],

1	”	NN	O	”	_	0	SENT_64	[p6l949t2741r1416b2817],

1	All	PDT	O	all	predet	3	SENT_65	[p6l93t2842r198b2901],
2	the	DT	O	the	det	3	SENT_65	[p6l247t2842r360b2902],
3	patients	NNS	O	patient	nsubjpass	9	SENT_65	[p6l409t2842r694b2918],
4	in	IN	O	in	_	0	SENT_65	[p6l746t2842r814b2901],
5	the	DT	O	the	det	7	SENT_65	[p6l863t2842r975b2902],
6	study	NN	O	study	nn	7	SENT_65	[p6l1027t2842r1224b2918],
7	group	NN	O	group	prep_in	3	SENT_65	[p6l1272t2861r1483b2918],
8	were	VBD	O	be	auxpass	9	SENT_65	[p6l1533t2861r1703b2902],
9	started	VBN	O	start	_	0	SENT_65	[p6l1755t2842r2002b2902],
10	on	IN	O	on	_	0	SENT_65	[p6l2053t2861r2143b2902],
11	warfarin	NN	O	warfarin	prep_on	9	SENT_65	[p6l9t2941r311b3002],
12	as	IN	O	as	_	0	SENT_65	[p6l363t2961r431b3002],
13	inpatients	NNS	O	inpatient	prep_as	9	SENT_65	[p6l483t2941r859b3017],
14	.	.	O	.	_	0	SENT_65	[p6l483t2941r859b3017],

1	Each	DT	O	each	det	2	SENT_66	[p6l915t2941r1098b3002],
2	patient	NN	O	patient	nsubj	3	SENT_66	[p6l1147t2941r1401b3017],
3	received	VBD	O	receive	_	0	SENT_66	[p6l1450t2941r1750b3002],
4	an	DT	O	a	det	6	SENT_66	[p6l1802t2961r1887b3002],
5	initial	JJ	O	initial	amod	6	SENT_66	[p6l1937t2941r2142b3002],
6	dose	NN	O	dose	dobj	3	SENT_66	[p6l11t3042r174b3102],
7	of	IN	O	of	_	0	SENT_66	[p6l216t3042r293b3102],
8	10	CD	NUMBER	10	num	10	SENT_66	[p6l332t3044r411b3102],
9	mg	NN	O	mg	nn	10	SENT_66	[p6l452t3061r567b3118],
10	warfarin	NN	O	warfarin	prep_of	6	SENT_66	[p6l603t3042r927b3115],
11	,	,	O	,	_	0	SENT_66	[p6l603t3042r927b3115],
12	with	IN	O	with	_	0	SENT_66	[p6l968t3042r1128b3102],
13	further	JJ	O	further	amod	15	SENT_66	[p6l1166t3042r1420b3102],
14	dose	NN	O	dose	nn	15	SENT_66	[p6l1458t3042r1620b3102],
15	requirements	NNS	O	requirement	prep_with	3	SENT_66	[p6l1660t3042r2141b3118],
16	determined	VBN	O	determine	partmod	15	SENT_66	[p6l11t3141r429b3202],
17	by	IN	O	by	_	0	SENT_66	[p6l454t3141r542b3217],
18	a	DT	O	a	det	22	SENT_66	[p6l569t3161r604b3202],
19	modiﬁed	JJ	O	modiﬁed	amod	22	SENT_66	[p6l631t3141r956b3202],
20	Fennerty	NN	O	fennerty	nn	22	SENT_66	[p6l983t3142r1315b3217],
21	formula	NN	O	formulum	nn	22	SENT_66	[p6l1339t3141r1675b3202],
22	”	NN	O	”	agent	16	SENT_66	[p6l1339t3141r1675b3202],
23	with	IN	O	with	_	0	SENT_66	[p6l1701t3141r1861b3202],
24	regular	JJ	O	regular	amod	25	SENT_66	[p6l1886t3141r2143b3217],
25	estimations	NNS	O	estimation	prep_with	16	SENT_66	[p6l11t3241r423b3301],
26	of	IN	O	of	_	0	SENT_66	[p6l469t3241r546b3301],
27	INR	NN	O	inr	prep_of	25	SENT_66	[p6l580t3242r760b3301],
28	.	.	O	.	_	0	SENT_66	[p6l580t3242r760b3301],

1	Peak	JJ	O	peak	amod	2	SENT_67	[p6l808t3241r984b3301],
2	INR	NN	O	inr	dep	14	SENT_67	[p6l1025t3242r1190b3301],
3	during	IN	O	during	_	0	SENT_67	[p6l1231t3241r1470b3317],
4	the	DT	O	the	det	6	SENT_67	[p6l1511t3241r1623b3301],
5	ﬁrst	NN	O	ﬁrst	nn	6	SENT_67	[p6l1667t3241r1807b3301],
6	week	NN	DURATION	week	prep_during	14	SENT_67	[p6l1848t3241r2033b3302],
7	of	IN	O	of	_	0	SENT_67	[p6l2075t3241r2153b3301],
8	warfarin	NN	O	warfarin	nn	9	SENT_67	[p6l9t3341r311b3402],
9	treatment	NN	O	treatment	prep_of	6	SENT_67	[p6l338t3356r694b3402],
10	in	IN	O	in	_	0	SENT_67	[p6l720t3342r789b3401],
11	the	DT	O	the	det	13	SENT_67	[p6l815t3341r927b3402],
12	low-dose	JJ	O	low-dose	amod	13	SENT_67	[p6l954t3341r1280b3402],
13	group	NN	O	group	prep_in	9	SENT_67	[p6l1307t3361r1518b3417],
14	ranged	VBD	O	range	_	0	SENT_67	[p6l1547t3341r1796b3417],
15	from	IN	O	from	_	0	SENT_67	[p6l1822t3341r1996b3402],
16	2-0	CD	NUMBER	2-0	prep_from	14	SENT_67	[p6l2025t3344r2136b3402],
17	to	TO	NUMBER	to	_	0	SENT_67	[p6l10t3455r79b3502],
18	10-0	CD	NUMBER	10-0	prep_to	14	SENT_67	[p6l117t3443r267b3502],
19	(	CD	NUMBER	(	num	22	SENT_67	[p6l303t3441r600b3516],
20	median	NN	O	median	nn	22	SENT_67	[p6l303t3441r600b3516],
21	4-4	CD	NUMBER	4-4	num	22	SENT_67	[p6l628t3441r790b3516],
22	)	NN	O	)	nsubj	14	SENT_67	[p6l628t3441r790b3516],
23	.	.	O	.	_	0	SENT_67	[p6l628t3441r790b3516],

1	20	CD	NUMBER	20	_	0	SENT_68	[p6l96t3544r182b3601],
2	of	IN	O	of	_	0	SENT_68	[p6l213t3541r291b3601],
3	36	CD	NUMBER	36	num	4	SENT_68	[p6l310t3544r395b3601],
4	patients	NNS	O	patient	prep_of	1	SENT_68	[p6l424t3541r709b3617],
5	(	IN	O	(	dep	1	SENT_68	[p6l744t3541r901b3616],
6	two	CD	NUMBER	two	num	7	SENT_68	[p6l744t3541r901b3616],
7	patients	NNS	O	patient	pobj	5	SENT_68	[p6l929t3541r1214b3617],
8	with	IN	O	with	_	0	SENT_68	[p6l1241t3541r1401b3601],
9	*	NN	O	*	prep_with	7	SENT_68	[p6l1439t3537r1620b3601],
10	1	CD	NUMBER	1	num	9	SENT_68	[p6l1439t3537r1620b3601],
11	/	:	O	/	punct	26	SENT_68	[p6l1439t3537r1620b3601],
12	*	CD	NUMBER	*	number	13	SENT_68	[p6l1439t3537r1620b3601],
13	1	CD	NUMBER	1	num	14	SENT_68	[p6l1439t3537r1620b3601],
14	genotype	NN	O	genotype	nsubj	26	SENT_68	[p6l1651t3555r1979b3617],
15	and	CC	O	and	_	0	SENT_68	[p6l2009t3541r2142b3601],
16	18	CD	NUMBER	18	nsubj	26	SENT_68	[p6l19t3643r97b3701],
17	with	IN	O	with	_	0	SENT_68	[p6l140t3640r300b3701],
18	one	CD	NUMBER	one	prep_with	16	SENT_68	[p6l342t3660r471b3701],
19	or	CC	O	or	_	0	SENT_68	[p6l514t3660r589b3701],
20	more	JJR	O	more	conj_or	18	SENT_68	[p6l628t3660r815b3701],
21	of	IN	O	of	_	0	SENT_68	[p6l859t3640r937b3701],
22	the	DT	O	the	det	25	SENT_68	[p6l968t3640r1080b3701],
23	mutant	JJ	O	mutant	amod	25	SENT_68	[p6l1122t3654r1387b3701],
24	alleles	NNS	O	allele	nn	25	SENT_68	[p6l1430t3640r1673b3715],
25	)	NN	O	)	prep_of	18	SENT_68	[p6l1430t3640r1673b3715],
26	had	VBD	O	have	dep	7	SENT_68	[p6l1720t3640r1855b3701],
27	a	DT	O	a	det	28	SENT_68	[p6l1898t3660r1933b3701],
28	peak	NN	O	peak	dobj	26	SENT_68	[p6l1974t3640r2145b3716],

1	INR	NN	O	inr	_	0	SENT_69	[p7l10t20r175b79],
2	above	IN	O	above	_	0	SENT_69	[p7l228t19r437b79],
3	the	DT	O	the	det	5	SENT_69	[p7l492t19r604b79],
4	therapeutic	JJ	O	therapeutic	amod	5	SENT_69	[p7l659t19r1070b95],
5	range	NN	O	range	prep_above	1	SENT_69	[p7l1126t38r1325b95],
6	of	IN	O	of	prep	1	SENT_69	[p7l1383t19r1460b79],
7	greater	JJR	O	greater	quantmod	8	SENT_69	[p7l1505t33r1758b95],
8	than	IN	O	than	pobj	6	SENT_69	[p7l1811t19r1973b79],
9	4-0	JJ	O	4-0	dep	8	SENT_69	[p7l2029t21r2141b79],
10	during	IN	O	during	_	0	SENT_69	[p7l11t118r251b194],
11	induction	NN	O	induction	prep_during	1	SENT_69	[p7l306t118r658b179],
12	of	IN	O	of	_	0	SENT_69	[p7l716t118r794b179],
13	warfarin	NN	O	warfarin	nn	14	SENT_69	[p7l839t118r1142b179],
14	therapy	NN	O	therapy	prep_of	1	SENT_69	[p7l1198t118r1473b194],
15	when	WRB	O	when	dep	14	SENT_69	[p7l1527t118r1723b179],
16	compared	VBN	O	compare	_	0	SENT_69	[p7l1781t118r2143b194],
17	with	IN	O	with	prepc_compared_with	1	SENT_69	[p7l9t219r169b279],
18	nine	CD	NUMBER	nine	dep	29	SENT_69	[p7l199t219r355b279],
19	of	IN	O	of	_	0	SENT_69	[p7l390t219r467b279],
20	52	CD	NUMBER	52	num	21	SENT_69	[p7l493t221r577b279],
21	patients	NNS	O	patient	prep_of	18	SENT_69	[p7l610t219r896b295],
22	in	IN	O	in	_	0	SENT_69	[p7l930t219r999b278],
23	the	DT	O	the	det	26	SENT_69	[p7l1030t219r1142b279],
24	clinic	NN	O	clinic	nn	26	SENT_69	[p7l1176t219r1368b279],
25	control	NN	O	control	nn	26	SENT_69	[p7l1402t219r1660b279],
26	group	NN	O	group	prep_in	21	SENT_69	[p7l1693t239r1903b295],
27	(	CD	NUMBER	(	num	28	SENT_69	[p7l1943t219r2142b294],
28	odds	NNS	O	odds	dep	29	SENT_69	[p7l1943t219r2142b294],
29	ratio	NN	O	ratio	dep	34	SENT_69	[p7l10t319r175b379],
30	5-97	CD	NUMBER	5-97	num	29	SENT_69	[p7l207t321r366b379],
31	[	CD	NUMBER	[	num	32	SENT_69	[p7l407t318r929b394],
32	2-26-15-82	CD	DATE	2-26-15-82	dep	29	SENT_69	[p7l407t318r929b394],
33	]	CD	NUMBER	]	num	34	SENT_69	[p7l407t318r929b394],
34	)	NN	O	)	dep	1	SENT_69	[p7l407t318r929b394],
35	.	.	O	.	_	0	SENT_69	[p7l407t318r929b394],

1	Nine	CD	TIME	nine	nsubj	14	SENT_70	[p7l968t319r1149b379],
2	of	IN	TIME	of	_	0	SENT_70	[p7l1186t318r1263b379],
3	20	CD	TIME	20	num	4	SENT_70	[p7l1290t321r1376b379],
4	patients	NNS	O	patient	prep_of	1	SENT_70	[p7l1412t319r1698b394],
5	in	IN	O	in	_	0	SENT_70	[p7l1735t319r1803b378],
6	the	DT	O	the	det	8	SENT_70	[p7l1837t318r1949b379],
7	lowdose	JJ	O	lowdose	amod	8	SENT_70	[p7l1985t318r2143b379, p7l12t419r174b479],
8	group	NN	O	group	prep_in	4	SENT_70	[p7l209t438r420b495],
9	with	IN	O	with	_	0	SENT_70	[p7l454t419r614b479],
10	supra-therapeutic	JJ	O	supra-therapeutic	amod	11	SENT_70	[p7l648t419r1291b495],
11	INR	NN	O	inr	prep_with	8	SENT_70	[p7l1325t420r1490b479],
12	during	IN	O	during	_	0	SENT_70	[p7l1521t419r1761b495],
13	induction	NN	O	induction	prep_during	11	SENT_70	[p7l1793t419r2144b479],
14	had	VBD	O	have	_	0	SENT_70	[p7l8t518r142b579],
15	their	PRP$	O	they	poss	17	SENT_70	[p7l171t518r340b579],
16	inpatient	JJ	O	inpatient	amod	17	SENT_70	[p7l366t519r692b594],
17	stay	NN	O	stay	dobj	14	SENT_70	[p7l721t533r861b594],
18	prolonged	VBN	O	prolong	partmod	17	SENT_70	[p7l887t518r1258b594],
19	for	IN	O	for	_	0	SENT_70	[p7l1286t518r1389b579],
20	1-9	CD	NUMBER	1-9	num	21	SENT_70	[p7l1425t521r1545b579],
21	days	NNS	NUMBER	day	prep_for	18	SENT_70	[p7l1579t518r1736b594],
22	(	RB	O	(	advmod	23	SENT_70	[p7l1772t518r2070b594],
23	median	JJ	O	median	amod	21	SENT_70	[p7l1772t518r2070b594],
24	2	CD	DURATION	2	num	25	SENT_70	[p7l2100t521r2139b578],
25	days	NNS	NUMBER	day	tmod	14	SENT_70	[p7l10t618r186b694],
26	)	RB	O	)	advmod	31	SENT_70	[p7l10t618r186b694],
27	while	IN	O	while	dep	31	SENT_70	[p7l219t618r402b679],
28	optimum	JJ	O	optimum	amod	29	SENT_70	[p7l433t618r751b694],
29	anticoagulation	NN	O	anticoagulation	nsubjpass	31	SENT_70	[p7l781t618r1316b694],
30	was	VBD	O	be	auxpass	31	SENT_70	[p7l1342t638r1468b679],
31	achieved	VBN	O	achieve	dep	14	SENT_70	[p7l1500t618r1817b679],
32	.	.	O	.	_	0	SENT_70	[p7l1500t618r1817b679],

1	In	IN	O	in	_	0	SENT_71	[p7l1851t619r1925b678],
2	seven	CD	NUMBER	seven	num	4	SENT_71	[p7l1954t638r2142b679],
3	additional	JJ	O	additional	amod	4	SENT_71	[p7l13t719r377b779],
4	patients	NNS	O	patient	prep_in	6	SENT_71	[p7l410t719r719b795],
5	,	,	O	,	_	0	SENT_71	[p7l410t719r719b795],
6	raised	VBD	O	raise	_	0	SENT_71	[p7l756t719r970b779],
7	INR	NN	O	inr	nsubj	8	SENT_71	[p7l1004t720r1169b779],
8	resulted	VBD	O	result	ccomp	6	SENT_71	[p7l1198t719r1488b779],
9	in	IN	O	in	_	0	SENT_71	[p7l1522t719r1591b778],
10	frequent	JJ	O	frequent	amod	11	SENT_71	[p7l1624t718r1932b795],
11	visits	NNS	O	visit	prep_in	8	SENT_71	[p7l1963t719r2142b779],
12	to	TO	O	to	_	0	SENT_71	[p7l8t832r76b879],
13	the	DT	O	the	det	15	SENT_71	[p7l115t818r225b879],
14	anticoagulant	JJ	O	anticoagulant	amod	15	SENT_71	[p7l265t818r749b894],
15	clinic	NN	O	clinic	prep_to	8	SENT_71	[p7l788t818r975b879],
16	or	CC	O	or	_	0	SENT_71	[p7l1015t838r1088b879],
17	additional	JJ	O	additional	amod	18	SENT_71	[p7l1126t818r1483b879],
18	investigations	NNS	O	investigation	prep_to	8	SENT_71	[p7l1521t818r2028b894],
19	,	,	O	,	_	0	SENT_71	[p7l1521t818r2028b894],
20	or	CC	O	or	_	0	SENT_71	[p7l2070t838r2144b879],
21	both	DT	O	both	prep_to	8	SENT_71	[p7l9t919r191b979],
22	.	.	O	.	_	0	SENT_71	[p7l9t919r191b979],

1	No	DT	O	no	det	2	SENT_72	[p7l243t920r356b979],
2	patient	NN	O	patient	nsubj	8	SENT_72	[p7l405t919r659b995],
3	in	IN	O	in	_	0	SENT_72	[p7l707t919r776b978],
4	the	DT	O	the	det	7	SENT_72	[p7l823t919r934b979],
5	clinic	NN	O	clinic	nn	7	SENT_72	[p7l985t919r1177b979],
6	control	NN	O	control	nn	7	SENT_72	[p7l1226t919r1484b979],
7	group	NN	O	group	prep_in	2	SENT_72	[p7l1533t938r1744b995],
8	had	VBD	O	have	_	0	SENT_72	[p7l1792t919r1927b979],
9	their	PRP$	O	they	poss	10	SENT_72	[p7l1974t919r2144b979],
10	hospital	NN	O	hospital	nsubj	12	SENT_72	[p7l8t1018r295b1094],
11	stay	VB	O	stay	cop	12	SENT_72	[p7l372t1032r509b1094],
12	prolonged	JJ	O	prolonged	ccomp	8	SENT_72	[p7l579t1018r943b1094],
13	because	IN	O	because	_	0	SENT_72	[p7l1014t1018r1295b1079],
14	of	IN	O	of	prepc_because_of	12	SENT_72	[p7l1371t1018r1446b1079],
15	poor	JJ	O	poor	amod	16	SENT_72	[p7l1508t1038r1676b1094],
16	control	NN	O	control	pobj	12	SENT_72	[p7l1748t1018r2001b1079],
17	of	IN	O	of	_	0	SENT_72	[p7l2076t1018r2152b1079],
18	anticoagulation	NN	O	anticoagulation	prep_of	16	SENT_72	[p7l12t1119r582b1195],
19	.	.	O	.	_	0	SENT_72	[p7l12t1119r582b1195],

1	Duration	NN	O	duration	nsubj	6	SENT_73	[p7l94t1219r429b1279],
2	of	IN	O	of	_	0	SENT_73	[p7l463t1218r540b1279],
3	warfarin	NN	O	warfarin	nn	4	SENT_73	[p7l562t1218r865b1279],
4	treatment	NN	O	treatment	prep_of	1	SENT_73	[p7l896t1233r1253b1279],
5	was	VBD	O	be	cop	6	SENT_73	[p7l1283t1238r1415b1279],
6	O-2-17	JJ	O	o-2-17	_	0	SENT_73	[p7l1452t1221r1695b1279],
7	(	NN	O	(	nn	8	SENT_73	[p7l1738t1218r2036b1293],
8	median	NN	O	median	dep	6	SENT_73	[p7l1738t1218r2036b1293],
9	2	CD	NUMBER	2	number	10	SENT_73	[p7l2070t1219r2137b1294],
10	)	CD	NUMBER	)	num	11	SENT_73	[p7l2070t1219r2137b1294],
11	years	NNS	NUMBER	year	npadvmod	8	SENT_73	[p7l7t1338r190b1394],
12	for	IN	O	for	_	0	SENT_73	[p7l224t1318r327b1378],
13	patients	NNS	O	patient	prep_for	8	SENT_73	[p7l355t1318r641b1394],
14	in	IN	O	in	_	0	SENT_73	[p7l674t1318r743b1378],
15	the	DT	O	the	det	17	SENT_73	[p7l773t1318r885b1378],
16	low-dose	JJ	O	low-dose	amod	17	SENT_73	[p7l918t1318r1243b1379],
17	group	NN	O	group	prep_in	6	SENT_73	[p7l1276t1338r1486b1394],
18	and	CC	O	and	_	0	SENT_73	[p7l1522t1318r1655b1379],
19	0-1-30	CD	NUMBER	0-1-30	number	20	SENT_73	[p7l1688t1320r1931b1379],
20	(	CD	NUMBER	(	prep_in	6	SENT_73	[p7l1966t1318r2137b1393],
21	3-1	CD	NUMBER	3-1	num	23	SENT_73	[p7l1966t1318r2137b1393],
22	)	CD	NUMBER	)	num	23	SENT_73	[p7l1966t1318r2137b1393],
23	years	NNS	NUMBER	year	dep	20	SENT_73	[p7l8t1438r191b1494],
24	for	IN	O	for	_	0	SENT_73	[p7l226t1418r329b1479],
25	patients	NNS	O	patient	prep_for	6	SENT_73	[p7l361t1419r646b1494],
26	in	IN	O	in	_	0	SENT_73	[p7l683t1419r751b1478],
27	the	DT	O	the	det	30	SENT_73	[p7l784t1418r896b1479],
28	clinic	NN	O	clinic	nn	30	SENT_73	[p7l933t1418r1125b1479],
29	control	NN	O	control	nn	30	SENT_73	[p7l1161t1418r1419b1479],
30	group	NN	O	group	prep_in	25	SENT_73	[p7l1454t1438r1686b1494],
31	.	.	O	.	_	0	SENT_73	[p7l1454t1438r1686b1494],

1	In	IN	O	in	_	0	SENT_74	[p7l1726t1419r1803b1478],
2	the	DT	O	the	det	4	SENT_74	[p7l1837t1418r1949b1479],
3	lowdose	JJ	O	lowdose	amod	4	SENT_74	[p7l1984t1418r2142b1479, p7l11t1518r173b1579],
4	group	NN	O	group	prep_in	25	SENT_74	[p7l243t1538r477b1594],
5	,	,	O	,	_	0	SENT_74	[p7l243t1538r477b1594],
6	during	IN	O	during	_	0	SENT_74	[p7l550t1518r790b1594],
7	1328	CD	DATE	1328	num	9	SENT_74	[p7l867t1520r1061b1579],
8	patient	NN	O	patient	nn	9	SENT_74	[p7l1132t1518r1386b1594],
9	years	NNS	DURATION	year	prep_during	25	SENT_74	[p7l1452t1538r1636b1594],
10	of	IN	O	of	_	0	SENT_74	[p7l1707t1518r1785b1578],
11	warfarin	NN	O	warfarin	nn	12	SENT_74	[p7l1842t1518r2145b1579],
12	treatment	NN	O	treatment	prep_of	9	SENT_74	[p7l9t1632r387b1691],
13	,	,	O	,	_	0	SENT_74	[p7l9t1632r387b1691],
14	seven	CD	NUMBER	seven	nsubj	25	SENT_74	[p7l468t1638r666b1679],
15	minor	JJ	O	minor	amod	18	SENT_74	[p7l741t1619r982b1691],
16	,	,	O	,	_	0	SENT_74	[p7l741t1619r982b1691],
17	ﬁve	JJ	O	ﬁve	amod	18	SENT_74	[p7l1062t1618r1188b1679],
18	serious	JJ	O	serious	amod	14	SENT_74	[p7l1267t1619r1540b1691],
19	,	,	O	,	_	0	SENT_74	[p7l1267t1619r1540b1691],
20	and	CC	O	and	_	0	SENT_74	[p7l1622t1619r1754b1679],
21	six	CD	NUMBER	six	conj_and	18	SENT_74	[p7l1832t1619r1927b1679],
22	lifethreatening	VBG	O	lifethreaten	rcmod	21	SENT_74	[p7l2003t1618r2142b1679, p7l9t1717r426b1793],
23	bleeding	JJ	O	bleeding	amod	24	SENT_74	[p7l475t1717r787b1793],
24	episodes	NNS	O	episode	dobj	22	SENT_74	[p7l839t1717r1144b1793],
25	occurred	VBD	O	occur	_	0	SENT_74	[p7l1198t1717r1519b1778],
26	in	IN	O	in	_	0	SENT_74	[p7l1571t1717r1639b1777],
27	11	CD	NUMBER	11	num	28	SENT_74	[p7l1699t1720r1771b1777],
28	patients	NNS	O	patient	prep_in	25	SENT_74	[p7l1831t1717r2139b1793],
29	,	,	O	,	_	0	SENT_74	[p7l1831t1717r2139b1793],
30	including	VBG	O	include	_	0	SENT_74	[p7l10t1818r354b1894],
31	one	CD	NUMBER	one	num	32	SENT_74	[p7l418t1837r546b1878],
32	patient	NN	O	patient	prep_including	25	SENT_74	[p7l610t1818r864b1894],
33	where	WRB	O	where	advmod	35	SENT_74	[p7l926t1818r1144b1878],
34	bleeding	NN	O	bleeding	nsubj	35	SENT_74	[p7l1207t1818r1519b1894],
35	contributed	VBD	O	contribute	rcmod	32	SENT_74	[p7l1583t1818r2008b1878],
36	to	TO	O	to	_	0	SENT_74	[p7l2071t1831r2141b1878],
37	death	NN	O	death	prep_to	35	SENT_74	[p7l11t1917r231b1978],
38	.	.	O	.	_	0	SENT_74	[p7l11t1917r231b1978],

1	This	DT	O	this	nsubj	2	SENT_75	[p7l280t1917r445b1978],
2	compares	VBZ	O	compare	_	0	SENT_75	[p7l493t1937r838b1993],
3	with	IN	O	with	_	0	SENT_75	[p7l883t1917r1042b1978],
4	six	CD	NUMBER	six	npadvmod	5	SENT_75	[p7l1088t1917r1183b1978],
5	minor	JJ	O	minor	amod	14	SENT_75	[p7l1226t1917r1467b1990],
6	,	,	O	,	_	0	SENT_75	[p7l1226t1917r1467b1990],
7	ﬁve	JJ	O	ﬁve	amod	8	SENT_75	[p7l1515t1917r1641b1978],
8	serious	JJ	O	serious	amod	14	SENT_75	[p7l1688t1917r1961b1990],
9	,	,	O	,	_	0	SENT_75	[p7l1688t1917r1961b1990],
10	and	CC	O	and	_	0	SENT_75	[p7l2010t1917r2143b1978],
11	two	CD	NUMBER	two	npadvmod	12	SENT_75	[p7l10t2032r141b2078],
12	life-threatening	JJ	O	life-threatening	conj_and	5	SENT_75	[p7l207t2018r766b2094],
13	bleeding	NN	O	bleeding	nn	14	SENT_75	[p7l826t2018r1138b2094],
14	episodes	NNS	O	episode	prep_with	2	SENT_75	[p7l1202t2018r1507b2094],
15	in	IN	O	in	_	0	SENT_75	[p7l1572t2018r1640b2077],
16	11	CD	NUMBER	11	num	17	SENT_75	[p7l1713t2020r1785b2077],
17	patients	NNS	O	patient	prep_in	14	SENT_75	[p7l1856t2018r2142b2094],
18	during	IN	O	during	_	0	SENT_75	[p7l12t2117r252b2193],
19	311-1	CD	NUMBER	311-1	num	21	SENT_75	[p7l306t2120r497b2178],
20	patient	NN	O	patient	nn	21	SENT_75	[p7l559t2118r814b2193],
21	years	NNS	DURATION	year	prep_during	2	SENT_75	[p7l865t2137r1048b2193],
22	of	IN	O	of	_	0	SENT_75	[p7l1105t2117r1182b2178],
23	warfarin	NN	O	warfarin	nn	24	SENT_75	[p7l1224t2117r1527b2178],
24	therapy	NN	O	therapy	prep_of	21	SENT_75	[p7l1580t2117r1855b2193],
25	in	IN	O	in	_	0	SENT_75	[p7l1907t2118r1976b2177],
26	the	DT	O	the	det	29	SENT_75	[p7l2028t2117r2141b2178],
27	clinic	NN	O	clinic	nn	29	SENT_75	[p7l10t2217r198b2277],
28	control	NN	O	control	nn	29	SENT_75	[p7l231t2217r483b2277],
29	group	NN	O	group	prep_in	24	SENT_75	[p7l514t2237r742b2293],
30	.	.	O	.	_	0	SENT_75	[p7l514t2237r742b2293],

1	In	IN	O	in	_	0	SENT_76	[p7l779t2218r854b2277],
2	the	DT	O	the	det	4	SENT_76	[p7l884t2217r994b2277],
3	low-dose	JJ	O	low-dose	amod	4	SENT_76	[p7l1025t2217r1344b2278],
4	group	NN	O	group	prep_in	13	SENT_76	[p7l1376t2237r1605b2293],
5	,	,	O	,	_	0	SENT_76	[p7l1376t2237r1605b2293],
6	six	CD	NUMBER	six	nsubj	13	SENT_76	[p7l1641t2217r1734b2277],
7	minor	JJ	O	minor	amod	6	SENT_76	[p7l1763t2217r1981b2277],
8	and	CC	O	and	_	0	SENT_76	[p7l2011t2217r2141b2278],
9	one	CD	NUMBER	one	num	12	SENT_76	[p7l11t2337r137b2378],
10	major	JJ	O	major	amod	12	SENT_76	[p7l164t2318r373b2393],
11	bleeding	NN	O	bleeding	nn	12	SENT_76	[p7l396t2317r702b2393],
12	episode	NN	O	episode	nsubj	13	SENT_76	[p7l728t2317r995b2393],
13	occurred	VBD	O	occur	_	0	SENT_76	[p7l1024t2317r1338b2378],
14	in	IN	O	in	_	0	SENT_76	[p7l1365t2318r1432b2377],
15	ﬁve	NN	O	ﬁve	nn	16	SENT_76	[p7l1458t2317r1581b2378],
16	patients	NNS	O	patient	prep_in	13	SENT_76	[p7l1607t2318r1887b2393],
17	within	IN	O	within	_	0	SENT_76	[p7l1913t2317r2140b2378],
18	the	DT	O	the	det	19	SENT_76	[p7l9t2417r115b2477],
19	ﬁrst	NN	O	ﬁrst	prep_within	13	SENT_76	[p7l153t2417r287b2477],
20	4	CD	DURATION	4	num	21	SENT_76	[p7l325t2419r363b2477],
21	weeks	NNS	NUMBER	week	tmod	19	SENT_76	[p7l401t2417r605b2478],
22	of	IN	O	of	_	0	SENT_76	[p7l646t2417r719b2477],
23	induction	NN	O	induction	prep_of	19	SENT_76	[p7l748t2417r1081b2478],
24	of	IN	O	of	_	0	SENT_76	[p7l1120t2417r1194b2477],
25	warfarin	NN	O	warfarin	nn	26	SENT_76	[p7l1221t2417r1508b2478],
26	therapy	NN	O	therapy	prep_of	23	SENT_76	[p7l1545t2417r1823b2493],
27	.	.	O	.	_	0	SENT_76	[p7l1545t2417r1823b2493],

1	Each	DT	O	each	nsubj	5	SENT_77	[p7l1866t2417r2039b2477],
2	of	IN	O	of	_	0	SENT_77	[p7l2078t2417r2152b2477],
3	these	DT	O	these	det	4	SENT_77	[p7l8t2518r184b2578],
4	patients	NNS	O	patient	prep_of	1	SENT_77	[p7l209t2518r481b2594],
5	had	VBD	O	have	_	0	SENT_77	[p7l506t2518r634b2578],
6	one	CD	NUMBER	one	num	11	SENT_77	[p7l661t2537r784b2578],
7	or	CC	O	or	_	0	SENT_77	[p7l811t2537r883b2578],
8	more	JJR	O	more	num	11	SENT_77	[p7l906t2537r1084b2578],
9	variant	JJ	O	variant	amod	11	SENT_77	[p7l1108t2518r1348b2578],
10	CYPZC9	NN	O	cypzc9	nn	11	SENT_77	[p7l1378t2518r1681b2578],
11	alleles	NNS	O	allele	dobj	5	SENT_77	[p7l1704t2518r1929b2578],
12	.	.	O	.	_	0	SENT_77	[p7l1704t2518r1929b2578],

1	718	CD	NUMBER	718	_	0	SENT_78	[p7l90t2692r149b2718],
2	THE	DT	O	the	det	3	SENT_78	[p7l1478t2697r1544b2718],
3	LANCET	NN	O	lancet	dep	1	SENT_78	[p7l1553t2696r1683b2718],
4	-	:	O	-	_	0	SENT_78	[p7l1693t2704r1700b2711],
5	Vol	NN	O	vol	dep	1	SENT_78	[p7l1709t2697r1753b2718],
6	353	CD	NUMBER	353	num	5	SENT_78	[p7l1763t2697r1809b2718],
7	-	:	O	-	_	0	SENT_78	[p7l1820t2704r1827b2711],
8	February	NNP	DATE	February	dep	5	SENT_78	[p7l1837t2696r1953b2723],
9	27	CD	DATE	27	num	8	SENT_78	[p7l1962t2697r2000b2722],
10	,	,	DATE	,	_	0	SENT_78	[p7l1962t2697r2000b2722],
11	1999	CD	DATE	1999	num	8	SENT_78	[p7l2013t2697r2072b2718],

1	Low-dose	JJ	O	low-dose	amod	2	SENT_79	[p7l742t2924r966b2967],
2	group	NN	O	group	dep	8	SENT_79	[p7l984t2929r1122b2977],
3	Random	NNP	O	Random	nn	5	SENT_79	[p7l1334t2924r1529b2967],
4	clinic	NN	O	clinic	nn	5	SENT_79	[p7l1549t2923r1679b2967],
5	p	NN	O	p	dep	2	SENT_79	[p7l1973t2934r1998b2977],
6	(	CD	NUMBER	(	num	7	SENT_79	[p7l741t2996r906b3049],
7	n	NN	O	n	dep	8	SENT_79	[p7l741t2996r906b3049],
8	=	JJ	O	=	dep	17	SENT_79	[p7l741t2996r906b3049],
9	36	CD	NUMBER	36	number	10	SENT_79	[p7l741t2996r906b3049],
10	)	CD	NUMBER	)	num	14	SENT_79	[p7l741t2996r906b3049],
11	control	NN	O	control	nn	14	SENT_79	[p7l1333t2996r1502b3039],
12	group	NN	O	group	nn	14	SENT_79	[p7l1522t3002r1660b3049],
13	(	CD	NUMBER	(	num	14	SENT_79	[p7l1680t2996r1844b3049],
14	n	NN	O	n	dep	8	SENT_79	[p7l1680t2996r1844b3049],
15	=	JJ	O	=	amod	14	SENT_79	[p7l1680t2996r1844b3049],
16	52	CD	NUMBER	52	tmod	15	SENT_79	[p7l1680t2996r1844b3049],
17	)	NN	O	)	_	0	SENT_79	[p7l1680t2996r1844b3049],

1	Male	NNP	O	Male	_	0	SENT_80	[p7l15t3139r145b3182],
2	:	:	O	:	_	0	SENT_80	[p7l15t3139r145b3182],
3	female	JJ	O	female	amod	1	SENT_80	[p7l166t3139r330b3182],
4	17:19	CD	TIME	17:19	num	8	SENT_80	[p7l746t3139r889b3182],
5	26:26	CD	NUMBER	26:26	num	8	SENT_80	[p7l1337t3139r1481b3182],
6	Age	NNP	O	Age	nn	8	SENT_80	[p7l13t3212r106b3266],
7	(	CD	NUMBER	(	num	8	SENT_80	[p7l127t3212r292b3265],
8	years	NNS	NUMBER	year	dep	14	SENT_80	[p7l127t3212r292b3265],
9	)	CD	NUMBER	)	num	11	SENT_80	[p7l127t3212r292b3265],
10	55-88	CD	NUMBER	55-88	num	11	SENT_80	[p7l744t3212r900b3255],
11	(	NN	O	(	dep	8	SENT_80	[p7l920t3212r1114b3265],
12	median	NN	O	median	dep	14	SENT_80	[p7l920t3212r1114b3265],
13	73	CD	NUMBER	73	num	12	SENT_80	[p7l1138t3212r1215b3265],
14	)	CD	NUMBER	)	dep	17	SENT_80	[p7l1138t3212r1215b3265],
15	39-95	CD	NUMBER	39-95	num	16	SENT_80	[p7l1336t3212r1491b3255],
16	(	NN	O	(	dep	14	SENT_80	[p7l1513t3212r1707b3265],
17	median	NN	O	median	dep	21	SENT_80	[p7l1513t3212r1707b3265],
18	70-5	CD	NUMBER	70-5	num	17	SENT_80	[p7l1730t3212r1856b3265],
19	)	CD	NUMBER	)	num	20	SENT_80	[p7l1730t3212r1856b3265],
20	0-11	CD	NUMBER	0-11	nsubj	21	SENT_80	[p7l1969t3212r2081b3255],
21	Follow	VB	O	follow	ccomp	3	SENT_80	[p7l16t3286r166b3329],
22	up	RP	O	up	prt	21	SENT_80	[p7l191t3296r245b3338],
23	(	CD	NUMBER	(	num	24	SENT_80	[p7l266t3286r431b3339],
24	years	NNS	NUMBER	year	tmod	21	SENT_80	[p7l266t3286r431b3339],
25	)	CD	NUMBER	)	num	26	SENT_80	[p7l266t3286r431b3339],
26	O-2-17	NN	O	o-2-17	dep	35	SENT_80	[p7l777t3285r948b3329],
27	(	CD	NUMBER	(	num	28	SENT_80	[p7l971t3286r1165b3338],
28	median	NN	O	median	dep	26	SENT_80	[p7l971t3286r1165b3338],
29	2	CD	NUMBER	2	number	30	SENT_80	[p7l1187t3285r1232b3339],
30	)	CD	NUMBER	)	num	31	SENT_80	[p7l1187t3285r1232b3339],
31	O-1-30	NN	O	o-1-30	dep	28	SENT_80	[p7l1370t3285r1543b3329],
32	(	CD	NUMBER	(	num	33	SENT_80	[p7l1563t3286r1757b3339],
33	median	NN	O	median	dep	35	SENT_80	[p7l1563t3286r1757b3339],
34	3-1	CD	NUMBER	3-1	num	35	SENT_80	[p7l1779t3285r1874b3339],
35	)	CD	NUMBER	)	dep	21	SENT_80	[p7l1779t3285r1874b3339],
36	0-35	CD	NUMBER	0-35	num	37	SENT_80	[p7l1971t3285r2082b3329],
37	Number	NN	O	number	dep	35	SENT_80	[p7l15t3359r200b3402],
38	with	IN	O	with	_	0	SENT_80	[p7l218t3359r320b3402],
39	INR	NN	O	inr	dep	40	SENT_80	[p7l344t3359r425b3402],
40	>	JJR	O	>	prep_with	21	SENT_80	[p7l448t3359r560b3402],
41	4-O	CD	NUMBER	4-o	num	44	SENT_80	[p7l448t3359r560b3402],
42	20	CD	NUMBER	20	number	43	SENT_80	[p7l746t3359r807b3402],
43	9	CD	NUMBER	9	amod	44	SENT_80	[p7l1371t3359r1399b3402],
44	O-OOO2	NN	O	o-ooo2	dep	40	SENT_80	[p7l1971t3359r2148b3402],
45	at	IN	O	at	_	0	SENT_80	[p7l14t3435r58b3476],
46	induction	NN	O	induction	nn	47	SENT_80	[p7l83t3433r303b3476],
47	Minor	NNP	O	Minor	prep_at	21	SENT_80	[p7l16t3507r152b3550],
48	bleeding	VBG	O	bleed	partmod	47	SENT_80	[p7l173t3507r375b3561],
49	episodes	NNS	O	episode	dobj	48	SENT_80	[p7l396t3507r612b3559],
50	5-27	CD	PERCENT	5-27	num	51	SENT_80	[p7l779t3506r889b3550],
51	1-93	CD	PERCENT	1-93	tmod	48	SENT_80	[p7l1371t3506r1482b3550],
52	0-07	CD	PERCENT	0-07	num	54	SENT_80	[p7l1970t3506r2081b3550],
53	(	CD	PERCENT	(	num	54	SENT_80	[p7l15t3579r71b3632],
54	%	NN	PERCENT	%	nsubj	58	SENT_80	[p7l15t3579r71b3632],
55	per	IN	O	per	_	0	SENT_80	[p7l92t3589r166b3632],
56	person	NN	O	person	nn	57	SENT_80	[p7l187t3589r346b3632],
57	years	NNS	DURATION	year	prep_per	54	SENT_80	[p7l366t3579r512b3633],
58	)	VBP	O	)	rcmod	51	SENT_80	[p7l366t3579r512b3633],
59	Major	JJ	O	major	amod	61	SENT_80	[p7l16t3652r152b3705],
60	bleeding	NN	O	bleeding	nn	61	SENT_80	[p7l172t3652r375b3706],
61	episodes	NNS	O	episode	nsubj	64	SENT_80	[p7l396t3652r612b3705],
62	8-28	CD	NUMBER	8-28	num	64	SENT_80	[p7l778t3652r890b3695],
63	2-25	CD	NUMBER	2-25	num	64	SENT_80	[p7l1370t3652r1481b3695],
64	O-O07	NN	O	o-o07	ccomp	58	SENT_80	[p7l1969t3652r2113b3695],
65	(	CD	PERCENT	(	num	66	SENT_80	[p7l14t3725r70b3779],
66	%	NN	PERCENT	%	dobj	64	SENT_80	[p7l14t3725r70b3779],
67	per	IN	O	per	_	0	SENT_80	[p7l91t3736r165b3778],
68	person	NN	O	person	nn	69	SENT_80	[p7l186t3736r344b3778],
69	years	NNS	DURATION	year	prep_per	66	SENT_80	[p7l364t3726r511b3779],
70	)	IN	O	)	prep	64	SENT_80	[p7l364t3726r511b3779],

1	Table	NNP	O	Table	_	0	SENT_81	[p8l11t32r190b85],
2	2	CD	NUMBER	2	num	1	SENT_81	[p8l220t31r277b84],
3	:	:	O	:	_	0	SENT_81	[p8l220t31r277b84],
4	Comparison	NN	O	comparison	dep	1	SENT_81	[p8l310t31r703b97],
5	of	IN	O	of	_	0	SENT_81	[p8l731t31r795b85],
6	low-dose	JJ	O	low-dose	amod	7	SENT_81	[p8l819t32r1108b85],
7	group	NN	O	group	prep_of	4	SENT_81	[p8l1133t39r1321b98],
8	with	IN	O	with	_	0	SENT_81	[p8l1346t31r1486b85],
9	random	JJ	O	random	amod	11	SENT_81	[p8l1517t32r1760b85],
10	clinic	NN	O	clinic	nn	11	SENT_81	[p8l1788t31r1964b85],
11	controls	NNS	O	control	prep_with	7	SENT_81	[p8l14t132r285b185],

1	The	DT	O	the	det	2	SENT_82	[p8l92t264r241b324],
2	incidence	NN	O	incidence	nsubj	19	SENT_82	[p8l268t264r616b324],
3	of	IN	O	of	_	0	SENT_82	[p8l645t263r722b324],
4	minor	JJ	O	minor	amod	6	SENT_82	[p8l739t264r961b324],
5	bleeding	NN	O	bleeding	nn	6	SENT_82	[p8l984t264r1297b340],
6	episodes	NNS	O	episode	prep_of	2	SENT_82	[p8l1324t264r1629b340],
7	was	VBD	O	be	cop	19	SENT_82	[p8l1657t283r1789b324],
8	higher	JJR	O	higher	advmod	19	SENT_82	[p8l1817t264r2049b340],
9	in	IN	O	in	_	0	SENT_82	[p8l2074t264r2143b323],
10	the	DT	O	the	det	12	SENT_82	[p8l8t364r120b424],
11	low-dose	JJ	O	low-dose	amod	12	SENT_82	[p8l160t364r486b425],
12	group	NN	O	group	prep_in	8	SENT_82	[p8l526t384r737b440],
13	(	CD	NUMBER	(	number	14	SENT_82	[p8l784t364r1011b439],
14	seven	CD	NUMBER	seven	dep	19	SENT_82	[p8l784t364r1011b439],
15	in	IN	O	in	_	0	SENT_82	[p8l1050t364r1119b424],
16	132-8	CD	NUMBER	132-8	num	18	SENT_82	[p8l1167t366r1360b425],
17	patient	NN	O	patient	nn	18	SENT_82	[p8l1400t364r1655b440],
18	years	NNS	DURATION	year	prep_in	14	SENT_82	[p8l1692t364r1904b440],
19	)	RB	O	)	dep	28	SENT_82	[p8l1692t364r1904b440],
20	when	WRB	O	when	advmod	21	SENT_82	[p8l1948t364r2144b425],
21	compared	VBN	O	compare	ccomp	19	SENT_82	[p8l10t466r373b542],
22	with	IN	O	with	_	0	SENT_82	[p8l426t466r585b526],
23	that	DT	O	that	prep_with	21	SENT_82	[p8l638t466r781b526],
24	in	IN	O	in	_	0	SENT_82	[p8l834t466r904b525],
25	random	JJ	O	random	amod	27	SENT_82	[p8l957t466r1243b526],
26	clinic	NN	O	clinic	nn	27	SENT_82	[p8l1299t466r1490b526],
27	controls	NNS	O	control	prep_in	23	SENT_82	[p8l1547t466r1837b526],
28	(	VBP	O	(	_	0	SENT_82	[p8l1899t466r2023b541],
29	six	CD	NUMBER	six	dobj	28	SENT_82	[p8l1899t466r2023b541],
30	in	IN	O	in	_	0	SENT_82	[p8l2076t466r2145b525],
31	311-1	CD	NUMBER	311-1	num	33	SENT_82	[p8l11t569r204b627],
32	patient	NN	O	patient	nn	33	SENT_82	[p8l240t566r495b642],
33	years	NNS	DURATION	year	prep_in	28	SENT_82	[p8l519t566r730b642],
34	)	CD	NUMBER	)	dep	39	SENT_82	[p8l519t566r730b642],
35	though	IN	O	though	dep	39	SENT_82	[p8l763t566r1021b642],
36	this	DT	O	this	nsubj	39	SENT_82	[p8l1047t566r1175b627],
37	did	VBD	O	do	aux	39	SENT_82	[p8l1205t566r1321b627],
38	not	RB	O	not	neg	39	SENT_82	[p8l1347t580r1468b627],
39	reach	VB	O	reach	dep	28	SENT_82	[p8l1494t566r1691b627],
40	signiﬁcance	NN	O	signiﬁcance	nn	43	SENT_82	[p8l1719t566r2142b642],
41	(	CD	NUMBER	(	num	43	SENT_82	[p8l15t668r178b743],
42	rate	NN	O	rate	nn	43	SENT_82	[p8l15t668r178b743],
43	ratio	NN	O	ratio	nn	48	SENT_82	[p8l205t668r371b728],
44	2-73	CD	PERCENT	2-73	num	45	SENT_82	[p8l401t670r560b728],
45	[	CD	PERCENT	[	dep	43	SENT_82	[p8l600t668r785b743],
46	95	CD	PERCENT	95	number	47	SENT_82	[p8l600t668r785b743],
47	%	NN	PERCENT	%	amod	48	SENT_82	[p8l600t668r785b743],
48	CI	NN	O	ci	dobj	39	SENT_82	[p8l820t668r911b728],
49	0-92-8-1	CD	NUMBER	0-92-8-1	num	50	SENT_82	[p8l941t668r1317b743],
50	]	NN	O	]	nsubj	28	SENT_82	[p8l941t668r1317b743],
51	,	,	O	,	_	0	SENT_82	[p8l941t668r1317b743],
52	p	NN	O	p	appos	50	SENT_82	[p8l1346t668r1654b744],
53	=	JJ	O	=	amod	55	SENT_82	[p8l1346t668r1654b744],
54	O-O7	NN	O	o-o7	nn	55	SENT_82	[p8l1346t668r1654b744],
55	)	NN	O	)	dep	52	SENT_82	[p8l1346t668r1654b744],
56	.	.	O	.	_	0	SENT_82	[p8l1346t668r1654b744],

1	Signiﬁcantly	RB	O	signiﬁcantly	advmod	2	SENT_83	[p8l1690t667r2143b744],
2	higher	JJR	O	higher	amod	3	SENT_83	[p8l8t768r240b844],
3	numbers	NNS	O	number	_	0	SENT_83	[p8l287t768r606b829],
4	of	IN	O	of	_	0	SENT_83	[p8l658t768r736b829],
5	major	JJ	O	major	amod	6	SENT_83	[p8l774t768r987b844],
6	(	NN	O	(	prep_of	3	SENT_83	[p8l1041t768r1319b843],
7	serious	JJ	O	serious	amod	6	SENT_83	[p8l1041t768r1319b843],
8	and	CC	O	and	_	0	SENT_83	[p8l1372t768r1504b829],
9	life-threatening	JJ	O	life-threatening	amod	6	SENT_83	[p8l1554t768r2138b844],
10	)	NN	O	)	nn	12	SENT_83	[p8l1554t768r2138b844],
11	bleeding	NN	O	bleeding	nn	12	SENT_83	[p8l8t870r321b946],
12	episodes	NNS	O	episode	nsubj	13	SENT_83	[p8l356t870r661b946],
13	occurred	VBD	O	occur	rcmod	6	SENT_83	[p8l700t870r1021b930],
14	in	IN	O	in	_	0	SENT_83	[p8l1057t870r1125b929],
15	the	DT	O	the	det	17	SENT_83	[p8l1160t870r1272b930],
16	low-dose	JJ	O	low-dose	amod	17	SENT_83	[p8l1308t870r1634b930],
17	group	NN	O	group	prep_in	13	SENT_83	[p8l1670t889r1881b946],
18	(	CD	NUMBER	(	number	19	SENT_83	[p8l1924t870r2032b945],
19	11	CD	NUMBER	11	num	17	SENT_83	[p8l1924t870r2032b945],
20	in	IN	O	in	_	0	SENT_83	[p8l2077t870r2145b929],
21	132-8	CD	NUMBER	132-8	num	23	SENT_83	[p8l18t973r206b1031],
22	patient	NN	O	patient	nn	23	SENT_83	[p8l234t971r481b1046],
23	years	NNS	DURATION	year	prep_in	17	SENT_83	[p8l505t971r710b1046],
24	)	RB	O	)	advmod	13	SENT_83	[p8l505t971r710b1046],
25	when	WRB	O	when	advmod	31	SENT_83	[p8l740t970r931b1031],
26	compared	VBN	O	compare	csubj	31	SENT_83	[p8l959t970r1310b1046],
27	with	IN	O	with	_	0	SENT_83	[p8l1335t970r1490b1031],
28	the	DT	O	the	det	30	SENT_83	[p8l1515t970r1623b1031],
29	random	JJ	O	random	amod	30	SENT_83	[p8l1650t970r1928b1031],
30	clinic	NN	O	clinic	prep_with	26	SENT_83	[p8l1956t970r2141b1031],
31	controls	VBZ	O	control	advcl	13	SENT_83	[p8l9t1071r291b1131],
32	(	RB	O	(	advmod	31	SENT_83	[p8l357t1071r576b1146],
33	seven	CD	NUMBER	seven	dobj	31	SENT_83	[p8l357t1071r576b1146],
34	in	IN	O	in	_	0	SENT_83	[p8l634t1071r701b1131],
35	311-1	CD	NUMBER	311-1	num	37	SENT_83	[p8l760t1073r950b1132],
36	patient	NN	O	patient	nn	37	SENT_83	[p8l1016t1071r1264b1147],
37	years	NNS	DURATION	year	prep_in	33	SENT_83	[p8l1319t1091r1520b1147],
38	;	:	O	;	_	0	SENT_83	[p8l1319t1091r1520b1147],
39	rate	NN	O	rate	nn	40	SENT_83	[p8l1581t1085r1713b1131],
40	ratio	NN	O	ratio	dep	3	SENT_83	[p8l1772t1071r1932b1131],
41	3-68	CD	NUMBER	3-68	number	42	SENT_83	[p8l1994t1073r2142b1132],
42	[	CD	NUMBER	[	dep	40	SENT_83	[p8l17t1172r442b1248],
43	l-43-9-50	JJ	O	l-43-9-50	amod	49	SENT_83	[p8l17t1172r442b1248],
44	]	NN	O	]	nn	49	SENT_83	[p8l17t1172r442b1248],
45	,	,	O	,	_	0	SENT_83	[p8l17t1172r442b1248],
46	p	NN	O	p	nn	49	SENT_83	[p8l482t1173r826b1248],
47	=	JJ	O	=	amod	49	SENT_83	[p8l482t1173r826b1248],
48	O-007	NN	O	o-007	nn	49	SENT_83	[p8l482t1173r826b1248],
49	)	NN	O	)	dep	42	SENT_83	[p8l482t1173r826b1248],
50	.	.	O	.	_	0	SENT_83	[p8l482t1173r826b1248],

1	Comparison	NN	O	comparison	nsubjpass	12	SENT_84	[p8l873t1173r1310b1248],
2	between	IN	O	between	_	0	SENT_84	[p8l1347t1172r1642b1233],
3	the	DT	O	the	det	5	SENT_84	[p8l1680t1172r1788b1233],
4	low-dose	JJ	O	low-dose	amod	5	SENT_84	[p8l1828t1172r2144b1233],
5	group	NN	O	group	prep_between	1	SENT_84	[p8l8t1293r213b1349],
6	and	CC	O	and	_	0	SENT_84	[p8l243t1273r372b1334],
7	the	DT	O	the	det	10	SENT_84	[p8l397t1273r506b1333],
8	random	JJ	O	random	amod	10	SENT_84	[p8l532t1273r810b1334],
9	clinic	NN	O	clinic	nn	10	SENT_84	[p8l838t1273r1024b1333],
10	controls	NNS	O	control	prep_between	1	SENT_84	[p8l1052t1273r1334b1333],
11	is	VBZ	O	be	auxpass	12	SENT_84	[p8l1362t1273r1412b1333],
12	shown	VBN	O	show	_	0	SENT_84	[p8l1441t1273r1667b1334],
13	in	IN	O	in	_	0	SENT_84	[p8l1693t1273r1759b1333],
14	table	NN	O	table	prep_in	12	SENT_84	[p8l1785t1273r1955b1333],
15	2	CD	NUMBER	2	num	14	SENT_84	[p8l1984t1276r2043b1333],
16	.	.	O	.	_	0	SENT_84	[p8l1984t1276r2043b1333],

1	Discussion	NN	O	discussion	nsubj	6	SENT_85	[p8l12t1433r496b1500],
2	In	IN	O	in	_	0	SENT_85	[p8l8t1542r86b1600],
3	this	DT	O	this	det	4	SENT_85	[p8l126t1541r254b1601],
4	study	NN	O	study	prep_in	6	SENT_85	[p8l297t1541r494b1617],
5	we	PRP	O	we	nsubj	6	SENT_85	[p8l531t1561r630b1601],
6	show	VBP	O	show	_	0	SENT_85	[p8l673t1541r858b1601],
7	that	IN	O	that	complm	9	SENT_85	[p8l898t1541r1040b1601],
8	there	EX	O	there	expl	9	SENT_85	[p8l1080t1541r1263b1601],
9	is	VBZ	O	be	ccomp	6	SENT_85	[p8l1305t1541r1356b1601],
10	a	DT	O	a	det	12	SENT_85	[p8l1400t1561r1435b1601],
11	strong	JJ	O	strong	amod	12	SENT_85	[p8l1477t1555r1705b1617],
12	association	NN	O	association	nsubj	9	SENT_85	[p8l1746t1541r2144b1601],
13	between	IN	O	between	_	0	SENT_85	[p8l7t1640r311b1701],
14	CYP2C9	NN	O	cyp2c9	nn	15	SENT_85	[p8l359t1641r677b1701],
15	genotype	NN	O	genotype	prep_between	12	SENT_85	[p8l716t1655r1045b1716],
16	and	CC	O	and	_	0	SENT_85	[p8l1090t1640r1224b1701],
17	warfarin	NN	O	warfarin	nn	18	SENT_85	[p8l1265t1640r1568b1701],
18	sensitivity	NN	O	sensitivity	prep_between	12	SENT_85	[p8l1613t1641r1990b1716],
19	.	.	O	.	_	0	SENT_85	[p8l1613t1641r1990b1716],

1	An	DT	O	a	det	2	SENT_86	[p8l2036t1641r2145b1700],
2	individual	JJ	O	individual	nsubj	12	SENT_86	[p8l9t1741r373b1801],
3	requiring	VBG	O	require	partmod	2	SENT_86	[p8l404t1741r739b1817],
4	a	DT	O	a	det	7	SENT_86	[p8l770t1761r805b1801],
5	low	JJ	O	low	amod	7	SENT_86	[p8l836t1741r965b1801],
6	warfarin	NN	O	warfarin	nn	7	SENT_86	[p8l993t1741r1296b1801],
7	dose	NN	O	dose	dobj	3	SENT_86	[p8l1328t1741r1490b1801],
8	is	VBZ	O	be	cop	12	SENT_86	[p8l1521t1741r1573b1801],
9	six	CD	NUMBER	six	num	10	SENT_86	[p8l1607t1741r1703b1801],
10	times	NNS	O	time	npadvmod	11	SENT_86	[p8l1731t1741r1925b1801],
11	more	RBR	O	more	advmod	12	SENT_86	[p8l1957t1760r2144b1801],
12	likely	JJ	O	likely	_	0	SENT_86	[p8l9t1840r201b1916],
13	to	TO	O	to	aux	15	SENT_86	[p8l232t1855r301b1901],
14	be	VB	O	be	cop	15	SENT_86	[p8l335t1840r419b1901],
15	positive	JJ	O	positive	xcomp	12	SENT_86	[p8l453t1841r732b1916],
16	for	IN	O	for	_	0	SENT_86	[p8l765t1840r869b1901],
17	one	CD	NUMBER	one	prep_for	15	SENT_86	[p8l901t1860r1030b1901],
18	or	CC	O	or	_	0	SENT_86	[p8l1066t1860r1141b1901],
19	more	JJR	O	more	conj_or	17	SENT_86	[p8l1172t1860r1360b1901],
20	of	IN	O	of	_	0	SENT_86	[p8l1395t1840r1473b1901],
21	the	DT	O	the	det	23	SENT_86	[p8l1495t1840r1608b1901],
22	variant	JJ	O	variant	amod	23	SENT_86	[p8l1640t1841r1893b1901],
23	alleles	NNS	O	allele	prep_of	17	SENT_86	[p8l1927t1840r2144b1901],
24	associated	VBN	O	associate	partmod	23	SENT_86	[p8l11t1940r380b2001],
25	with	IN	O	with	_	0	SENT_86	[p8l497t1940r657b2001],
26	impaired	JJ	O	impaired	amod	31	SENT_86	[p8l775t1940r1099b2016],
27	S-warfarin	NN	MISC	s-warfarin	nn	31	SENT_86	[p8l1221t1940r1602b2001],
28	metabolism	NN	O	metabolism	nn	31	SENT_86	[p8l1719t1940r2145b2000],
29	(	CD	NUMBER	(	num	31	SENT_86	[p8l16t2036r451b2114],
30	CYP2C9	NN	O	cyp2c9	nn	31	SENT_86	[p8l16t2036r451b2114],
31	*	NN	O	*	prep_with	24	SENT_86	[p8l16t2036r451b2114],
32	2	CD	NUMBER	2	dep	31	SENT_86	[p8l16t2036r451b2114],
33	and	CC	O	and	_	0	SENT_86	[p8l487t2040r620b2100],
34	CYP2C9	CD	NUMBER	cyp2c9	number	35	SENT_86	[p8l660t2036r1091b2115],
35	*	CD	NUMBER	*	conj_and	31	SENT_86	[p8l660t2036r1091b2115],
36	3	CD	NUMBER	3	num	37	SENT_86	[p8l660t2036r1091b2115],
37	)	NN	O	)	dep	35	SENT_86	[p8l660t2036r1091b2115],
38	compared	VBN	O	compare	_	0	SENT_86	[p8l1136t2040r1499b2115],
39	with	IN	O	with	prepc_compared_with	24	SENT_86	[p8l1535t2040r1695b2100],
40	the	DT	O	the	det	42	SENT_86	[p8l1731t2040r1843b2100],
41	general	JJ	O	general	amod	42	SENT_86	[p8l1881t2040r2144b2115],
42	population	NN	O	population	pobj	24	SENT_86	[p8l7t2139r424b2215],
43	.	.	O	.	_	0	SENT_86	[p8l7t2139r424b2215],

1	CYPZC9	NN	O	cypzc9	nn	2	SENT_87	[p8l493t2139r812b2199],
2	genotyping	NN	O	genotyping	nsubj	3	SENT_87	[p8l869t2139r1275b2215],
3	appears	VBZ	O	appear	_	0	SENT_87	[p8l1336t2159r1611b2215],
4	to	TO	O	to	aux	5	SENT_87	[p8l1673t2153r1742b2199],
5	have	VB	O	have	xcomp	3	SENT_87	[p8l1804t2139r1969b2200],
6	the	DT	O	the	det	7	SENT_87	[p8l2031t2139r2143b2199],
7	potential	JJ	O	potential	dobj	5	SENT_87	[p8l7t2240r330b2316],
8	to	TO	O	to	aux	9	SENT_87	[p8l375t2254r444b2300],
9	identify	VB	O	identify	xcomp	5	SENT_87	[p8l491t2239r768b2316],
10	a	DT	O	a	det	11	SENT_87	[p8l813t2259r847b2300],
11	subgroup	NN	O	subgroup	dobj	9	SENT_87	[p8l894t2240r1234b2316],
12	of	IN	O	of	_	0	SENT_87	[p8l1282t2239r1360b2300],
13	individuals	NNS	O	individual	prep_of	11	SENT_87	[p8l1395t2240r1791b2300],
14	who	WP	O	who	nsubj	17	SENT_87	[p8l1836t2240r1988b2300],
15	are	VBP	O	be	cop	17	SENT_87	[p8l2037t2259r2143b2300],
16	poor	JJ	O	poor	amod	17	SENT_87	[p8l7t2359r178b2415],
17	metabolisers	NNS	O	metaboliser	rcmod	13	SENT_87	[p8l214t2339r670b2400],
18	of	IN	O	of	_	0	SENT_87	[p8l711t2339r789b2400],
19	warfarin	NN	O	warfarin	prep_of	17	SENT_87	[p8l815t2339r1140b2412],
20	,	,	O	,	_	0	SENT_87	[p8l815t2339r1140b2412],
21	hence	RB	O	hence	advmod	3	SENT_87	[p8l1179t2339r1392b2400],
22	they	PRP	O	they	nsubj	23	SENT_87	[p8l1431t2339r1586b2415],
23	require	VBP	O	require	ccomp	3	SENT_87	[p8l1622t2339r1880b2415],
24	a	DT	O	a	det	27	SENT_87	[p8l1921t2359r1956b2400],
25	very	RB	O	very	advmod	26	SENT_87	[p8l1992t2359r2146b2415],
26	low	JJ	O	low	amod	27	SENT_87	[p8l9t2440r137b2500],
27	dose	NN	O	dose	dobj	23	SENT_87	[p8l197t2440r359b2500],
28	of	IN	O	of	_	0	SENT_87	[p8l421t2439r499b2500],
29	drug	NN	O	drug	prep_of	27	SENT_87	[p8l550t2440r736b2516],
30	.	.	O	.	_	0	SENT_87	[p8l550t2440r736b2516],

1	Our	PRP$	O	we	poss	2	SENT_88	[p8l804t2440r950b2500],
2	ﬁndings	NNS	O	ﬁndings	nsubj	4	SENT_88	[p8l1007t2439r1296b2516],
3	also	RB	O	also	advmod	4	SENT_88	[p8l1359t2440r1496b2500],
4	indicate	VBP	O	indicate	_	0	SENT_88	[p8l1557t2440r1845b2500],
5	that	IN	O	that	complm	12	SENT_88	[p8l1905t2440r2048b2500],
6	a	DT	O	a	det	8	SENT_88	[p8l2109t2459r2144b2500],
7	signiﬁcant	JJ	O	signiﬁcant	amod	8	SENT_88	[p8l10t2539r384b2615],
8	proportion	NN	O	proportion	nsubj	12	SENT_88	[p8l409t2539r804b2615],
9	of	IN	O	of	_	0	SENT_88	[p8l832t2539r909b2600],
10	these	DT	O	these	det	11	SENT_88	[p8l926t2539r1111b2600],
11	individuals	NNS	O	individual	prep_of	8	SENT_88	[p8l1139t2539r1535b2600],
12	have	VBP	O	have	ccomp	4	SENT_88	[p8l1563t2539r1729b2600],
13	difﬁculties	NNS	O	difﬁculties	dobj	12	SENT_88	[p8l1758t2539r2135b2600],
14	at	IN	O	at	_	0	SENT_88	[p8l10t2654r75b2700],
15	the	DT	O	the	det	16	SENT_88	[p8l109t2640r221b2700],
16	time	NN	O	time	prep_at	13	SENT_88	[p8l256t2640r416b2700],
17	of	IN	O	of	_	0	SENT_88	[p8l453t2640r531b2700],
18	induction	NN	O	induction	prep_of	16	SENT_88	[p8l556t2640r907b2700],
19	of	IN	O	of	_	0	SENT_88	[p8l943t2640r1021b2700],
20	warfarin	NN	O	warfarin	nn	21	SENT_88	[p8l1044t2640r1347b2700],
21	therapy	NN	O	therapy	prep_of	18	SENT_88	[p8l1381t2640r1656b2716],
22	and	CC	O	and	_	0	SENT_88	[p8l1691t2640r1824b2700],
23	have	VBP	O	have	conj_and	12	SENT_88	[p8l1857t2640r2023b2700],
24	an	DT	O	a	det	26	SENT_88	[p8l2060t2659r2145b2700],
25	increased	VBN	O	increase	amod	26	SENT_88	[p8l9t2739r351b2800],
26	risk	NN	O	risk	dobj	23	SENT_88	[p8l387t2739r519b2800],
27	of	IN	O	of	_	0	SENT_88	[p8l554t2739r632b2800],
28	bleeding	VBG	O	bleed	amod	29	SENT_88	[p8l656t2739r969b2815],
29	complications	NNS	O	complication	prep_of	26	SENT_88	[p8l1005t2739r1511b2815],
30	when	WRB	O	when	advmod	31	SENT_88	[p8l1548t2739r1744b2800],
31	compared	VBN	O	compare	advcl	12	SENT_88	[p8l1782t2739r2145b2815],
32	with	IN	O	with	_	0	SENT_88	[p8l8t2840r167b2900],
33	clinic	NN	O	clinic	nn	34	SENT_88	[p8l195t2840r387b2900],
34	controls	NNS	O	control	prep_with	31	SENT_88	[p8l416t2840r728b2900],
35	.	.	O	.	_	0	SENT_88	[p8l416t2840r728b2900],

1	With	IN	O	with	_	0	SENT_89	[p8l91t2939r273b2999],
2	the	DT	O	the	det	3	SENT_89	[p8l304t2939r416b2999],
3	exception	NN	O	exception	prep_with	18	SENT_89	[p8l450t2939r801b3014],
4	of	IN	O	of	_	0	SENT_89	[p8l833t2938r911b2999],
5	homozygosity	NN	O	homozygosity	prep_of	3	SENT_89	[p8l930t2939r1435b3014],
6	for	IN	O	for	_	0	SENT_89	[p8l1465t2938r1568b2999],
7	CYPZC9	NN	O	cypzc9	prep_for	5	SENT_89	[p8l1599t2939r1918b2999],
8	*	CD	NUMBER	*	number	9	SENT_89	[p8l1930t2935r2025b3011],
9	3	CD	NUMBER	3	num	7	SENT_89	[p8l1930t2935r2025b3011],
10	,	,	O	,	_	0	SENT_89	[p8l1930t2935r2025b3011],
11	all	PDT	O	all	predet	14	SENT_89	[p8l2057t2939r2138b2999],
12	the	DT	O	the	det	14	SENT_89	[p8l7t3039r119b3099],
13	other	JJ	O	other	amod	14	SENT_89	[p8l163t3039r354b3099],
14	combinations	NNS	O	combination	nsubj	18	SENT_89	[p8l394t3039r887b3099],
15	of	IN	O	of	_	0	SENT_89	[p8l931t3039r1009b3099],
16	variant	JJ	O	variant	amod	17	SENT_89	[p8l1038t3039r1291b3099],
17	alleles	NNS	O	allele	prep_of	14	SENT_89	[p8l1333t3039r1549b3099],
18	occurred	VBD	O	occur	_	0	SENT_89	[p8l1593t3039r1915b3099],
19	more	RBR	O	more	advmod	20	SENT_89	[p8l1956t3058r2143b3099],
20	frequently	RB	O	frequently	advmod	18	SENT_89	[p8l8t3138r381b3214],
21	in	IN	O	in	_	0	SENT_89	[p8l438t3139r506b3198],
22	the	DT	O	the	det	24	SENT_89	[p8l564t3138r676b3199],
23	low-dose	JJ	O	low-dose	amod	24	SENT_89	[p8l736t3138r1062b3199],
24	group	NN	O	group	prep_in	18	SENT_89	[p8l1121t3158r1332b3214],
25	compared	VBN	O	compare	_	0	SENT_89	[p8l1394t3138r1757b3214],
26	with	IN	O	with	prepc_compared_with	18	SENT_89	[p8l1814t3138r1973b3199],
27	the	DT	O	the	det	28	SENT_89	[p8l2031t3138r2143b3199],
28	controls	NNS	O	control	pobj	18	SENT_89	[p8l10t3238r322b3298],
29	.	.	O	.	_	0	SENT_89	[p8l10t3238r322b3298],

1	One	CD	NUMBER	one	nsubj	6	SENT_90	[p8l397t3238r547b3299],
2	of	IN	O	of	_	0	SENT_90	[p8l617t3238r695b3298],
3	100	CD	NUMBER	100	num	4	SENT_90	[p8l761t3240r887b3299],
4	controls	NNS	O	control	prep_of	1	SENT_90	[p8l958t3238r1249b3299],
5	was	VBD	O	be	cop	6	SENT_90	[p8l1316t3258r1449b3299],
6	homozygous	JJ	O	homozygous	_	0	SENT_90	[p8l1517t3238r1974b3314],
7	for	IN	O	for	_	0	SENT_90	[p8l2043t3238r2146b3298],
8	CYP2C9	NN	O	cyp2c9	prep_for	6	SENT_90	[p8l11t3334r417b3398],
9	*	CD	NUMBER	*	number	10	SENT_90	[p8l11t3334r417b3398],
10	3	CD	NUMBER	3	num	8	SENT_90	[p8l11t3334r417b3398],
11	while	IN	O	while	mark	17	SENT_90	[p8l462t3338r655b3398],
12	none	NN	O	none	nsubj	17	SENT_90	[p8l702t3358r881b3398],
13	in	IN	O	in	_	0	SENT_90	[p8l929t3338r998b3397],
14	the	DT	O	the	det	16	SENT_90	[p8l1043t3338r1155b3398],
15	low-dose	JJ	O	low-dose	amod	16	SENT_90	[p8l1203t3338r1528b3398],
16	group	NN	O	group	prep_in	12	SENT_90	[p8l1576t3358r1788b3414],
17	had	VBD	O	have	advcl	6	SENT_90	[p8l1835t3338r1970b3398],
18	this	DT	O	this	det	19	SENT_90	[p8l2016t3338r2144b3398],
19	genotype	NN	O	genotype	dobj	17	SENT_90	[p8l8t3451r357b3513],
20	.	.	O	.	_	0	SENT_90	[p8l8t3451r357b3513],

1	It	PRP	O	it	nsubjpass	3	SENT_91	[p8l427t3438r485b3498],
2	is	VBZ	O	be	auxpass	3	SENT_91	[p8l548t3437r599b3498],
3	predicted	VBN	O	predict	_	0	SENT_91	[p8l664t3437r1010b3513],
4	from	IN	O	from	_	0	SENT_91	[p8l1074t3437r1248b3498],
5	the	DT	O	the	det	8	SENT_91	[p8l1312t3437r1424b3498],
6	control	NN	O	control	nn	8	SENT_91	[p8l1491t3437r1749b3498],
7	genotype	NN	O	genotype	nn	8	SENT_91	[p8l1813t3451r2143b3513],
8	frequencies	NNS	O	frequency	prep_from	3	SENT_91	[p8l8t3537r422b3614],
9	that	WDT	O	that	dobj	18	SENT_91	[p8l532t3538r675b3598],
10	eight	CD	NUMBER	eight	num	11	SENT_91	[p8l785t3538r962b3614],
11	individuals	NNS	O	individual	nsubjpass	18	SENT_91	[p8l1070t3538r1467b3598],
12	attending	VBG	O	attend	partmod	11	SENT_91	[p8l1579t3538r1924b3614],
13	the	DT	O	the	det	15	SENT_91	[p8l2031t3538r2143b3598],
14	anticoagulation	NN	O	anticoagulation	nn	15	SENT_91	[p9l10t18r573b94],
15	clinic	NN	O	clinic	dobj	12	SENT_91	[p9l672t18r864b79],
16	would	MD	O	would	aux	18	SENT_91	[p9l962t18r1188b79],
17	be	VB	O	be	auxpass	18	SENT_91	[p9l1285t18r1370b79],
18	expected	VBN	O	expect	rcmod	8	SENT_91	[p9l1470t18r1792b94],
19	to	TO	O	to	aux	24	SENT_91	[p9l1890t32r1959b79],
20	be	VB	O	be	cop	24	SENT_91	[p9l2058t18r2143b79],
21	CYP2C9	NN	O	cyp2c9	nn	24	SENT_91	[p9l11t114r417b178],
22	*	NN	O	*	nn	24	SENT_91	[p9l11t114r417b178],
23	3	CD	NUMBER	3	num	24	SENT_91	[p9l11t114r417b178],
24	homozygotes	NNS	O	homozygote	xcomp	18	SENT_91	[p9l512t118r1012b194],
25	,	,	O	,	_	0	SENT_91	[p9l512t118r1012b194],
26	making	VBG	O	make	partmod	24	SENT_91	[p9l1114t118r1383b194],
27	the	DT	O	the	det	28	SENT_91	[p9l1479t118r1591b178],
28	absence	NN	O	absence	nsubj	40	SENT_91	[p9l1692t118r1976b178],
29	of	IN	O	of	_	0	SENT_91	[p9l2077t118r2154b178],
30	CYP2C9	NN	O	cyp2c9	prep_of	28	SENT_91	[p9l11t212r417b277],
31	*	CD	NUMBER	*	number	32	SENT_91	[p9l11t212r417b277],
32	3	CD	NUMBER	3	num	33	SENT_91	[p9l11t212r417b277],
33	homozygotes	NNS	O	homozygote	dep	30	SENT_91	[p9l453t216r930b292],
34	in	IN	O	in	_	0	SENT_91	[p9l971t217r1039b276],
35	the	DT	O	the	det	39	SENT_91	[p9l1078t216r1190b277],
36	low-warfarin	JJ	O	low-warfarin	amod	39	SENT_91	[p9l1229t216r1891b277],
37	—	NN	O	—	nn	39	SENT_91	[p9l1229t216r1891b277],
38	dose	NN	O	dose	nn	39	SENT_91	[p9l1229t216r1891b277],
39	group	NN	O	group	prep_in	33	SENT_91	[p9l1931t237r2142b292],
40	unexpected	JJ	O	unexpected	xcomp	26	SENT_91	[p9l8t317r448b393],
41	.	.	O	.	_	0	SENT_91	[p9l8t317r448b393],

1	However	RB	O	however	advmod	7	SENT_92	[p9l526t318r877b390],
2	,	,	O	,	_	0	SENT_92	[p9l526t318r877b390],
3	because	IN	O	because	_	0	SENT_92	[p9l951t317r1239b377],
4	in-vitro	FW	O	in-vitro	prep_because	7	SENT_92	[p9l1312t317r1579b377],
5	studies	NNS	O	study	nsubj	7	SENT_92	[p9l1656t317r1904b377],
6	have	VBP	O	have	aux	7	SENT_92	[p9l1977t317r2143b377],
7	shown	VBN	O	show	_	0	SENT_92	[p9l10t416r244b477],
8	extremely	RB	O	extremely	advmod	9	SENT_92	[p9l284t416r640b492],
9	slow	JJ	O	slow	amod	10	SENT_92	[p9l678t416r839b477],
10	hydroxylation	NN	O	hydroxylation	dobj	7	SENT_92	[p9l876t416r1381b492],
11	of	IN	O	of	_	0	SENT_92	[p9l1422t416r1499b477],
12	S-warfarin	NN	O	s-warfarin	prep_of	10	SENT_92	[p9l1531t416r1911b477],
13	when	WRB	O	when	advmod	18	SENT_92	[p9l1949t416r2145b477],
14	CYP2C9	NN	O	cyp2c9	nsubjpass	18	SENT_92	[p9l11t512r417b576],
15	*	CD	NUMBER	*	num	16	SENT_92	[p9l11t512r417b576],
16	3	CD	NUMBER	3	dep	14	SENT_92	[p9l11t512r417b576],
17	is	VBZ	O	be	auxpass	18	SENT_92	[p9l469t516r520b576],
18	expressed	VBN	O	express	advcl	7	SENT_92	[p9l575t516r950b592],
19	,	,	O	,	_	0	SENT_92	[p9l575t516r950b592],
20	it	PRP	O	it	nsubj	22	SENT_92	[p9l1005t516r1054b576],
21	is	VBZ	O	be	cop	22	SENT_92	[p9l1105t516r1157b576],
22	possible	JJ	O	possible	conj_and	7	SENT_92	[p9l1209t516r1500b592],
23	that	IN	O	that	complm	29	SENT_92	[p9l1553t516r1696b576],
24	individuals	NNS	O	individual	nsubj	29	SENT_92	[p9l1747t516r2144b576],
25	homozygous	JJ	O	homozygous	amod	24	SENT_92	[p9l6t615r464b691],
26	for	IN	O	for	_	0	SENT_92	[p9l498t615r602b676],
27	this	DT	O	this	det	28	SENT_92	[p9l633t615r761b676],
28	allele	NN	O	allele	prep_for	25	SENT_92	[p9l797t615r981b676],
29	have	VBP	O	have	ccomp	22	SENT_92	[p9l1013t615r1179b676],
30	such	JJ	O	such	prep	29	SENT_92	[p9l1215t615r1380b676],
31	a	DT	O	a	det	33	SENT_92	[p9l1414t635r1449b676],
32	low	JJ	O	low	amod	33	SENT_92	[p9l1483t615r1612b676],
33	warfarin	NN	O	warfarin	dep	30	SENT_92	[p9l1642t615r1946b676],
34	dose	NN	O	dose	nn	35	SENT_92	[p9l1980t615r2143b676],
35	requirement	NN	O	requirement	dobj	29	SENT_92	[p9l7t715r435b791],
36	that	WDT	O	that	dobj	40	SENT_92	[p9l460t715r596b775],
37	stabilisation	NN	O	stabilisation	nsubj	40	SENT_92	[p9l621t715r1035b775],
38	is	VBZ	O	be	cop	40	SENT_92	[p9l1060t715r1109b775],
39	not	RB	O	not	neg	40	SENT_92	[p9l1135t729r1250b775],
40	successful	JJ	O	successful	rcmod	35	SENT_92	[p9l1277t715r1620b776],
41	and	CC	O	and	_	0	SENT_92	[p9l1648t715r1774b776],
42	treatment	NN	O	treatment	nsubjpass	46	SENT_92	[p9l1799t729r2138b775],
43	with	IN	O	with	_	0	SENT_92	[p9l8t816r168b876],
44	warfarin	NN	O	warfarin	prep_with	42	SENT_92	[p9l227t815r530b876],
45	is	VBZ	O	be	auxpass	46	SENT_92	[p9l591t816r642b876],
46	abandoned	VBN	O	abandon	conj_and	7	SENT_92	[p9l707t816r1131b876],
47	.	.	O	.	_	0	SENT_92	[p9l707t816r1131b876],

1	Interestingly	RB	O	interestingly	advmod	18	SENT_93	[p9l1197t816r1675b892],
2	,	,	O	,	_	0	SENT_93	[p9l1197t816r1675b892],
3	diminished	VBD	O	diminish	csubjpass	18	SENT_93	[p9l1741t816r2145b876],
4	clearance	NN	O	clearance	dobj	3	SENT_93	[p9l9t915r347b976],
5	of	IN	O	of	_	0	SENT_93	[p9l410t915r487b976],
6	S-warfarin	NN	O	s-warfarin	prep_of	4	SENT_93	[p9l540t915r921b976],
7	with	IN	O	with	_	0	SENT_93	[p9l979t915r1139b976],
8	exacerbated	JJ	O	exacerbated	amod	9	SENT_93	[p9l1200t915r1635b976],
9	response	NN	O	response	prep_with	3	SENT_93	[p9l1694t935r2011b991],
10	to	TO	O	to	_	0	SENT_93	[p9l2072t929r2142b976],
11	normal	JJ	O	normal	amod	12	SENT_93	[p9l7t1016r268b1076],
12	doses	NNS	O	dose	prep_to	3	SENT_93	[p9l304t1016r499b1076],
13	of	IN	O	of	_	0	SENT_93	[p9l537t1015r614b1076],
14	warfarin	NN	O	warfarin	prep_of	12	SENT_93	[p9l637t1015r941b1076],
15	has	VBZ	O	have	aux	18	SENT_93	[p9l974t1016r1092b1076],
16	been	VBN	O	be	auxpass	18	SENT_93	[p9l1126t1016r1301b1076],
17	recently	RB	DATE	recently	advmod	18	SENT_93	[p9l1335t1016r1626b1092],
18	reported	VBN	O	report	_	0	SENT_93	[p9l1658t1016r1969b1092],
19	in	IN	O	in	_	0	SENT_93	[p9l2003t1016r2072b1075],
20	a	DT	O	a	det	21	SENT_93	[p9l2108t1035r2143b1076],
21	patient	NN	O	patient	prep_in	18	SENT_93	[p9l7t1115r262b1190],
22	who	WP	O	who	nsubj	24	SENT_93	[p9l286t1115r438b1175],
23	was	VBD	O	be	cop	24	SENT_93	[p9l465t1135r598b1175],
24	homozygous	JJ	O	homozygous	rcmod	21	SENT_93	[p9l625t1115r1083b1190],
25	for	IN	O	for	_	0	SENT_93	[p9l1111t1114r1215b1175],
26	CYPZC9	NN	O	cypzc9	prep_for	24	SENT_93	[p9l1242t1115r1560b1175],
27	*	CD	NUMBER	*	number	28	SENT_93	[p9l1572t1111r1663b1175],
28	3	CD	NUMBER	3	num	26	SENT_93	[p9l1572t1111r1663b1175],
29	.	.	O	.	_	0	SENT_93	[p9l1572t1111r1663b1175],

1	14	CD	NUMBER	14	_	0	SENT_94	[p9l1682t1115r1722b1144],

1	Impaired	JJ	O	impaired	amod	2	SENT_95	[p9l94t1215r427b1291],
2	metabolism	NN	O	metabolism	nsubj	12	SENT_95	[p9l466t1215r892b1275],
3	of	IN	O	of	_	0	SENT_95	[p9l934t1215r1011b1275],
4	a	DT	O	a	det	8	SENT_95	[p9l1043t1235r1078b1275],
5	low	JJ	O	low	amod	8	SENT_95	[p9l1118t1215r1247b1275],
6	therapeutic	JJ	O	therapeutic	amod	8	SENT_95	[p9l1285t1215r1697b1291],
7	index	NN	O	index	nn	8	SENT_95	[p9l1737t1215r1938b1275],
8	drug	NN	O	drug	prep_of	2	SENT_95	[p9l1977t1215r2146b1291],
9	such	JJ	O	such	_	0	SENT_95	[p9l10t1314r176b1375],
10	as	IN	O	as	_	0	SENT_95	[p9l232t1334r299b1375],
11	warfarin	NN	O	warfarin	prep_such_as	8	SENT_95	[p9l354t1314r658b1375],
12	has	VBZ	O	have	_	0	SENT_95	[p9l711t1314r829b1375],
13	important	JJ	O	important	amod	15	SENT_95	[p9l885t1315r1251b1390],
14	clinical	JJ	O	clinical	amod	15	SENT_95	[p9l1306t1314r1562b1375],
15	consequences	NNS	O	consequence	dobj	12	SENT_95	[p9l1619t1334r2139b1390],
16	.	.	O	.	_	0	SENT_95	[p9l1619t1334r2139b1390],

1	Difﬁculty	NNP	O	Difﬁculty	nsubjpass	7	SENT_96	[p9l9t1415r358b1491],
2	in	IN	O	in	_	0	SENT_96	[p9l408t1415r477b1474],
3	establishing	VBG	O	establish	prepc_in	1	SENT_96	[p9l530t1415r958b1491],
4	optimum	JJ	O	optimum	amod	5	SENT_96	[p9l1009t1415r1345b1491],
5	anticoagulation	NN	O	anticoagulation	dobj	3	SENT_96	[p9l1398t1415r1961b1491],
6	was	VBD	O	be	auxpass	7	SENT_96	[p9l2010t1435r2143b1475],
7	experienced	VBN	O	experience	_	0	SENT_96	[p9l11t1514r447b1590],
8	in	IN	O	in	_	0	SENT_96	[p9l486t1515r555b1574],
9	20	CD	PERCENT	20	number	10	SENT_96	[p9l596t1517r682b1575],
10	(	CD	PERCENT	(	prep_in	7	SENT_96	[p9l729t1514r950b1590],
11	56	CD	PERCENT	56	number	12	SENT_96	[p9l729t1514r950b1590],
12	%	NN	PERCENT	%	amod	10	SENT_96	[p9l729t1514r950b1590],
13	)	CD	NUMBER	)	tmod	7	SENT_96	[p9l729t1514r950b1590],
14	of	IN	O	of	_	0	SENT_96	[p9l997t1514r1075b1575],
15	36	CD	NUMBER	36	num	16	SENT_96	[p9l1106t1517r1191b1575],
16	patients	NNS	O	patient	prep_of	13	SENT_96	[p9l1232t1515r1518b1590],
17	in	IN	O	in	_	0	SENT_96	[p9l1559t1514r1628b1574],
18	the	DT	O	the	det	20	SENT_96	[p9l1666t1514r1778b1575],
19	low-dose	JJ	O	low-dose	amod	20	SENT_96	[p9l1819t1514r2144b1575],
20	group	NN	O	group	prep_in	16	SENT_96	[p9l9t1634r220b1690],
21	with	IN	O	with	_	0	SENT_96	[p9l259t1614r418b1675],
22	their	PRP$	O	they	poss	24	SENT_96	[p9l455t1614r624b1675],
23	peak	NN	O	peak	nn	24	SENT_96	[p9l659t1614r830b1690],
24	INR	NN	O	inr	prep_with	20	SENT_96	[p9l866t1615r1030b1674],
25	rising	VBG	O	rise	xcomp	7	SENT_96	[p9l1064t1614r1265b1690],
26	above	IN	O	above	_	0	SENT_96	[p9l1303t1614r1511b1675],
27	the	DT	O	the	det	29	SENT_96	[p9l1549t1614r1661b1675],
28	target	NN	O	target	nn	29	SENT_96	[p9l1699t1628r1909b1690],
29	range	NN	O	range	prep_above	25	SENT_96	[p9l1945t1634r2144b1690],
30	after	IN	O	after	_	0	SENT_96	[p9l11t1714r175b1775],
31	a	DT	O	a	det	33	SENT_96	[p9l220t1734r254b1775],
32	ﬁxed-dose	JJ	O	ﬁxed-dose	amod	33	SENT_96	[p9l299t1714r674b1775],
33	regimen	NN	O	regimen	prep_after	25	SENT_96	[p9l719t1715r1035b1790],
34	.	.	O	.	_	0	SENT_96	[p9l719t1715r1035b1790],

1	18	CD	NUMBER	18	nsubj	5	SENT_97	[p9l1093t1717r1171b1775],
2	of	IN	O	of	_	0	SENT_97	[p9l1220t1714r1298b1775],
3	these	DT	O	these	det	4	SENT_97	[p9l1332t1714r1517b1775],
4	patients	NNS	O	patient	prep_of	1	SENT_97	[p9l1561t1715r1847b1790],
5	carried	VBD	O	carry	_	0	SENT_97	[p9l1895t1714r2145b1775],
6	one	CD	NUMBER	one	num	11	SENT_97	[p9l11t1834r140b1874],
7	or	CC	O	or	_	0	SENT_97	[p9l181t1834r256b1874],
8	more	JJR	O	more	num	11	SENT_97	[p9l292t1834r480b1874],
9	variant	JJ	O	variant	amod	11	SENT_97	[p9l517t1814r770b1874],
10	CYPZC9	NN	O	cypzc9	nn	11	SENT_97	[p9l810t1814r1129b1874],
11	alleles	NNS	O	allele	dobj	5	SENT_97	[p9l1165t1814r1402b1874],
12	.	.	O	.	_	0	SENT_97	[p9l1165t1814r1402b1874],

1	Difﬁcult	NN	O	difﬁcult	nn	2	SENT_98	[p9l1446t1814r1754b1874],
2	induction	NN	O	induction	nsubj	3	SENT_98	[p9l1792t1814r2143b1874],
3	resulted	VBD	O	result	_	0	SENT_98	[p9l7t1915r298b1975],
4	in	IN	O	in	_	0	SENT_98	[p9l360t1915r428b1974],
5	delayed	VBN	O	delay	amod	6	SENT_98	[p9l491t1915r767b1991],
6	discharges	NNS	O	discharge	prep_in	3	SENT_98	[p9l830t1915r1228b1991],
7	,	,	O	,	_	0	SENT_98	[p9l830t1915r1228b1991],
8	multiple	JJ	O	multiple	amod	9	SENT_98	[p9l1293t1915r1596b1991],
9	visits	NNS	O	visit	appos	6	SENT_98	[p9l1656t1915r1835b1975],
10	to	TO	O	to	_	0	SENT_98	[p9l1898t1928r1967b1975],
11	the	DT	O	the	det	12	SENT_98	[p9l2030t1915r2143b1975],
12	clinics	NNS	O	clinic	prep_to	9	SENT_98	[p9l9t2012r257b2085],
13	,	,	O	,	_	0	SENT_98	[p9l9t2012r257b2085],
14	and	CC	O	and	_	0	SENT_98	[p9l289t2012r422b2073],
15	additional	JJ	O	additional	amod	16	SENT_98	[p9l451t2012r815b2073],
16	investigations	NNS	O	investigation	appos	6	SENT_98	[p9l843t2012r1337b2088],
17	in	IN	O	in	_	0	SENT_98	[p9l1366t2012r1435b2072],
18	an	DT	O	a	det	19	SENT_98	[p9l1463t2032r1548b2073],
19	attempt	NN	O	attempt	prep_in	16	SENT_98	[p9l1576t2026r1858b2088],
20	to	TO	O	to	aux	21	SENT_98	[p9l1884t2026r1953b2073],
21	seek	VB	O	seek	infmod	19	SENT_98	[p9l1983t2012r2137b2073],
22	an	DT	O	a	det	23	SENT_98	[p9l10t2131r95b2171],
23	explanation	NN	O	explanation	dobj	21	SENT_98	[p9l127t2111r551b2187],
24	for	IN	O	for	_	0	SENT_98	[p9l581t2111r684b2171],
25	warfarin	NN	O	warfarin	nn	26	SENT_98	[p9l712t2111r1016b2171],
26	sensitivity	NN	O	sensitivity	prep_for	23	SENT_98	[p9l1047t2111r1424b2187],
27	.	.	O	.	_	0	SENT_98	[p9l1047t2111r1424b2187],

1	A	DT	O	a	det	3	SENT_99	[p9l1459t2112r1520b2170],
2	smaller	JJR	O	smaller	amod	3	SENT_99	[p9l1551t2111r1814b2171],
3	warfarin	NN	O	warfarin	nsubjpass	8	SENT_99	[p9l1841t2111r2144b2171],
4	dose	NN	O	dose	nn	5	SENT_99	[p9l10t2208r173b2269],
5	requirement	NN	O	requirement	dep	3	SENT_99	[p9l257t2208r708b2284],
6	may	MD	O	may	aux	8	SENT_99	[p9l791t2228r944b2284],
7	be	VB	O	be	auxpass	8	SENT_99	[p9l1026t2208r1111b2269],
8	associated	VBN	O	associate	_	0	SENT_99	[p9l1198t2208r1567b2269],
9	with	IN	O	with	_	0	SENT_99	[p9l1649t2208r1809b2269],
10	greater	JJR	O	greater	amod	11	SENT_99	[p9l1893t2223r2146b2284],
11	variability	NN	O	variability	prep_with	8	SENT_99	[p9l7t2307r369b2383],
12	of	IN	O	of	_	0	SENT_99	[p9l407t2307r484b2367],
13	INR3	NN	O	inr3	prep_of	11	SENT_99	[p9l512t2307r695b2367],
14	and	CC	O	and	_	0	SENT_99	[p9l734t2307r867b2367],
15	this	DT	O	this	nsubj	26	SENT_99	[p9l904t2307r1055b2380],
16	,	,	O	,	_	0	SENT_99	[p9l904t2307r1055b2380],
17	coupled	VBN	O	couple	partmod	15	SENT_99	[p9l1098t2307r1386b2383],
18	with	IN	O	with	_	0	SENT_99	[p9l1422t2307r1581b2367],
19	warfarin	NN	O	warfarin	poss	23	SENT_99	[p9l1617t2307r1977b2367],
20	’s	POS	O	’s	_	0	SENT_99	[p9l1617t2307r1977b2367],
21	low	JJ	O	low	amod	23	SENT_99	[p9l2016t2307r2144b2367],
22	therapeutic	JJ	O	therapeutic	amod	23	SENT_99	[p9l7t2404r419b2480],
23	index	NN	O	index	prep_with	17	SENT_99	[p9l467t2404r688b2477],
24	,	,	O	,	_	0	SENT_99	[p9l467t2404r688b2477],
25	may	MD	O	may	aux	26	SENT_99	[p9l738t2424r892b2480],
26	lead	VB	O	lead	conj_and	8	SENT_99	[p9l938t2404r1086b2465],
27	to	TO	O	to	_	0	SENT_99	[p9l1133t2419r1203b2465],
28	bleeding	VBG	O	bleed	amod	29	SENT_99	[p9l1251t2404r1563b2480],
29	complications	NNS	O	complication	prep_to	26	SENT_99	[p9l1611t2404r2138b2480],
30	.	.	O	.	_	0	SENT_99	[p9l1611t2404r2138b2480],

1	These	DT	O	these	nsubj	3	SENT_100	[p9l7t2503r229b2563],
2	are	VBP	O	be	cop	3	SENT_100	[p9l290t2522r396b2563],
3	likely	JJ	O	likely	_	0	SENT_100	[p9l455t2503r647b2579],
4	to	TO	O	to	aux	5	SENT_100	[p9l702t2517r772b2563],
5	occur	VB	O	occur	xcomp	3	SENT_100	[p9l834t2522r1037b2563],
6	later	RB	O	later	advmod	5	SENT_100	[p9l1093t2503r1256b2563],
7	during	IN	O	during	_	0	SENT_100	[p9l1313t2503r1553b2579],
8	the	DT	O	the	det	9	SENT_100	[p9l1609t2503r1721b2563],
9	course	NN	O	course	prep_during	6	SENT_100	[p9l1782t2523r2015b2563],
10	of	IN	O	of	_	0	SENT_100	[p9l2076t2503r2154b2563],
11	warfarin	NN	O	warfarin	nn	12	SENT_100	[p9l7t2600r310b2661],
12	therapy	NN	O	therapy	prep_of	9	SENT_100	[p9l336t2600r631b2676],
13	,	,	O	,	_	0	SENT_100	[p9l336t2600r631b2676],
14	presumably	RB	O	presumably	advmod	6	SENT_100	[p9l660t2600r1087b2676],
15	when	WRB	O	when	advmod	18	SENT_100	[p9l1110t2600r1307b2661],
16	monitoring	NN	O	monitoring	nsubjpass	18	SENT_100	[p9l1333t2601r1743b2676],
17	is	VBZ	O	be	auxpass	18	SENT_100	[p9l1768t2601r1820b2661],
18	relaxed	VBN	O	relax	advcl	5	SENT_100	[p9l1848t2600r2130b2661],
19	.	.	O	.	_	0	SENT_100	[p9l1848t2600r2130b2661],

1	Consistent	JJ	O	consistent	nsubj	18	SENT_101	[p9l12t2698r402b2759],
2	with	IN	O	with	_	0	SENT_101	[p9l454t2698r614b2759],
3	this	DT	O	this	prep_with	1	SENT_101	[p9l667t2698r819b2771],
4	,	,	O	,	_	0	SENT_101	[p9l667t2698r819b2771],
5	the	DT	O	the	det	6	SENT_101	[p9l876t2698r987b2758],
6	incidence	NN	O	incidence	appos	3	SENT_101	[p9l1044t2698r1390b2758],
7	of	IN	O	of	_	0	SENT_101	[p9l1447t2698r1525b2758],
8	major	JJ	O	major	amod	10	SENT_101	[p9l1569t2698r1782b2774],
9	bleeding	NN	O	bleeding	nn	10	SENT_101	[p9l1833t2698r2146b2774],
10	complications	NNS	O	complication	prep_of	6	SENT_101	[p9l10t2796r517b2872],
11	in	IN	O	in	_	0	SENT_101	[p9l580t2796r648b2856],
12	the	DT	O	the	det	14	SENT_101	[p9l709t2796r821b2857],
13	low-dose	JJ	O	low-dose	amod	14	SENT_101	[p9l883t2796r1208b2857],
14	group	NN	O	group	prep_in	10	SENT_101	[p9l1270t2816r1482b2872],
15	was	VBD	O	be	cop	18	SENT_101	[p9l1543t2816r1676b2857],
16	four	CD	NUMBER	four	num	17	SENT_101	[p9l1738t2796r1890b2857],
17	times	NNS	O	time	npadvmod	18	SENT_101	[p9l1949t2797r2143b2857],
18	higher	JJR	O	higher	_	0	SENT_101	[p9l7t2894r240b2970],
19	than	IN	O	than	_	0	SENT_101	[p9l264t2894r427b2954],
20	that	DT	O	that	prep_than	18	SENT_101	[p9l453t2894r596b2954],
21	in	IN	O	in	_	0	SENT_101	[p9l622t2894r691b2954],
22	the	DT	O	the	det	24	SENT_101	[p9l717t2894r829b2954],
23	clinic	NN	O	clinic	nn	24	SENT_101	[p9l858t2894r1050b2954],
24	controls	NNS	O	control	prep_in	20	SENT_101	[p9l1079t2894r1390b2955],
25	.	.	O	.	_	0	SENT_101	[p9l1079t2894r1390b2955],

1	We	PRP	O	we	nsubj	2	SENT_102	[p9l91t2993r213b3053],
2	suggest	VBP	O	suggest	_	0	SENT_102	[p9l247t3007r512b3068],
3	that	IN	O	that	complm	15	SENT_102	[p9l542t2992r685b3053],
4	knowledge	NN	O	knowledge	nsubj	15	SENT_102	[p9l716t2992r1105b3068],
5	of	IN	O	of	_	0	SENT_102	[p9l1139t2992r1216b3053],
6	CYP2C9	NN	O	cyp2c9	nn	7	SENT_102	[p9l1239t2993r1558b3053],
7	genotype	NN	O	genotype	prep_of	4	SENT_102	[p9l1587t3007r1916b3068],
8	when	WRB	O	when	advmod	9	SENT_102	[p9l1943t2992r2139b3053],
9	deciding	VBG	O	decide	dep	7	SENT_102	[p9l9t3090r320b3166],
10	on	IN	O	on	_	0	SENT_102	[p9l358t3110r448b3150],
11	treatment	NN	O	treatment	prep_on	9	SENT_102	[p9l484t3104r841b3150],
12	with	IN	O	with	_	0	SENT_102	[p9l876t3090r1035b3151],
13	warfarin	NN	O	warfarin	prep_with	9	SENT_102	[p9l1070t3090r1373b3151],
14	may	MD	O	may	aux	15	SENT_102	[p9l1410t3110r1563b3166],
15	help	VB	O	help	ccomp	2	SENT_102	[p9l1597t3090r1751b3166],
16	to	TO	O	to	aux	17	SENT_102	[p9l1790t3104r1860b3150],
17	reduce	VB	O	reduce	xcomp	15	SENT_102	[p9l1898t3090r2143b3151],
18	problems	NNS	O	problem	dobj	17	SENT_102	[p9l7t3188r333b3264],
19	during	IN	O	during	_	0	SENT_102	[p9l366t3188r596b3264],
20	induction	NN	O	induction	prep_during	17	SENT_102	[p9l625t3188r981b3249],
21	.	.	O	.	_	0	SENT_102	[p9l625t3188r981b3249],

1	In	IN	O	in	_	0	SENT_103	[p9l1016t3189r1090b3248],
2	addition	NN	O	addition	prep_in	15	SENT_103	[p9l1122t3188r1432b3261],
3	,	,	O	,	_	0	SENT_103	[p9l1122t3188r1432b3261],
4	the	DT	O	the	det	7	SENT_103	[p9l1465t3188r1572b3249],
5	likely	JJ	O	likely	amod	7	SENT_103	[p9l1604t3188r1787b3264],
6	increased	VBN	O	increase	amod	7	SENT_103	[p9l1815t3188r2144b3249],
7	risk	NN	O	risk	nsubj	15	SENT_103	[p9l8t3286r132b3346],
8	of	IN	O	of	_	0	SENT_103	[p9l159t3286r232b3347],
9	bleeding	NN	O	bleeding	prep_of	7	SENT_103	[p9l248t3286r546b3362],
10	in	IN	O	in	_	0	SENT_103	[p9l571t3286r636b3346],
11	patients	NNS	O	patient	prep_in	9	SENT_103	[p9l661t3286r933b3362],
12	with	IN	O	with	_	0	SENT_103	[p9l961t3286r1112b3347],
13	mutations	NNS	O	mutation	prep_with	11	SENT_103	[p9l1139t3286r1486b3347],
14	may	MD	O	may	aux	15	SENT_103	[p9l1514t3306r1660b3362],
15	inﬂuence	VB	O	inﬂuence	_	0	SENT_103	[p9l1685t3286r2002b3346],
16	the	DT	O	the	det	17	SENT_103	[p9l2031t3286r2143b3346],
17	decision	NN	O	decision	dobj	15	SENT_103	[p9l9t3385r308b3445],
18	to	TO	O	to	aux	19	SENT_103	[p9l341t3399r410b3445],
19	start	VB	O	start	infmod	17	SENT_103	[p9l447t3399r606b3445],
20	warfarin	NN	O	warfarin	nn	21	SENT_103	[p9l637t3384r941b3445],
21	therapy	NN	O	therapy	dobj	19	SENT_103	[p9l974t3385r1269b3461],
22	,	,	O	,	_	0	SENT_103	[p9l974t3385r1269b3461],
23	particularly	RB	O	particularly	advmod	19	SENT_103	[p9l1305t3385r1723b3461],
24	in	IN	O	in	_	0	SENT_103	[p9l1755t3385r1824b3444],
25	patients	NNS	O	patient	prep_in	19	SENT_103	[p9l1856t3385r2142b3461],
26	in	IN	O	in	_	0	SENT_103	[p9l8t3482r77b3542],
27	whom	WP	O	whom	rel	31	SENT_103	[p9l102t3482r329b3543],
28	the	DT	O	the	det	29	SENT_103	[p9l356t3482r468b3542],
29	beneﬁt	NN	O	beneﬁt	nsubjpass	31	SENT_103	[p9l494t3482r746b3542],
30	is	VBZ	O	be	auxpass	31	SENT_103	[p9l773t3482r824b3542],
31	perceived	VBN	O	perceive	rcmod	25	SENT_103	[p9l851t3482r1200b3558],
32	to	TO	O	to	aux	34	SENT_103	[p9l1227t3496r1296b3542],
33	be	VB	O	be	cop	34	SENT_103	[p9l1323t3482r1408b3542],
34	small	JJ	O	small	xcomp	31	SENT_103	[p9l1438t3482r1646b3543],
35	.	.	O	.	_	0	SENT_103	[p9l1438t3482r1646b3543],

1	Contributors	NNS	O	contributor	_	0	SENT_104	[p9l14t3595r428b3649],

1	Guruprasad	NNP	PERSON	Guruprasad	nn	2	SENT_105	[p10l9t18r350b77],
2	Aithal	NNP	PERSON	Aithal	nsubjpass	4	SENT_105	[p10l369t18r542b65],
3	was	VBD	O	be	auxpass	4	SENT_105	[p10l562t33r665b65],
4	involved	VBN	O	involve	_	0	SENT_105	[p10l687t18r926b65],
5	in	IN	O	in	_	0	SENT_105	[p10l947t18r1001b64],
6	genotyping	NN	O	genotyping	prep_in	4	SENT_105	[p10l1021t18r1337b77],
7	and	CC	O	and	_	0	SENT_105	[p10l1358t18r1461b65],
8	wrote	VBD	O	write	conj_and	4	SENT_105	[p10l1481t28r1640b65],
9	the	DT	O	the	det	10	SENT_105	[p10l1662t18r1749b65],
10	paper	NN	O	paper	dobj	8	SENT_105	[p10l1769t33r1944b77],
11	.	.	O	.	_	0	SENT_105	[p10l1769t33r1944b77],

1	Christopher	NNP	MISC	Christopher	nn	2	SENT_106	[p10l12t85r353b145],
2	Day	NNP	DURATION	Day	nsubj	11	SENT_106	[p10l373t86r491b144],
3	and	CC	O	and	_	0	SENT_106	[p10l511t85r615b133],
4	Ann	NNP	PERSON	Ann	nn	5	SENT_106	[p10l634t86r756b132],
5	Daly	NNP	PERSON	Daly	nsubj	7	SENT_106	[p10l777t85r913b144],
6	jointly	RB	O	jointly	advmod	7	SENT_106	[p10l932t85r1111b144],
7	supervised	VBD	O	supervise	_	0	SENT_106	[p10l1132t85r1430b145],
8	the	DT	O	the	det	9	SENT_106	[p10l1450t85r1537b133],
9	study	NN	O	study	dobj	7	SENT_106	[p10l1560t85r1713b144],
10	and	CC	O	and	_	0	SENT_106	[p10l1733t85r1837b133],
11	revised	VBD	O	revise	conj_and	7	SENT_106	[p10l1857t85r2056b133],
12	the	DT	O	the	det	13	SENT_106	[p10l7t154r94b201],
13	paper	NN	O	paper	dobj	11	SENT_106	[p10l115t170r290b213],
14	.	.	O	.	_	0	SENT_106	[p10l115t170r290b213],

1	Patrick	NNP	PERSON	Patrick	nn	2	SENT_107	[p10l315t154r517b201],
2	Kesteven	NNP	PERSON	Kesteven	nsubj	3	SENT_107	[p10l537t155r797b201],
3	contributed	VBD	O	contribute	_	0	SENT_107	[p10l819t154r1150b202],
4	to	TO	O	to	_	0	SENT_107	[p10l1170t165r1225b201],
5	the	DT	O	the	det	7	SENT_107	[p10l1246t154r1334b201],
6	study	NN	O	study	nn	7	SENT_107	[p10l1356t154r1510b213],
7	design	NN	O	design	prep_to	3	SENT_107	[p10l1530t154r1711b213],
8	and	CC	O	and	_	0	SENT_107	[p10l1733t154r1836b202],
9	data	NN	O	datum	nn	10	SENT_107	[p10l1858t154r1977b202],
10	analysis	NN	O	analysis	prep_to	3	SENT_107	[p10l11t223r243b282],
11	.	.	O	.	_	0	SENT_107	[p10l11t223r243b282],

1	Acknowledgments	NNS	O	acknowledgment	nsubjpass	5	SENT_108	[p10l8t339r632b406],
2	This	DT	O	this	det	3	SENT_108	[p10l7t420r136b467],
3	study	NN	O	study	dep	1	SENT_108	[p10l159t420r312b479],
4	was	VBD	O	be	auxpass	5	SENT_108	[p10l331t435r434b467],
5	supported	VBN	O	support	_	0	SENT_108	[p10l457t420r743b479],
6	in	IN	O	in	_	0	SENT_108	[p10l764t420r817b466],
7	part	NN	O	part	prep_in	5	SENT_108	[p10l837t430r951b479],
8	by	IN	O	by	_	0	SENT_108	[p10l970t420r1039b479],
9	Eurohepatox	NNP	O	Eurohepatox	nn	10	SENT_108	[p10l1058t420r1428b479],
10	Biomed	NNP	O	Biomed	agent	5	SENT_108	[p10l1448t420r1670b467],
11	2	CD	NUMBER	2	num	12	SENT_108	[p10l1692t422r1723b466],
12	programme	NN	O	programme	dep	10	SENT_108	[p10l1744t435r2074b479],
13	of	IN	O	of	_	0	SENT_108	[p10l9t495r70b543],
14	the	DT	O	the	det	16	SENT_108	[p10l83t495r169b543],
15	European	NNP	ORGANIZATION	European	nn	16	SENT_108	[p10l191t496r469b555],
16	Union	NNP	ORGANIZATION	Union	prep_of	12	SENT_108	[p10l489t495r687b543],
17	.	.	O	.	_	0	SENT_108	[p10l489t495r687b543],

1	We	PRP	O	we	nsubj	3	SENT_109	[p10l710t496r806b543],
2	are	VBP	O	be	cop	3	SENT_109	[p10l829t511r912b543],
3	grateful	JJ	O	grateful	_	0	SENT_109	[p10l933t495r1149b555],
4	to	TO	O	to	_	0	SENT_109	[p10l1169t506r1224b543],
5	Annette	NNP	PERSON	Annette	nn	6	SENT_109	[p10l1245t496r1472b543],
6	Steward	NNP	PERSON	Steward	prep_to	3	SENT_109	[p10l1495t495r1742b552],
7	,	,	O	,	_	0	SENT_109	[p10l1495t495r1742b552],
8	Selahaddin	NNP	PERSON	Selahaddin	nn	9	SENT_109	[p10l1768t495r2083b543],
9	Tekes	NNP	PERSON	Tekes	prep_to	3	SENT_109	[p10l8t570r195b627],
10	,	,	O	,	_	0	SENT_109	[p10l8t570r195b627],
11	and	CC	O	and	_	0	SENT_109	[p10l220t570r323b618],
12	Catherine	NNP	PERSON	Catherine	nn	13	SENT_109	[p10l347t570r625b618],
13	Lamb	NNP	PERSON	Lamb	prep_to	3	SENT_109	[p10l647t570r813b618],
14	for	IN	O	for	_	0	SENT_109	[p10l835t570r916b618],
15	their	PRP$	O	they	poss	16	SENT_109	[p10l935t570r1067b618],
16	assistance	NN	O	assistance	prep_for	3	SENT_109	[p10l1088t570r1364b618],
17	in	IN	O	in	_	0	SENT_109	[p10l1386t570r1439b617],
18	genotyping	NN	O	genotyping	prep_in	16	SENT_109	[p10l1460t570r1790b629],
19	.	.	O	.	_	0	SENT_109	[p10l1460t570r1790b629],

1	References	NNS	O	reference	_	0	SENT_110	[p10l10t720r361b771],

1	1	CD	NUMBER	1	_	0	SENT_111	[p10l15t829r34b874],
2	Atrial	NNP	O	Atrial	nn	4	SENT_111	[p10l111t827r272b874],
3	Fibrillation	NNP	O	Fibrillation	nn	4	SENT_111	[p10l293t827r612b874],
4	Investigators	NNS	O	investigator	dep	1	SENT_111	[p10l633t827r1010b886],
5	.	.	O	.	_	0	SENT_111	[p10l633t827r1010b886],

1	Risk	NN	O	risk	nn	2	SENT_112	[p10l1036t827r1159b874],
2	factors	NNS	O	factor	_	0	SENT_112	[p10l1178t827r1366b874],
3	for	IN	O	for	_	0	SENT_112	[p10l1388t827r1468b874],
4	stroke	NN	O	stroke	prep_for	2	SENT_112	[p10l1489t827r1658b874],
5	and	CC	O	and	_	0	SENT_112	[p10l1681t827r1784b874],
6	efﬁcacy	NN	O	efﬁcacy	conj_and	4	SENT_112	[p10l1806t827r2019b886],
7	of	IN	O	of	_	0	SENT_112	[p10l2040t827r2100b874],
8	antithrombotic	JJ	O	antithrombotic	amod	9	SENT_112	[p10l114t903r539b950],
9	therapy	NN	O	therapy	prep_of	2	SENT_112	[p10l560t903r775b962],
10	in	IN	O	in	_	0	SENT_112	[p10l795t903r848b949],
11	atrial	JJ	O	atrial	amod	12	SENT_112	[p10l869t903r1011b950],
12	ﬁbrillation	NN	O	ﬁbrillation	prep_in	9	SENT_112	[p10l1032t902r1344b950],
13	:	:	O	:	_	0	SENT_112	[p10l1032t902r1344b950],
14	analysis	NN	O	analysis	dep	2	SENT_112	[p10l1371t903r1586b962],
15	of	IN	O	of	_	0	SENT_112	[p10l1609t902r1670b950],
16	pooled	JJ	O	pooled	amod	17	SENT_112	[p10l1682t903r1876b962],
17	data	NNS	O	datum	prep_of	14	SENT_112	[p10l1897t903r2017b950],
18	from	IN	O	from	_	0	SENT_112	[p10l112t979r249b1027],
19	ﬁve	NN	O	ﬁve	prep_from	17	SENT_112	[p10l269t979r367b1027],
20	randomized	VBN	O	randomize	partmod	19	SENT_112	[p10l388t979r727b1027],
21	controlled	JJ	O	controlled	amod	22	SENT_112	[p10l749t979r1037b1027],
22	trials	NNS	O	trial	dobj	20	SENT_112	[p10l1057t979r1210b1027],
23	.	.	O	.	_	0	SENT_112	[p10l1057t979r1210b1027],

1	Arch	NNP	O	Arch	nn	3	SENT_113	[p10l1229t979r1363b1027],
2	Intern	NNP	O	Intern	nn	3	SENT_113	[p10l1382t980r1544b1027],
3	Med	NNP	O	Med	_	0	SENT_113	[p10l1562t979r1690b1027],
4	1994	CD	DATE	1994	num	3	SENT_113	[p10l1713t981r1866b1036],
5	;	:	O	;	_	0	SENT_113	[p10l1713t981r1866b1036],
6	154	CD	NUMBER	154	num	8	SENT_113	[p10l1891t981r2012b1027],
7	:	:	O	:	_	0	SENT_113	[p10l1891t981r2012b1027],
8	1449-57	CD	NUMBER	1449-57	dep	3	SENT_113	[p10l119t1058r376b1102],
9	.	.	O	.	_	0	SENT_113	[p10l119t1058r376b1102],

1	2	CD	NUMBER	2	_	0	SENT_114	[p10l9t1142r40b1187],
2	Stroke	NNP	O	Stroke	nn	3	SENT_114	[p10l115t1140r296b1188],
3	Prevention	NNP	O	Prevention	dep	1	SENT_114	[p10l318t1140r627b1188],
4	in	IN	O	in	_	0	SENT_114	[p10l648t1140r701b1187],
5	Atrial	NNP	O	Atrial	nn	7	SENT_114	[p10l720t1140r880b1187],
6	Fibrillation	NNP	O	Fibrillation	nn	7	SENT_114	[p10l901t1140r1221b1187],
7	Investigators	NNS	O	investigator	prep_in	3	SENT_114	[p10l1242t1140r1619b1199],
8	.	.	O	.	_	0	SENT_114	[p10l1242t1140r1619b1199],

1	Bleeding	VBG	O	bleed	_	0	SENT_115	[p10l1644t1140r1894b1199],
2	during	IN	O	during	_	0	SENT_115	[p10l1915t1140r2102b1199],
3	antithrombotic	JJ	O	antithrombotic	amod	4	SENT_115	[p10l113t1216r538b1263],
4	therapy	NN	O	therapy	prep_during	1	SENT_115	[p10l559t1216r774b1275],
5	in	IN	O	in	_	0	SENT_115	[p10l793t1216r847b1262],
6	patients	NNS	O	patient	prep_in	4	SENT_115	[p10l866t1216r1088b1275],
7	with	IN	O	with	_	0	SENT_115	[p10l1109t1216r1234b1263],
8	atrial	JJ	O	atrial	amod	9	SENT_115	[p10l1255t1216r1397b1263],
9	ﬁbrillation	NN	O	ﬁbrillation	prep_with	6	SENT_115	[p10l1418t1215r1730b1263],
10	.	.	O	.	_	0	SENT_115	[p10l1418t1215r1730b1263],

1	Arch	NNP	O	Arch	nn	3	SENT_116	[p10l1751t1216r1884b1263],
2	Intern	NNP	O	Intern	nn	3	SENT_116	[p10l1904t1216r2065b1263],
3	Med	NNP	O	Med	_	0	SENT_116	[p10l110t1292r238b1340],
4	1996	CD	DATE	1996	num	3	SENT_116	[p10l261t1294r414b1349],
5	;	:	O	;	_	0	SENT_116	[p10l261t1294r414b1349],
6	156	CD	NUMBER	156	num	8	SENT_116	[p10l442t1293r563b1340],
7	:	:	O	:	_	0	SENT_116	[p10l442t1293r563b1340],
8	409-16	CD	NUMBER	409-16	dep	3	SENT_116	[p10l583t1294r810b1340],
9	.	.	O	.	_	0	SENT_116	[p10l583t1294r810b1340],

1	3	CD	NUMBER	3	num	3	SENT_117	[p10l9t1379r39b1425],
2	Finn	NNP	O	Finn	nn	3	SENT_117	[p10l112t1377r247b1424],
3	SD	NN	O	sd	_	0	SENT_117	[p10l270t1377r377b1434],
4	,	,	O	,	_	0	SENT_117	[p10l270t1377r377b1434],
5	Callahan	NNP	PERSON	Callahan	nn	6	SENT_117	[p10l403t1377r655b1425],
6	CM	NN	O	cm	dep	3	SENT_117	[p10l678t1377r808b1434],
7	,	,	O	,	_	0	SENT_117	[p10l678t1377r808b1434],
8	Martin	NNP	ORGANIZATION	Martin	nn	9	SENT_117	[p10l831t1377r1030b1425],
9	DC	NNP	ORGANIZATION	DC	appos	6	SENT_117	[p10l1051t1377r1172b1434],
10	,	,	O	,	_	0	SENT_117	[p10l1051t1377r1172b1434],
11	McDonell	NNP	PERSON	McDonell	nn	12	SENT_117	[p10l1195t1377r1486b1425],
12	MB	NNP	O	MB	appos	6	SENT_117	[p10l1507t1378r1634b1434],
13	,	,	O	,	_	0	SENT_117	[p10l1507t1378r1634b1434],
14	Henikoff	NNP	PERSON	Henikoff	nn	16	SENT_117	[p10l1658t1377r2022b1435],
15	]	CD	NUMBER	]	num	16	SENT_117	[p10l1658t1377r2022b1435],
16	G	NN	O	g	appos	6	SENT_117	[p10l1658t1377r2022b1435],
17	,	,	O	,	_	0	SENT_117	[p10l1658t1377r2022b1435],

1	White	NNP	O	White	nn	2	SENT_118	[p10l111t1453r284b1501],
2	RH	NNP	O	RH	_	0	SENT_118	[p10l306t1454r422b1500],
3	.	.	O	.	_	0	SENT_118	[p10l306t1454r422b1500],

1	The	DT	O	the	det	2	SENT_119	[p10l446t1453r562b1500],
2	risk	NN	O	risk	_	0	SENT_119	[p10l583t1453r685b1500],
3	for	IN	O	for	prep	2	SENT_119	[p10l704t1453r785b1500],
4	and	CC	O	and	_	0	SENT_119	[p10l805t1453r908b1501],
5	severity	NN	O	severity	conj_and	2	SENT_119	[p10l930t1453r1144b1512],
6	of	IN	O	of	_	0	SENT_119	[p10l1165t1453r1225b1500],
7	bleeding	VBG	O	bleed	amod	8	SENT_119	[p10l1237t1453r1481b1512],
8	complications	NNS	O	complication	prep_of	5	SENT_119	[p10l1501t1453r1895b1512],
9	in	IN	O	in	_	0	SENT_119	[p10l1917t1453r1971b1500],
10	elderly	JJ	O	elderly	amod	11	SENT_119	[p10l112t1529r302b1588],
11	patients	NNS	O	patient	prep_in	8	SENT_119	[p10l320t1529r543b1588],
12	treated	VBN	O	treat	partmod	11	SENT_119	[p10l565t1529r763b1576],
13	with	IN	O	with	_	0	SENT_119	[p10l782t1529r907b1576],
14	warfarin	NN	O	warfarin	prep_with	12	SENT_119	[p10l926t1529r1177b1576],
15	:	:	O	:	_	0	SENT_119	[p10l926t1529r1177b1576],
16	the	DT	O	the	det	18	SENT_119	[p10l1202t1529r1289b1576],
17	national	JJ	O	national	amod	18	SENT_119	[p10l1310t1529r1540b1576],
18	consortium	NN	O	consortium	dep	2	SENT_119	[p10l1562t1529r1885b1576],
19	of	IN	O	of	_	0	SENT_119	[p10l1907t1529r1967b1576],
20	anticoagulation	NN	O	anticoagulation	prep_of	18	SENT_119	[p10l113t1605r566b1665],
21	.	.	O	.	_	0	SENT_119	[p10l113t1605r566b1665],

1	Ann	NNP	PERSON	Ann	nn	3	SENT_120	[p10l586t1606r707b1653],
2	Intern	NNP	O	Intern	nn	3	SENT_120	[p10l726t1606r887b1653],
3	Med	NNP	O	Med	_	0	SENT_120	[p10l905t1606r1033b1653],
4	1996	CD	DATE	1996	num	3	SENT_120	[p10l1056t1607r1209b1662],
5	;	:	O	;	_	0	SENT_120	[p10l1056t1607r1209b1662],
6	124	CD	NUMBER	124	num	8	SENT_120	[p10l1237t1607r1358b1653],
7	:	:	O	:	_	0	SENT_120	[p10l1237t1607r1358b1653],
8	970-79	CD	NUMBER	970-79	dep	3	SENT_120	[p10l1377t1607r1603b1653],
9	.	.	O	.	_	0	SENT_120	[p10l1377t1607r1603b1653],

1	4	CD	NUMBER	4	num	3	SENT_121	[p10l9t1691r41b1736],
2	James	NNP	O	James	nn	3	SENT_121	[p10l109t1690r279b1747],
3	AH	NNP	O	AH	_	0	SENT_121	[p10l299t1690r419b1746],
4	,	,	O	,	_	0	SENT_121	[p10l299t1690r419b1746],
5	Britt	NNP	PERSON	Britt	nn	6	SENT_121	[p10l443t1689r572b1737],
6	RP	NNP	PERSON	RP	appos	3	SENT_121	[p10l593t1690r696b1746],
7	,	,	O	,	_	0	SENT_121	[p10l593t1690r696b1746],
8	Risking	VBG	O	risk	amod	9	SENT_121	[p10l720t1689r932b1749],
9	CL	NN	O	cl	appos	6	SENT_121	[p10l954t1690r1062b1746],
10	,	,	O	,	_	0	SENT_121	[p10l954t1690r1062b1746],
11	Thompson	NNP	PERSON	Thompson	nn	12	SENT_121	[p10l1085t1689r1400b1749],
12	SG	NNP	O	SG	appos	6	SENT_121	[p10l1423t1690r1528b1737],
13	.	.	O	.	_	0	SENT_121	[p10l1423t1690r1528b1737],

1	Factors	NNS	O	factor	_	0	SENT_122	[p10l1553t1690r1764b1737],
2	affecting	VBG	O	affect	partmod	1	SENT_122	[p10l1787t1689r2030b1749],
3	the	DT	O	the	det	5	SENT_122	[p10l2049t1689r2136b1737],
4	maintenance	NN	O	maintenance	nn	5	SENT_122	[p10l112t1765r476b1812],
5	dose	NN	O	dose	dobj	2	SENT_122	[p10l498t1765r625b1813],
6	of	IN	O	of	_	0	SENT_122	[p10l648t1765r708b1812],
7	Warfarin	NNP	O	Warfarin	prep_of	5	SENT_122	[p10l720t1765r971b1813],
8	.	.	O	.	_	0	SENT_122	[p10l720t1765r971b1813],

1	_	NN	O	_	nn	4	SENT_123	[p10l988t1765r1030b1824],
2	7	CD	NUMBER	7	num	4	SENT_123	[p10l988t1765r1030b1824],
3	Clin	NNP	O	Clin	nn	4	SENT_123	[p10l1047t1765r1158b1812],
4	Pathol	NNP	O	Pathol	_	0	SENT_123	[p10l1178t1765r1355b1812],
5	1992	CD	DATE	1992	dep	4	SENT_123	[p10l1379t1767r1532b1822],
6	;	:	O	;	_	0	SENT_123	[p10l1379t1767r1532b1822],
7	45	CD	NUMBER	45	num	9	SENT_123	[p10l1555t1766r1644b1813],
8	:	:	O	:	_	0	SENT_123	[p10l1555t1766r1644b1813],
9	704-06	CD	NUMBER	704-06	dep	4	SENT_123	[p10l1665t1767r1891b1813],
10	.	.	O	.	_	0	SENT_123	[p10l1665t1767r1891b1813],

1	5	CD	NUMBER	5	num	3	SENT_124	[p10l11t1851r39b1897],
2	Hallak	NNP	ORGANIZATION	Hallak	nn	3	SENT_124	[p10l111t1849r299b1896],
3	HO	NNP	ORGANIZATION	HO	_	0	SENT_124	[p10l319t1849r443b1906],
4	,	,	O	,	_	0	SENT_124	[p10l319t1849r443b1906],
5	Wedlund	NNP	PERSON	Wedlund	nn	7	SENT_124	[p10l464t1849r730b1897],
6	P	NN	O	p	nn	7	SENT_124	[p10l751t1850r830b1907],
7	]	NN	O	]	appos	3	SENT_124	[p10l751t1850r830b1907],
8	,	,	O	,	_	0	SENT_124	[p10l751t1850r830b1907],
9	Modi	NNP	PERSON	Modi	nn	10	SENT_124	[p10l853t1849r1009b1896],
10	MW	NNP	O	MW	appos	3	SENT_124	[p10l1030t1850r1177b1906],
11	,	,	O	,	_	0	SENT_124	[p10l1030t1850r1177b1906],
12	et	FW	O	et	nn	13	SENT_124	[p10l1202t1860r1251b1896],
13	al.	FW	O	al.	appos	3	SENT_124	[p10l1273t1849r1334b1896],
14	.	.	O	.	_	0	SENT_124	[p10l1273t1849r1334b1896],

1	High	JJ	O	high	amod	2	SENT_125	[p10l1359t1849r1501b1908],
2	clearance	NN	O	clearance	_	0	SENT_125	[p10l1523t1849r1786b1896],
3	of	IN	O	of	prep	2	SENT_125	[p10l1809t1849r1869b1896],

1	(	NN	O	(	nn	2	SENT_126	[p10l117t1925r461b1983],
2	S	NN	O	s	_	0	SENT_126	[p10l117t1925r461b1983],
3	)	SYM	O	)	dep	5	SENT_126	[p10l117t1925r461b1983],
4	-	:	O	-	_	0	SENT_126	[p10l117t1925r461b1983],
5	warfarin	NN	O	warfarin	dep	2	SENT_126	[p10l117t1925r461b1983],
6	resistant	JJ	O	resistant	dep	7	SENT_126	[p10l482t1925r719b1972],
7	subject	NN	O	subject	dep	5	SENT_126	[p10l741t1925r955b1984],
8	.	.	O	.	_	0	SENT_126	[p10l741t1925r955b1984],

1	Brj	NN	O	brj	_	0	SENT_127	[p10l977t1925r1101b1984],
2	‘	CD	NUMBER	‘	num	1	SENT_127	[p10l977t1925r1101b1984],
3	Clin	NNP	O	Clin	nn	4	SENT_127	[p10l1117t1925r1229b1972],
4	Phcmnacol	NNP	O	Phcmnacol	dep	1	SENT_127	[p10l1249t1925r1540b1972],
5	1993	CD	DATE	1993	num	4	SENT_127	[p10l1561t1927r1714b1982],
6	,	,	O	,	_	0	SENT_127	[p10l1561t1927r1714b1982],
7	35	CD	NUMBER	35	num	4	SENT_127	[p10l1741t1926r1829b1972],
8	:	:	O	:	_	0	SENT_127	[p10l1741t1926r1829b1972],
9	327-30	CD	NUMBER	327-30	dep	1	SENT_127	[p10l1852t1927r2078b1972],
10	.	.	O	.	_	0	SENT_127	[p10l1852t1927r2078b1972],

1	6	CD	NUMBER	6	num	4	SENT_128	[p10l12t2011r41b2056],
2	Doecke	NN	O	doecke	nn	4	SENT_128	[p10l112t2009r326b2056],
3	C	NN	O	c	nn	4	SENT_128	[p10l351t2009r437b2067],
4	]	NN	O	]	_	0	SENT_128	[p10l351t2009r437b2067],
5	,	,	O	,	_	0	SENT_128	[p10l351t2009r437b2067],
6	Cosh	NNP	O	Cosh	nn	7	SENT_128	[p10l463t2009r609b2056],
7	DG	NNS	O	dg	appos	4	SENT_128	[p10l630t2009r755b2066],
8	,	,	O	,	_	0	SENT_128	[p10l630t2009r755b2066],
9	Gallus	NNP	PERSON	Gallus	nn	10	SENT_128	[p10l779t2009r960b2056],
10	AS	NNP	O	AS	appos	7	SENT_128	[p10l981t2009r1082b2056],
11	.	.	O	.	_	0	SENT_128	[p10l981t2009r1082b2056],

1	Standardized	JJ	O	standardized	amod	4	SENT_129	[p10l1109t2009r1483b2056],
2	initial	JJ	O	initial	amod	4	SENT_129	[p10l1503t2009r1664b2056],
3	warfarin	NN	O	warfarin	nn	4	SENT_129	[p10l1684t2009r1920b2056],
4	treatment	NN	O	treatment	_	0	SENT_129	[p10l112t2096r404b2133],
5	:	:	O	:	_	0	SENT_129	[p10l112t2096r404b2133],
6	evaluation	NN	O	evaluation	dep	4	SENT_129	[p10l430t2085r722b2133],
7	of	IN	O	of	_	0	SENT_129	[p10l744t2085r804b2133],
8	initial	JJ	O	initial	amod	10	SENT_129	[p10l817t2085r977b2133],
9	treatment	NN	O	treatment	nn	10	SENT_129	[p10l998t2096r1276b2133],
10	response	NN	O	response	prep_of	6	SENT_129	[p10l1296t2101r1542b2145],
11	and	CC	O	and	_	0	SENT_129	[p10l1565t2085r1669b2133],
12	maintenance	NN	O	maintenance	nn	14	SENT_129	[p10l1689t2086r2053b2133],
13	dose	NN	O	dose	nn	14	SENT_129	[p10l113t2161r239b2209],
14	prediction	NN	O	prediction	prep_of	6	SENT_129	[p10l260t2161r552b2220],
15	by	IN	O	by	_	0	SENT_129	[p10l571t2161r640b2220],
16	randomized	VBN	O	randomize	prepc_by	10	SENT_129	[p10l659t2161r997b2209],
17	trial	NN	O	trial	nn	20	SENT_129	[p10l1018t2161r1129b2209],
18	and	CC	O	and	_	0	SENT_129	[p10l1152t2161r1255b2209],
19	risk	NN	O	risk	nn	20	SENT_129	[p10l1276t2161r1378b2209],
20	factors	NNS	O	factor	dobj	16	SENT_129	[p10l1397t2161r1585b2209],
21	for	IN	O	for	_	0	SENT_129	[p10l1607t2161r1687b2209],
22	an	DT	O	a	det	25	SENT_129	[p10l1708t2177r1774b2209],
23	excessive	JJ	O	excessive	amod	25	SENT_129	[p10l1795t2161r2050b2209],
24	warfarin	NN	O	warfarin	nn	25	SENT_129	[p10l110t2237r346b2284],
25	response	NN	O	response	prep_for	20	SENT_129	[p10l366t2252r629b2296],
26	.	.	O	.	_	0	SENT_129	[p10l366t2252r629b2296],

1	Aust	NNP	O	Aust	nn	3	SENT_130	[p10l649t2237r779b2284],
2	NZ	NNP	O	NZ	nn	3	SENT_130	[p10l795t2237r944b2296],
3	}	NNP	O	}	nsubj	4	SENT_130	[p10l795t2237r944b2296],
4	Med	VBD	O	med	_	0	SENT_130	[p10l957t2237r1085b2284],
5	1991	CD	DATE	1991	dobj	4	SENT_130	[p10l1110t2239r1263b2294],
6	,	,	O	,	_	0	SENT_130	[p10l1110t2239r1263b2294],
7	2	CD	NUMBER	2	number	8	SENT_130	[p10l1287t2239r1317b2284],
8	1	CD	NUMBER	1	appos	5	SENT_130	[p10l1328t2239r1376b2284],
9	:	:	O	:	_	0	SENT_130	[p10l1328t2239r1376b2284],
10	319-24	CD	NUMBER	319-24	dep	5	SENT_130	[p10l1396t2239r1622b2284],
11	.	.	O	.	_	0	SENT_130	[p10l1396t2239r1622b2284],

1	7	CD	NUMBER	7	num	3	SENT_131	[p10l11t2323r40b2368],
2	Furuya	NN	PERSON	furuya	nn	3	SENT_131	[p10l111t2322r316b2380],
3	H	NN	O	h	_	0	SENT_131	[p10l337t2322r408b2378],
4	,	,	O	,	_	0	SENT_131	[p10l337t2322r408b2378],
5	Fernandez-Salguero	NN	O	fernandez-salguero	nn	6	SENT_131	[p10l431t2321r1006b2380],
6	P	NN	O	p	appos	3	SENT_131	[p10l1029t2322r1085b2378],
7	,	,	O	,	_	0	SENT_131	[p10l1029t2322r1085b2378],
8	Gregory	NNP	PERSON	Gregory	nn	9	SENT_131	[p10l1109t2321r1343b2380],
9	W	NNP	PERSON	W	appos	3	SENT_131	[p10l1360t2322r1442b2378],
10	,	,	O	,	_	0	SENT_131	[p10l1360t2322r1442b2378],
11	et	FW	O	et	nn	12	SENT_131	[p10l1467t2332r1517b2368],
12	al.	FW	O	al.	appos	3	SENT_131	[p10l1538t2321r1599b2368],
13	.	.	O	.	_	0	SENT_131	[p10l1538t2321r1599b2368],

1	Genetic	JJ	O	genetic	amod	2	SENT_132	[p10l1625t2321r1846b2368],
2	polymorphism	NN	O	polymorphism	_	0	SENT_132	[p10l112t2397r526b2456],
3	of	IN	O	of	_	0	SENT_132	[p10l548t2396r608b2444],
4	CYP2C9	NN	O	cyp2c9	prep_of	2	SENT_132	[p10l624t2397r881b2444],
5	and	CC	O	and	_	0	SENT_132	[p10l907t2397r1010b2444],
6	its	PRP$	O	its	poss	7	SENT_132	[p10l1031t2397r1093b2444],
7	effects	NNS	O	effect	conj_and	2	SENT_132	[p10l1116t2396r1293b2444],
8	on	IN	O	on	_	0	SENT_132	[p10l1316t2412r1387b2444],
9	warfarin	NN	O	warfarin	nn	12	SENT_132	[p10l1406t2396r1642b2444],
10	maintenance	NN	O	maintenance	nn	12	SENT_132	[p10l1663t2397r2026b2444],
11	dose	NN	O	dose	nn	12	SENT_132	[p10l112t2473r238b2521],
12	requirement	NN	O	requirement	prep_on	7	SENT_132	[p10l260t2473r610b2532],
13	in	IN	O	in	_	0	SENT_132	[p10l631t2473r684b2520],
14	patients	NNS	O	patient	prep_in	12	SENT_132	[p10l704t2473r926b2532],
15	undergoing	VBG	O	undergo	partmod	2	SENT_132	[p10l948t2473r1274b2532],
16	anticoagulation	NN	O	anticoagulation	nn	17	SENT_132	[p10l1295t2473r1733b2532],
17	therapy	NN	O	therapy	dobj	15	SENT_132	[p10l1753t2473r1981b2532],
18	.	.	O	.	_	0	SENT_132	[p10l1753t2473r1981b2532],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_133	[p10l111t2549r582b2608],
2	19955	CD	NUMBER	19955	number	3	SENT_133	[p10l610t2551r763b2606],
3	5	CD	NUMBER	5	dep	1	SENT_133	[p10l788t2550r839b2597],
4	:	:	O	:	_	0	SENT_133	[p10l788t2550r839b2597],
5	389-92	CD	NUMBER	389-92	dep	1	SENT_133	[p10l864t2551r1090b2597],
6	.	.	O	.	_	0	SENT_133	[p10l864t2551r1090b2597],

1	8	CD	NUMBER	8	num	3	SENT_134	[p10l12t2635r41b2681],
2	Choonara	NN	ORGANIZATION	choonara	nn	3	SENT_134	[p10l114t2633r395b2681],
3	IA	NN	ORGANIZATION	ia	_	0	SENT_134	[p10l416t2634r503b2690],
4	,	,	O	,	_	0	SENT_134	[p10l416t2634r503b2690],
5	Cholerton	NNP	PERSON	Cholerton	nn	6	SENT_134	[p10l528t2633r817b2681],
6	S	NNP	O	S	appos	3	SENT_134	[p10l840t2633r891b2690],
7	,	,	O	,	_	0	SENT_134	[p10l840t2633r891b2690],
8	Haynes	NNP	ORGANIZATION	Haynes	nn	9	SENT_134	[p10l915t2634r1125b2692],
9	BP	NNP	ORGANIZATION	BP	appos	3	SENT_134	[p10l1148t2634r1249b2690],
10	,	,	O	,	_	0	SENT_134	[p10l1148t2634r1249b2690],
11	Breckenridge	NNP	ORGANIZATION	Breckenridge	nn	12	SENT_134	[p10l1273t2633r1648b2692],
12	AM	NNP	ORGANIZATION	AM	appos	3	SENT_134	[p10l1668t2634r1799b2690],
13	,	,	O	,	_	0	SENT_134	[p10l1668t2634r1799b2690],
14	Park	NNP	O	Park	nn	15	SENT_134	[p10l1822t2633r1953b2680],
15	BK	NNP	O	BK	appos	3	SENT_134	[p10l1973t2634r2083b2680],
16	.	.	O	.	_	0	SENT_134	[p10l1973t2634r2083b2680],

1	Stereoselective	JJ	O	stereoselective	amod	2	SENT_135	[p10l115t2709r532b2756],
2	interaction	NN	O	interaction	_	0	SENT_135	[p10l554t2709r861b2756],
3	between	IN	O	between	_	0	SENT_135	[p10l881t2709r1117b2756],
4	the	DT	O	the	det	7	SENT_135	[p10l1138t2709r1225b2756],
5	R	NN	O	r	nn	7	SENT_135	[p10l1247t2709r1644b2756],
6	—	NN	O	—	nn	7	SENT_135	[p10l1247t2709r1644b2756],
7	enantiomer	NN	O	enantiomer	prep_between	2	SENT_135	[p10l1247t2709r1644b2756],
8	of	IN	O	of	_	0	SENT_135	[p10l1664t2708r1724b2756],
9	warfarin	NN	O	warfarin	prep_of	2	SENT_135	[p10l1736t2708r1972b2756],
10	and	CC	O	and	_	0	SENT_135	[p10l1994t2709r2098b2756],
11	cimetidine	NN	O	cimetidine	conj_and	9	SENT_135	[p10l112t2786r425b2834],
12	.	.	O	.	_	0	SENT_135	[p10l112t2786r425b2834],

1	Br	NN	O	br	nn	4	SENT_136	[p10l451t2787r574b2846],
2	}	CD	NUMBER	}	num	4	SENT_136	[p10l451t2787r574b2846],
3	Clin	NNP	O	Clin	nn	4	SENT_136	[p10l591t2787r702b2834],
4	Pharmacol	NNP	O	Pharmacol	_	0	SENT_136	[p10l722t2787r1013b2834],
5	1986	CD	DATE	1986	dep	4	SENT_136	[p10l1037t2788r1190b2843],
6	;	:	O	;	_	0	SENT_136	[p10l1037t2788r1190b2843],
7	21	CD	NUMBER	21	num	9	SENT_136	[p10l1211t2788r1300b2834],
8	:	:	O	:	_	0	SENT_136	[p10l1211t2788r1300b2834],
9	271-77	CD	NUMBER	271-77	dep	4	SENT_136	[p10l1322t2788r1549b2834],
10	.	.	O	.	_	0	SENT_136	[p10l1322t2788r1549b2834],

1	9	CD	NUMBER	9	num	3	SENT_137	[p10l10t2872r40b2918],
2	Kaminsky	NNP	ORGANIZATION	Kaminsky	nn	3	SENT_137	[p10l111t2870r399b2930],
3	LS	NN	ORGANIZATION	l	_	0	SENT_137	[p10l418t2871r517b2927],
4	,	,	O	,	_	0	SENT_137	[p10l418t2871r517b2927],
5	Zhang	NNP	PERSON	Zhang	nn	6	SENT_137	[p10l540t2870r723b2930],
6	Z-Y	NNP	O	Z-Y	appos	3	SENT_137	[p10l743t2871r871b2918],
7	.	.	O	.	_	0	SENT_137	[p10l743t2871r871b2918],

1	Human	JJ	O	human	amod	3	SENT_138	[p10l897t2871r1115b2918],
2	P450	NN	O	p450	nn	3	SENT_138	[p10l1136t2871r1283b2918],
3	metabolism	NN	O	metabolism	_	0	SENT_138	[p10l1305t2870r1636b2918],
4	of	IN	O	of	_	0	SENT_138	[p10l1658t2870r1718b2918],
5	Warfarin	NNP	O	Warfarin	prep_of	3	SENT_138	[p10l1730t2870r1981b2918],
6	.	.	O	.	_	0	SENT_138	[p10l1730t2870r1981b2918],

1	Pharmacol	NNP	O	Pharmacol	nn	2	SENT_139	[p10l111t2946r402b2994],
2	Ther	NNP	O	Ther	_	0	SENT_139	[p10l425t2946r547b2994],
3	1997	CD	DATE	1997	num	2	SENT_139	[p10l568t2948r721b3003],
4	;	:	O	;	_	0	SENT_139	[p10l568t2948r721b3003],
5	73	CD	NUMBER	73	num	7	SENT_139	[p10l749t2948r836b2994],
6	:	:	O	:	_	0	SENT_139	[p10l749t2948r836b2994],
7	67-74	CD	NUMBER	67-74	dep	2	SENT_139	[p10l860t2948r1049b2994],
8	.	.	O	.	_	0	SENT_139	[p10l860t2948r1049b2994],

1	10	CD	NUMBER	10	num	2	SENT_140	[p10l15t3033r77b3079],
2	Stubbins	NNS	ORGANIZATION	stubbin	_	0	SENT_140	[p10l114t3031r363b3079],
3	M	NN	ORGANIZATION	m	nn	4	SENT_140	[p10l385t3032r489b3089],
4	]	NN	O	]	dep	2	SENT_140	[p10l385t3032r489b3089],
5	,	,	O	,	_	0	SENT_140	[p10l385t3032r489b3089],
6	Harries	NNP	ORGANIZATION	Harries	nn	7	SENT_140	[p10l513t3031r721b3079],
7	LW	NNP	ORGANIZATION	LW	appos	4	SENT_140	[p10l744t3032r869b3088],
8	,	,	O	,	_	0	SENT_140	[p10l744t3032r869b3088],
9	Smith	NNP	PERSON	Smith	nn	10	SENT_140	[p10l894t3031r1063b3079],
10	G	NNP	O	G	appos	4	SENT_140	[p10l1085t3031r1153b3088],
11	,	,	O	,	_	0	SENT_140	[p10l1085t3031r1153b3088],
12	Tarbit	NNP	O	Tarbit	nn	13	SENT_140	[p10l1175t3031r1358b3079],
13	MH	NNP	O	MH	appos	4	SENT_140	[p10l1378t3032r1515b3088],
14	,	,	O	,	_	0	SENT_140	[p10l1378t3032r1515b3088],
15	Wolf	NNP	PERSON	Wolf	nn	16	SENT_140	[p10l1537t3031r1684b3079],
16	CR	NN	O	cr	appos	4	SENT_140	[p10l1700t3031r1809b3079],
17	.	.	O	.	_	0	SENT_140	[p10l1700t3031r1809b3079],

1	Genetic	JJ	O	genetic	amod	2	SENT_141	[p10l1835t3031r2057b3079],
2	analysis	NN	O	analysis	_	0	SENT_141	[p10l114t3107r330b3166],
3	of	IN	O	of	_	0	SENT_141	[p10l353t3106r414b3154],
4	the	DT	O	the	det	9	SENT_141	[p10l426t3107r513b3154],
5	human	JJ	O	human	amod	9	SENT_141	[p10l534t3107r734b3154],
6	cytochrome	NN	O	cytochrome	nn	9	SENT_141	[p10l756t3107r1088b3166],
7	P450	NN	O	p450	nn	9	SENT_141	[p10l1110t3107r1257b3154],
8	CYP2C9	NN	O	cyp2c9	nn	9	SENT_141	[p10l1282t3107r1540b3154],
9	locus	NN	O	locus	prep_of	2	SENT_141	[p10l1563t3107r1724b3154],
10	.	.	O	.	_	0	SENT_141	[p10l1563t3107r1724b3154],

1	Pharrnacogenetics	NNS	O	pharrnacogenetic	_	0	SENT_142	[p10l111t3184r583b3243],
2	19965	CD	NUMBER	19965	number	3	SENT_142	[p10l610t3185r763b3240],
3	6	CD	NUMBER	6	dep	1	SENT_142	[p10l787t3185r839b3231],
4	:	:	O	:	_	0	SENT_142	[p10l787t3185r839b3231],
5	429-39	CD	NUMBER	429-39	dep	1	SENT_142	[p10l863t3185r1090b3231],
6	.	.	O	.	_	0	SENT_142	[p10l863t3185r1090b3231],

1	11	CD	NUMBER	11	num	3	SENT_143	[p10l16t3269r73b3314],
2	Rettie	NN	ORGANIZATION	rettie	nn	3	SENT_143	[p10l113t3268r281b3315],
3	AE	NN	ORGANIZATION	ae	_	0	SENT_143	[p10l301t3268r409b3324],
4	,	,	O	,	_	0	SENT_143	[p10l301t3268r409b3324],
5	Wienkers	NNPS	ORGANIZATION	Wienkers	nn	6	SENT_143	[p10l430t3267r697b3315],
6	LC	NNP	ORGANIZATION	LC	appos	3	SENT_143	[p10l719t3268r830b3324],
7	,	,	O	,	_	0	SENT_143	[p10l719t3268r830b3324],
8	Gonzalez	NNP	PERSON	Gonzalez	nn	10	SENT_143	[p10l854t3267r1117b3315],
9	F	NN	O	f	nn	10	SENT_143	[p10l1138t3268r1219b3325],
10	]	NN	O	]	appos	3	SENT_143	[p10l1138t3268r1219b3325],
11	,	,	O	,	_	0	SENT_143	[p10l1138t3268r1219b3325],
12	Trager	NNP	PERSON	Trager	nn	13	SENT_143	[p10l1242t3268r1436b3327],
13	WF	NNP	PERSON	WF	appos	3	SENT_143	[p10l1454t3268r1579b3324],
14	,	,	O	,	_	0	SENT_143	[p10l1454t3268r1579b3324],
15	Korzekwa	NNP	LOCATION	Korzekwa	nn	16	SENT_143	[p10l1603t3267r1887b3315],
16	KR	NNP	LOCATION	KR	appos	3	SENT_143	[p10l1908t3268r2021b3315],
17	.	.	O	.	_	0	SENT_143	[p10l1908t3268r2021b3315],

1	Impaired	JJ	O	impaired	amod	3	SENT_144	[p10l111t3343r371b3402],
2	S-Warfarin	NN	O	s-warfarin	nn	3	SENT_144	[p10l394t3343r690b3391],
3	metabolism	NN	O	metabolism	nsubj	4	SENT_144	[p10l710t3343r1042b3390],
4	catalyzed	VBN	O	catalyze	_	0	SENT_144	[p10l1064t3343r1323b3402],
5	by	IN	O	by	_	0	SENT_144	[p10l1343t3343r1412b3402],
6	Rl44C	NN	O	rl44c	prep_by	4	SENT_144	[p10l1432t3343r1634b3391],
7	allelic	JJ	O	allelic	amod	8	SENT_144	[p10l1659t3343r1819b3390],
8	Variant	JJ	O	variant	amod	6	SENT_144	[p10l1839t3343r2036b3391],
9	of	IN	O	of	_	0	SENT_144	[p10l2058t3343r2118b3390],
10	CYP2C9	NN	O	cyp2c9	prep_of	6	SENT_144	[p10l115t3419r390b3466],
11	.	.	O	.	_	0	SENT_144	[p10l115t3419r390b3466],

1	Phcmnacogenetics	NNS	O	phcmnacogenetic	_	0	SENT_145	[p10l413t3419r888b3478],
2	1994	CD	DATE	1994	num	1	SENT_145	[p10l917t3421r1070b3476],
3	;	:	O	;	_	0	SENT_145	[p10l917t3421r1070b3476],
4	4	CD	NUMBER	4	num	6	SENT_145	[p10l1093t3421r1146b3466],
5	:	:	O	:	_	0	SENT_145	[p10l1093t3421r1146b3466],
6	39-42	CD	NUMBER	39-42	dep	1	SENT_145	[p10l1170t3421r1360b3466],
7	.	.	O	.	_	0	SENT_145	[p10l1170t3421r1360b3466],

1	12	CD	NUMBER	12	_	0	SENT_146	[p11l15t21r77b66],
2	Haining	NNP	ORGANIZATION	Haining	nn	3	SENT_146	[p11l112t19r343b78],
3	RL	NNP	ORGANIZATION	RL	dep	1	SENT_146	[p11l363t20r469b76],
4	,	,	O	,	_	0	SENT_146	[p11l363t20r469b76],
5	Hunter	NNP	O	Hunter	nn	6	SENT_146	[p11l493t20r701b66],
6	AP	NNP	O	AP	appos	3	SENT_146	[p11l719t20r824b76],
7	,	,	O	,	_	0	SENT_146	[p11l719t20r824b76],
8	Veronese	NNP	O	Veronese	nn	9	SENT_146	[p11l846t20r1108b66],
9	ME	NNP	O	ME	appos	3	SENT_146	[p11l1130t20r1256b76],
10	,	,	O	,	_	0	SENT_146	[p11l1130t20r1256b76],
11	Trager	NNP	PERSON	Trager	nn	12	SENT_146	[p11l1278t20r1474b78],
12	WF	NNP	PERSON	WF	appos	3	SENT_146	[p11l1491t20r1616b76],
13	,	,	O	,	_	0	SENT_146	[p11l1491t20r1616b76],
14	Rettie	NNP	O	Rettie	nn	15	SENT_146	[p11l1640t19r1808b66],
15	AE	NNP	O	AE	appos	3	SENT_146	[p11l1828t20r1934b66],
16	.	.	O	.	_	0	SENT_146	[p11l1828t20r1934b66],

1	Allelic	JJ	O	allelic	_	0	SENT_147	[p11l1957t19r2137b66],

1	Variants	NNS	O	variant	_	0	SENT_148	[p11l111t95r333b142],
2	of	IN	O	of	_	0	SENT_148	[p11l356t94r417b142],
3	human	JJ	O	human	amod	6	SENT_148	[p11l428t95r629b142],
4	cytochrome	NN	O	cytochrome	nn	6	SENT_148	[p11l651t95r983b154],
5	P450	NN	O	p450	nn	6	SENT_148	[p11l1005t95r1151b142],
6	2C9	NN	O	2c9	prep_of	1	SENT_148	[p11l1176t95r1311b142],
7	:	:	O	:	_	0	SENT_148	[p11l1176t95r1311b142],
8	baculovirus	NN	O	baculovirus	nn	9	SENT_148	[p11l1335t95r1954b142],
9	—	NN	O	—	dep	1	SENT_148	[p11l1335t95r1954b142],
10	mediated	VBN	O	mediate	partmod	9	SENT_148	[p11l1335t95r1954b142],
11	expression	NN	O	expression	nn	12	SENT_148	[p11l114t171r411b230],
12	puriﬁcation	NN	O	puriﬁcation	dobj	10	SENT_148	[p11l431t171r778b230],
13	,	,	O	,	_	0	SENT_148	[p11l431t171r778b230],
14	structural	JJ	O	structural	amod	15	SENT_148	[p11l803t171r1074b219],
15	characterization	NN	O	characterization	conj_and	12	SENT_148	[p11l1097t171r1567b228],
16	,	,	O	,	_	0	SENT_148	[p11l1097t171r1567b228],
17	substrate	NN	O	substrate	nn	18	SENT_148	[p11l1591t171r1845b219],
18	stereoselectivity	NN	O	stereoselectivity	dobj	10	SENT_148	[p11l113t247r561b306],
19	and	CC	O	and	_	0	SENT_148	[p11l582t247r685b294],
20	prochiral	JJ	O	prochiral	amod	21	SENT_148	[p11l705t247r961b306],
21	selectivity	NN	O	selectivity	dobj	10	SENT_148	[p11l983t247r1261b306],
22	of	IN	O	of	_	0	SENT_148	[p11l1282t247r1342b294],
23	the	DT	O	the	det	24	SENT_148	[p11l1355t247r1442b294],
24	wild-type	JJ	O	wild-type	prep_of	21	SENT_148	[p11l1462t247r1728b306],
25	and	CC	O	and	_	0	SENT_148	[p11l1751t247r1854b294],
26	I359L	NN	O	i359l	nn	28	SENT_148	[p11l1875t248r2054b294],
27	mutant	JJ	O	mutant	amod	28	SENT_148	[p11l111t333r318b370],
28	forms	NNS	O	form	prep_of	21	SENT_148	[p11l338t322r515b370],
29	.	.	O	.	_	0	SENT_148	[p11l338t322r515b370],

1	Arch	NNP	O	Arch	nn	3	SENT_149	[p11l538t323r671b370],
2	Biochem	NNP	O	Biochem	nn	3	SENT_149	[p11l690t323r918b370],
3	Biophys	NNP	O	Biophys	_	0	SENT_149	[p11l938t323r1152b382],
4	1996	CD	DATE	1996	num	3	SENT_149	[p11l1179t324r1332b379],
5	;	:	O	;	_	0	SENT_149	[p11l1179t324r1332b379],
6	333	CD	NUMBER	333	num	8	SENT_149	[p11l1354t325r1478b370],
7	:	:	O	:	_	0	SENT_149	[p11l1354t325r1478b370],
8	447-58	CD	NUMBER	447-58	dep	3	SENT_149	[p11l1498t325r1725b370],
9	.	.	O	.	_	0	SENT_149	[p11l1498t325r1725b370],

1	13	CD	NUMBER	13	num	3	SENT_150	[p11l15t409r75b454],
2	Crespi	NNP	ORGANIZATION	Crespi	nn	3	SENT_150	[p11l114t407r297b466],
3	CL	NN	ORGANIZATION	cl	_	0	SENT_150	[p11l320t407r429b463],
4	,	,	O	,	_	0	SENT_150	[p11l320t407r429b463],
5	Miller	NNP	PERSON	Miller	nn	6	SENT_150	[p11l452t407r627b454],
6	VP	NNP	O	VP	appos	3	SENT_150	[p11l645t407r748b454],
7	.	.	O	.	_	0	SENT_150	[p11l645t407r748b454],

1	The	DT	O	the	det	3	SENT_151	[p11l772t407r888b454],
2	R144C	JJ	O	r144c	amod	3	SENT_151	[p11l910t407r1113b454],
3	change	NN	O	change	nsubj	10	SENT_151	[p11l1137t407r1334b466],
4	in	IN	O	in	_	0	SENT_151	[p11l1356t407r1409b453],
5	the	DT	O	the	det	9	SENT_151	[p11l1430t407r1517b454],
6	CYP2C9	NN	O	cyp2c9	nn	9	SENT_151	[p11l1540t405r1869b454],
7	*	NN	O	*	nn	9	SENT_151	[p11l1540t405r1869b454],
8	2	CD	NUMBER	2	num	9	SENT_151	[p11l1540t405r1869b454],
9	allele	NN	O	allele	prep_in	3	SENT_151	[p11l1893t407r2035b454],
10	alters	VBZ	O	alter	_	0	SENT_151	[p11l114t483r263b531],
11	interaction	NN	O	interaction	dobj	10	SENT_151	[p11l285t483r592b531],
12	of	IN	O	of	_	0	SENT_151	[p11l614t483r674b531],
13	the	DT	O	the	det	15	SENT_151	[p11l687t483r774b531],
14	cytochrome	NN	O	cytochrome	nn	15	SENT_151	[p11l797t483r1129b542],
15	P450	NN	O	p450	prep_of	11	SENT_151	[p11l1151t484r1298b531],
16	with	IN	O	with	_	0	SENT_151	[p11l1320t483r1443b531],
17	NADPH	NN	O	nadph	prep_with	15	SENT_151	[p11l1462t483r2074b542],
18	:	:	O	:	_	0	SENT_151	[p11l1462t483r2074b542],
19	cytochrome	NN	O	cytochrome	nn	21	SENT_151	[p11l1462t483r2074b542],
20	P450	NN	O	p450	nn	21	SENT_151	[p11l112t560r259b607],
21	oxidoreductase	NN	O	oxidoreductase	dep	11	SENT_151	[p11l283t559r727b607],
22	.	.	O	.	_	0	SENT_151	[p11l283t559r727b607],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_152	[p11l753t559r1225b618],
2	19975	CD	NUMBER	19975	number	3	SENT_152	[p11l1250t561r1403b616],
3	7	CD	NUMBER	7	dep	1	SENT_152	[p11l1428t562r1479b607],
4	:	:	O	:	_	0	SENT_152	[p11l1428t562r1479b607],
5	203-10	CD	NUMBER	203-10	dep	1	SENT_152	[p11l1503t561r1730b607],
6	.	.	O	.	_	0	SENT_152	[p11l1503t561r1730b607],

1	14	CD	NUMBER	14	num	3	SENT_153	[p11l15t645r77b690],
2	Steward	NN	O	steward	nn	3	SENT_153	[p11l113t643r343b691],
3	D	NN	O	d	_	0	SENT_153	[p11l365t644r458b701],
4	]	CD	NUMBER	]	dep	3	SENT_153	[p11l365t644r458b701],
5	,	,	O	,	_	0	SENT_153	[p11l365t644r458b701],
6	Haining	NNP	ORGANIZATION	Haining	nn	7	SENT_153	[p11l481t643r712b702],
7	RL	NNP	ORGANIZATION	RL	appos	4	SENT_153	[p11l732t644r838b700],
8	,	,	O	,	_	0	SENT_153	[p11l732t644r838b700],
9	Henne	NNP	PERSON	Henne	nn	10	SENT_153	[p11l862t644r1053b690],
10	KR	NNP	O	KR	appos	4	SENT_153	[p11l1074t644r1189b700],
11	,	,	O	,	_	0	SENT_153	[p11l1074t644r1189b700],
12	et	FW	O	et	nn	13	SENT_153	[p11l1213t654r1263b690],
13	al.	FW	O	al.	appos	4	SENT_153	[p11l1285t643r1345b690],
14	.	.	O	.	_	0	SENT_153	[p11l1285t643r1345b690],

1	Genetic	JJ	O	genetic	amod	2	SENT_154	[p11l1372t643r1593b691],
2	association	NN	O	association	_	0	SENT_154	[p11l1616t643r1926b691],
3	between	IN	O	between	_	0	SENT_154	[p11l110t719r347b766],
4	sensitivity	NN	O	sensitivity	prep_between	2	SENT_154	[p11l368t719r648b778],
5	to	TO	O	to	_	0	SENT_154	[p11l667t729r721b766],
6	warfarin	NN	O	warfarin	prep_to	2	SENT_154	[p11l743t718r978b766],
7	and	CC	O	and	_	0	SENT_154	[p11l1001t719r1104b766],
8	expression	NN	O	expression	prep_to	2	SENT_154	[p11l1126t719r1423b778],
9	of	IN	O	of	_	0	SENT_154	[p11l1445t718r1506b766],
10	CYP2C9	NN	O	cyp2c9	prep_of	2	SENT_154	[p11l1521t717r1866b766],
11	*	CD	NUMBER	*	number	12	SENT_154	[p11l1521t717r1866b766],
12	3	CD	NUMBER	3	num	10	SENT_154	[p11l1521t717r1866b766],
13	.	.	O	.	_	0	SENT_154	[p11l1521t717r1866b766],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_155	[p11l111t795r583b854],
2	19975	CD	NUMBER	19975	number	3	SENT_155	[p11l610t797r763b852],
3	7	CD	NUMBER	7	dep	1	SENT_155	[p11l789t798r839b843],
4	:	:	O	:	_	0	SENT_155	[p11l789t798r839b843],
5	361-67	CD	NUMBER	361-67	dep	1	SENT_155	[p11l864t797r1089b843],
6	.	.	O	.	_	0	SENT_155	[p11l864t797r1089b843],

1	15	CD	NUMBER	15	num	3	SENT_156	[p11l16t881r76b927],
2	Daly	NNP	ORGANIZATION	Daly	nn	3	SENT_156	[p11l113t879r248b938],
3	AK	NNP	ORGANIZATION	AK	_	0	SENT_156	[p11l266t880r383b936],
4	,	,	O	,	_	0	SENT_156	[p11l266t880r383b936],
5	Steen	NNP	PERSON	Steen	nn	6	SENT_156	[p11l408t879r565b927],
6	VM	NNP	O	VM	appos	3	SENT_156	[p11l584t880r713b936],
7	,	,	O	,	_	0	SENT_156	[p11l584t880r713b936],
8	Fairbrother	NNP	PERSON	Fairbrother	nn	9	SENT_156	[p11l736t879r1065b927],
9	KS	NN	O	k	appos	3	SENT_156	[p11l1085t879r1191b936],
10	,	,	O	,	_	0	SENT_156	[p11l1085t879r1191b936],
11	Idle	NNP	O	Idle	nn	12	SENT_156	[p11l1214t879r1322b927],
12	JR.	NNP	O	JR.	appos	3	SENT_156	[p11l1340t880r1428b937],
13	.	.	O	.	_	0	SENT_156	[p11l1340t880r1428b937],

1	CYPZD6	NN	O	cypzd6	_	0	SENT_157	[p11l1455t879r1717b927],
2	multiallelism	NN	O	multiallelism	dep	1	SENT_157	[p11l1740t879r2123b927],
3	.	.	O	.	_	0	SENT_157	[p11l1740t879r2123b927],

1	Methods	NNS	O	method	_	0	SENT_158	[p11l110t955r339b1002],
2	Enzym0l19965	NN	O	enzym0l19965	dep	1	SENT_158	[p11l358t955r774b1014],
3	272	CD	NUMBER	272	num	2	SENT_158	[p11l800t957r925b1003],
4	:	:	O	:	_	0	SENT_158	[p11l800t957r925b1003],
5	199-210	CD	NUMBER	199-210	dep	1	SENT_158	[p11l949t957r1206b1003],
6	.	.	O	.	_	0	SENT_158	[p11l949t957r1206b1003],

1	16	CD	NUMBER	16	num	3	SENT_159	[p11l15t1041r76b1087],
2	Wang	NNP	PERSON	Wang	nn	3	SENT_159	[p11l112t1040r281b1098],
3	S-L	NNP	O	S-L	_	0	SENT_159	[p11l302t1039r423b1096],
4	,	,	O	,	_	0	SENT_159	[p11l302t1039r423b1096],
5	Huang	NNP	PERSON	Huang	nn	6	SENT_159	[p11l446t1040r641b1098],
6	J-D	NNP	PERSON	J-D	appos	3	SENT_159	[p11l657t1040r778b1097],
7	,	,	O	,	_	0	SENT_159	[p11l657t1040r778b1097],
8	Lai	NNP	PERSON	Lai	nn	9	SENT_159	[p11l801t1039r893b1087],
9	M-D	NNP	O	M-D	appos	3	SENT_159	[p11l914t1040r1075b1096],
10	,	,	O	,	_	0	SENT_159	[p11l914t1040r1075b1096],
11	Tsai	NNP	PERSON	Tsai	nn	12	SENT_159	[p11l1098t1039r1222b1087],
12	J-J	NNP	PERSON	J-J	appos	3	SENT_159	[p11l1238t1040r1326b1097],
13	.	.	O	.	_	0	SENT_159	[p11l1238t1040r1326b1097],

1	Detection	NN	O	detection	nsubj	5	SENT_160	[p11l1351t1039r1633b1086],
2	of	IN	O	of	_	0	SENT_160	[p11l1655t1039r1715b1086],
3	CYPZC9	NN	O	cypzc9	nn	4	SENT_160	[p11l1731t1039r1988b1087],
4	polymorphism	NN	O	polymorphism	prep_of	1	SENT_160	[p11l112t1115r526b1174],
5	based	VBN	O	base	_	0	SENT_160	[p11l546t1115r708b1162],
6	on	IN	O	on	_	0	SENT_160	[p11l729t1130r800b1162],
7	the	DT	O	the	det	10	SENT_160	[p11l820t1115r907b1162],
8	polymerase	NN	O	polymerase	nn	10	SENT_160	[p11l927t1115r1249b1174],
9	chain	NN	O	chain	nn	10	SENT_160	[p11l1272t1115r1424b1162],
10	reaction	NN	O	reaction	prep_on	5	SENT_160	[p11l1444t1115r1674b1162],
11	in	IN	O	in	_	0	SENT_160	[p11l1695t1115r1748b1162],
12	Chinese	NNP	MISC	Chinese	prep_in	10	SENT_160	[p11l1771t1115r2010b1162],
13	.	.	O	.	_	0	SENT_160	[p11l1771t1115r2010b1162],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_161	[p11l111t1192r583b1251],
2	19955	CD	NUMBER	19955	number	3	SENT_161	[p11l611t1193r764b1248],
3	5	CD	NUMBER	5	dep	1	SENT_161	[p11l789t1193r839b1239],
4	:	:	O	:	_	0	SENT_161	[p11l789t1193r839b1239],
5	37-42	CD	NUMBER	37-42	dep	1	SENT_161	[p11l865t1193r1054b1239],
6	.	.	O	.	_	0	SENT_161	[p11l865t1193r1054b1239],

1	17	CD	NUMBER	17	npadvmod	2	SENT_162	[p11l16t1277r76b1322],
2	Anonymous	JJ	O	anonymous	_	0	SENT_162	[p11l111t1276r472b1334],
3	.	.	O	.	_	0	SENT_162	[p11l111t1276r472b1334],

1	How	WRB	O	how	advmod	3	SENT_163	[p11l498t1276r637b1323],
2	to	TO	O	to	aux	3	SENT_163	[p11l656t1286r710b1323],
3	anticoagulate	VB	O	anticoagulate	_	0	SENT_163	[p11l734t1275r1126b1335],
4	.	.	O	.	_	0	SENT_163	[p11l734t1275r1126b1335],

1	Drug	NN	O	drug	nn	3	SENT_164	[p11l1150t1276r1291b1335],
2	Ther	NNP	O	Ther	nn	3	SENT_164	[p11l1314t1276r1436b1323],
3	Bull	NNP	O	Bull	_	0	SENT_164	[p11l1451t1276r1568b1323],
4	1992	CD	DATE	1992	num	3	SENT_164	[p11l1591t1277r1744b1332],
5	;	:	O	;	_	0	SENT_164	[p11l1591t1277r1744b1332],
6	30	CD	NUMBER	30	num	8	SENT_164	[p11l1768t1277r1856b1323],
7	:	:	O	:	_	0	SENT_164	[p11l1768t1277r1856b1323],
8	77-80	CD	NUMBER	77-80	dep	3	SENT_164	[p11l1877t1277r2066b1323],
9	.	.	O	.	_	0	SENT_164	[p11l1877t1277r2066b1323],

1	THE	DT	O	the	det	2	SENT_165	[p11l87t1438r153b1459],
2	LANCET	NN	O	lancet	_	0	SENT_165	[p11l163t1438r292b1459],
3	-	:	O	-	_	0	SENT_165	[p11l302t1445r309b1452],
4	Vol	NN	O	vol	dep	2	SENT_165	[p11l319t1438r362b1459],
5	353	CD	NUMBER	353	num	4	SENT_165	[p11l373t1438r418b1459],
6	-	:	O	-	_	0	SENT_165	[p11l429t1445r437b1452],
7	February	NNP	DATE	February	dep	4	SENT_165	[p11l446t1438r562b1464],
8	27	CD	DATE	27	num	7	SENT_165	[p11l571t1438r609b1463],
9	,	,	DATE	,	_	0	SENT_165	[p11l571t1438r609b1463],
10	1999	CD	DATE	1999	num	7	SENT_165	[p11l622t1438r681b1459],
11	719	CD	NUMBER	719	dep	7	SENT_165	[p11l2011t1433r2069b1459],

